View Filing Data

5,478

3,759

Long-term marketable investments

3,595

3,123

Other current assets

164

147

Total current assets

16,039

12,457

^[1]

473

617

Property, plant, and equipment

23,672

19,431

Intangible assets

331

387

Deferred tax assets

1,022

766

Goodwill

1,228

Other noncurrent assets

611

450

Total assets

43,376

35,336

Liabilities and equity

Accounts payable and accrued expenses

4,611

3,664

Deferred income

284

408

Total current liabilities

859

1,262

5,754

5,334

Other noncurrent liabilities

3,777

9,872

581

639

Total liabilities

10,112

15,845

Commitments and contingencies

Redeemable convertible notes

Redeemable noncontrolling interest

Micron shareholders' equity

Common stock, $0.10 par value, 3,000 shares authorized, 1,170 shares issued and 1,161 outstanding (1,116 shares issued and 1,112 outstanding as of August 31, 2017)

117

112

Additional capital

8,201

8,287

Retained earnings

24,395

10,260

Treasury stock, 9 shares held (4 shares as of August 31, 2017)

(429)

(67)

Accumulated other comprehensive income

Total Micron shareholders' equity

32,294

18,621

Noncontrolling interests in subsidiaries

870

849

Total equity

33,164

19,470

Total liabilities and equity

$ 43,376

$ 35,336

[1]	The maturities of long-term marketable securities range from one to four years.

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares shares in Millions	Aug. 30, 2018	Aug. 31, 2017
Liabilities and equity
Common Stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common Stock, authorized shares (in shares)	3,000	3,000
Common Stock, issued (in shares)	1,170	1,116
Common Stock, outstanding (in shares)	1,161	1,112
Treasury Stock, held (in shares)	9	4

STATEMENT OF CHANGES IN EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Total Micron Shareholders' Equity	Noncontrolling Interests in Subsidiaries
Balance (in shares) at Sep. 03, 2015		1,084
Balance at Sep. 03, 2015	$ 13,239	$ 108	$ 7,474	$ 5,588	$ (881)	$ 13	$ 12,302	$ 937
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(275)			(276)			(276)	1
Other comprehensive income (loss), net	(48)					(48)	(48)	0
Stock issued under stock plans (in shares)		11
Stock issued under stock plans	48	$ 1	47				48
Stock-based compensation expense	191		191				191
Contributions from noncontrolling interests	37						0	37
Distributions to noncontrolling interests	(34)						0	(34)
Acquisitions of noncontrolling interests	(93)						0	(93)
Repurchase and retirement of stock (in shares)		(1)
Repurchase and retirement of stock	(23)	$ 0	(10)	(13)			(23)
Repurchase of treasury stock	(125)				(125)		(125)
Settlement of capped calls	0		23		(23)		0
Reclassification of redeemable convertible notes, net	49		49				49
Conversion and repurchase of convertible notes	(38)		(38)				(38)
Balance (in shares) at Sep. 01, 2016		1,094
Balance at Sep. 01, 2016	12,928	$ 109	7,736	5,299	(1,029)	(35)	12,080	848
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	5,090			5,089			5,089	1
Other comprehensive income (loss), net	64					64	64	0
Stock issued under stock plans (in shares)		20
Stock issued under stock plans	142	$ 3	139				142
Stock-based compensation expense	215		217	(2)			215
Repurchase and retirement of stock (in shares)		(2)
Repurchase and retirement of stock	(35)	$ 0	(13)	(22)			(35)
Stock issued to Nanya for Inotera Acquisition (in shares)		4
Stock issued to Nanya for Inotera Acquisition	995	$ 0	70				995
Treasury stock issued to Nanya for Inotera Acquisition				(104)	1,029
Settlement of capped calls	125		192		(67)		125
Reclassification of redeemable convertible notes, net	(21)		(21)				(21)
Conversion and repurchase of convertible notes	$ (33)		(33)				(33)
Balance (in shares) at Aug. 31, 2017	1,116	1,116
Balance at Aug. 31, 2017	$ 19,470	$ 112	8,287	10,260	(67)	29	18,621	849
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	14,138			14,135			14,135	3
Other comprehensive income (loss), net	(19)					(19)	(19)	0
Stock issued in public offering (in shares)		34
Stock issued in public offering	1,366	$ 3	1,363				1,366
Stock issued under stock plans (in shares)		22
Stock issued under stock plans	289	$ 2	287				289
Stock-based compensation expense	198		198				198
Contributions from noncontrolling interests	18						0	18
Repurchase and retirement of stock (in shares)		(2)
Repurchase and retirement of stock	(71)	$ 0	(71)				(71)
Settlement of capped calls	0		429		(429)		0
Reclassification of redeemable convertible notes, net	18		18				18
Conversion and repurchase of convertible notes	$ (2,243)		(2,310)				(2,243)
Decrease in treasury stock due to reissuance of treasury shares					67
Balance (in shares) at Aug. 30, 2018	1,170	1,170
Balance at Aug. 30, 2018	$ 33,164	$ 117	$ 8,201	$ 24,395	$ (429)	$ 10	$ 32,294	$ 870

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Cash flows from operating activities
Net income (loss)	$ 14,138	$ 5,090	$ (275)
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Depreciation expense and amortization of intangible assets	4,759	3,861	2,980
Amortization of debt discount and other costs	101	125	126
Loss on debt prepayments, repurchases, and conversions	385	99	4
Stock-based compensation	198	215	191
Gain on remeasurement of previously-held equity interest in Inotera	0	(71)	0
Change in operating assets and liabilities
Receivables	(1,734)	(1,651)	465
Inventories	(472)	50	(549)
Accounts payable and accrued expenses	549	564	272
Payments attributed to intercompany balances with Inotera	0	(361)	0
Deferred income taxes, net	(265)	(22)	(15)
Other	(259)	254	(31)
Net cash provided by operating activities	17,400	8,153	3,168
Cash flows from investing activities
Expenditures for property, plant, and equipment	(8,879)	(4,734)	(5,817)
Purchases of available-for-sale securities	(760)	(1,239)	(1,026)
Payments to settle hedging activities	(185)	(274)	(152)
Acquisition of Inotera	0	(2,634)	0
Proceeds from sales of available-for-sale securities	604	776	2,314
Proceeds from government incentives	355	21	16
Proceeds from maturities of available-for-sale securities	320	194	1,376
Proceeds from settlement of hedging activities	163	184	335
Other	166	169	(90)
Net cash provided by (used for) investing activities	(8,216)	(7,537)	(3,044)
Cash flows from financing activities
Repayments of debt	(10,194)	(2,558)	(870)
Payments on equipment purchase contracts	(206)	(519)	(46)
Proceeds from issuance of stock	1,655	142	48
Proceeds from issuance of debt	1,009	3,311	2,199
Proceeds from equipment sale-leaseback transactions	0	0	765
Other	(40)	(27)	(351)
Net cash provided by (used for) financing activities	(7,776)	349	1,745
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash	(37)	(12)	19
Net increase in cash, cash equivalents, and restricted cash	1,371	953	1,888
Cash, cash equivalents, and restricted cash at beginning of period	5,216	4,263	2,375
Cash, cash equivalents, and restricted cash at end of period	6,587	5,216	4,263
Supplemental disclosures
Income taxes paid, net	(226)	(99)	(90)
Interest paid, net of amounts capitalized	(312)	(468)	(267)
Noncash investing and financing activity
Equipment acquisitions on contracts payable and capital leases	$ 84	$ 813	$ 993

Significant Accounting Policies	12 Months Ended
Significant Accounting Policies	Aug. 30, 2018
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Basis of Presentation: Micron Technology, Inc., including its consolidated subsidiaries, is an industry leader in innovative memory and storage solutions. Through our global brands – Micron, Crucial, and Ballistix – our broad portfolio of high-performance memory and storage technologies, including DRAM, NAND, NOR Flash, and 3D XPoint memory, is transforming how the world uses information to enrich life. Backed by 40 years of technology leadership, our memory and storage solutions enable disruptive trends, including artificial intelligence, machine learning, and autonomous vehicles, in key market segments like cloud, data center, networking, and mobile. The accompanying consolidated financial statements include the accounts of Micron and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America. Certain reclassifications have been made to prior period amounts to conform to current period presentation. Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2018, 2017, and 2016 each contained 52 weeks. All period references are to our fiscal periods unless otherwise indicated. Derivative and Hedging Instruments: We use derivative instruments to manage our exposure to changes in currency exchange rates from (1) our monetary assets and liabilities denominated in currencies other than the U.S. dollar and (2) forecasted cash flows for certain capital expenditures. Derivative instruments are measured at their fair values and recognized as either assets or liabilities. The accounting for changes in the fair value of derivative instruments is based on the intended use of the derivative and the resulting designation. For derivative instruments that are not designated for hedge accounting, gains or losses from changes in fair values are recognized in other non-operating income (expense). For derivative instruments designated as cash flow hedges, the effective portion of the realized and unrealized gains or losses on derivatives is included as a component of accumulated other comprehensive income. Amounts in accumulated other comprehensive income are reclassified into earnings in the same line items and in the same periods in which the underlying transactions affect earnings. For the periods presented prior to the second quarter of 2018, the ineffective and excluded portion of the realized and unrealized gain or loss was included in other non-operating income (expense). As a result of adopting Accounting Standards Update ("ASU") 2017-12, beginning in the second quarter of 2018, such amounts are included in the same line item in which the underlying transactions affect earnings. For derivative forward contracts designated as fair value hedges, hedge effectiveness is determined by the change in the fair value of the undiscounted spot rate of the forward contract. The changes in fair values of hedge instruments attributed to changes in undiscounted spot rates are recognized in other non-operating income (expense). The time value associated with hedge instruments is excluded from the assessment of the effectiveness of hedges and is recognized on a straight-line basis over the life of hedges to other non-operating income (expense). We enter into master netting arrangements with our counterparties to mitigate credit risk in derivative hedge transactions. These master netting arrangements allow us and our counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled with each counterparty have been presented in our consolidated balance sheet on a net basis. Financial Instruments: Cash equivalents include highly liquid short-term investments with original maturities to us of three months or less that are readily convertible to known amounts of cash. Other investments with remaining maturities of less than one year are included in short-term investments. Investments with remaining maturities greater than one year are included in long-term marketable investments. The carrying value of investment securities sold is determined using the specific identification method. Functional Currency: The U.S. dollar is the functional currency for us and all of our consolidated subsidiaries. Goodwill and Non-Amortizing Intangible Assets: We perform an annual impairment assessment for goodwill and non-amortizing intangible assets in the fourth quarter of our fiscal year. Government Incentives: We receive incentives from governmental entities related to expenses, assets, and other activities. Our government incentives may require that we meet or maintain specified spending levels and other operational metrics and may be subject to reimbursement if such conditions are not met or maintained. Government incentives are recorded in the financial statements in accordance with their purpose: as a reduction of expenses, a reduction of asset costs, or other income. Incentives related to specific operating activities are offset against the related expense in the period the expense is incurred. Incentives related to the acquisition or construction of fixed assets are recognized as a reduction in the carrying amounts of the related assets and reduce depreciation expense over the useful lives of the assets. Other incentives are recognized as other operating income. Government incentives received prior to being earned are recognized in current or noncurrent deferred income, whereas government incentives earned prior to being received are recognized in current or noncurrent receivables. Cash received from government incentives related to operating expenses are included as an operating activity in the statement of cash flows, whereas cash received from incentives related to the acquisition of property, plant, and equipment are included as an investing activity. Inventories: Inventories are stated at the lower of average cost or net realizable value. Cost includes depreciation, labor, material, and overhead costs, including product and process technology costs. Determining net realizable value of inventories involves numerous judgments, including projecting future average selling prices, sales volumes, and costs to complete products in work in process inventories. When net realizable value is below cost, we record a charge to cost of goods sold to write down inventories to their estimated net realizable value in advance of when inventories are actually sold. We review the major characteristics of product type and markets in determining the unit of account for which we perform the lower of average cost or net realizable value analysis and categorize inventories primarily as memory (including DRAM, NAND, and other memory). We remove amounts from inventory and charge such amounts to cost of goods sold on an average cost basis. Product and Process Technology: Costs incurred to (1) acquire product and process technology, (2) patent technology, and (3) maintain patent technology, are capitalized and amortized on a straight-line basis over periods ranging up to 12.5 years. We capitalize a portion of the costs incurred to patent technology based on historical data of patents issued as a percent of patents we file. Capitalized product and process technology costs are amortized over the shorter of (1) the estimated useful life of the technology, (2) the patent term, or (3) the term of the technology agreement. Fully-amortized assets are removed from product and process technology and accumulated amortization. Product Warranty: We generally provide a limited warranty that our products are in compliance with applicable specifications existing at the time of delivery. Under our standard terms and conditions of sale, liability for certain failures of product during a stated warranty period is usually limited to repair or replacement of defective items or return of, or a credit with respect to, amounts paid for such items. Under certain circumstances, we provide more extensive limited warranty coverage than that provided under our standard terms and conditions. Our warranty obligations are not material. Property, Plant, and Equipment: Property, plant, and equipment is stated at cost and depreciated using the straight-line method over estimated useful lives of generally 10 to 30 years for buildings, 5 to 7 years for equipment, and 3 to 5 years for software. Assets held for sale are carried at the lower of cost or estimated fair value and are included in other noncurrent assets. When property, plant, or equipment is retired or otherwise disposed, the net book value is removed and we recognize any gain or loss in results of operations. We capitalize interest on borrowings during the period of time we carry out the activities necessary to bring assets to the condition of their intended use and location. Capitalized interest becomes part of the cost of assets. We periodically assess the estimated useful lives of our property, plant, and equipment. In the fourth quarter of 2016, we revised the estimated useful lives of equipment in our DRAM wafer fabrication facilities from five to seven years as a result of the lengthening period of time between DRAM product technology node transitions, an increased re-use rate of equipment, and industry trends. The effect of the revision reduced depreciation expense at the time by approximately $100 million per quarter. Research and Development: Costs related to the conceptual formulation and design of products and processes are charged to R&D expense as incurred. Development of a product is deemed complete when it is qualified through reviews and tests for performance and reliability. Subsequent to product qualification, product costs are included in cost of goods sold. Product design and other R&D costs for certain technologies may be shared with a development partner. Amounts receivable from cost-sharing arrangements are reflected as a reduction of R&D expense. Revenue Recognition: We recognize product or license revenue when persuasive evidence that a sales arrangement exists, delivery has occurred, the price is fixed or determinable, and collectibility is reasonably assured, which is generally at the time of shipment to our customers. If we are unable to reasonably estimate returns or the price is not fixed or determinable, sales made under agreements allowing rights of return or price protection are deferred until customers have resold the product. Stock-based Compensation: Stock-based compensation is measured at the grant date, based on the fair value of the award, and recognized as expense under the straight-line attribution method over the requisite service period. We account for forfeitures as they occur. We issue new shares upon the exercise of stock options or conversion of share units. Treasury Stock: Treasury stock is carried at cost. When we retire our treasury stock, any excess of the repurchase price paid over par value is allocated between additional capital and retained earnings. Use of Estimates: The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that we believe to be reasonable under the circumstances. Estimates and judgments may differ under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis. Actual results could differ from estimates.

Variable Interest Entities	12 Months Ended
Variable Interest Entities	Aug. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	Variable Interest Entities We have interests in entities that are VIEs. If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing, and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments. Unconsolidated VIEs PTI Xi'an: Powertech Technology Inc. Xi'an ("PTI Xi'an") is a wholly-owned subsidiary of Powertech Technology Inc. ("PTI") and was created to provide assembly services to us at our manufacturing site in Xi'an, China. We do not have an equity interest in PTI Xi'an. PTI Xi'an is a VIE because of the terms of its service agreement with us and its dependency on PTI to finance its operations. We have determined that we do not have the power to direct the activities of PTI Xi'an that most significantly impact its economic performance, primarily because we have no governance rights. Therefore, we do not consolidate PTI Xi'an. In connection with our assembly services with PTI, we had capital lease obligations and net property, plant, and equipment of $63 million and $63 million, respectively, as of August 30, 2018 and $80 million and $76 million, respectively, as of August 31, 2017. Consolidated VIE IMFT: IMFT is a VIE because all of its costs are passed to us and its other member, Intel, through product purchase agreements and because IMFT is dependent upon us or Intel for additional cash requirements. The primary activities of IMFT are driven by the constant introduction of product and process technology. Because we perform a significant majority of the technology development, we have the power to direct its key activities. We consolidate IMFT because we have the power to direct the activities of IMFT that most significantly impact its economic performance and because we have the obligation to absorb losses and the right to receive benefits from IMFT that could potentially be significant to it. (See "Equity – Noncontrolling Interests in Subsidiaries – IMFT" note.)

Recently Issued Accounting Standards	12 Months Ended
Recently Issued Accounting Standards	Aug. 30, 2018
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recently Issued Accounting Standards	Recently Issued Accounting Standards In October 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-16 – Intra-Entity Transfers Other Than Inventory, which requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. This ASU will be effective for us in the first quarter of 2019 and requires modified retrospective adoption. We do not anticipate the adoption of this ASU will have a material impact to our financial statements. In June 2016, the FASB issued ASU 2016-13 – Measurement of Credit Losses on Financial Instruments, which requires a financial asset (or a group of financial assets) measured on the basis of amortized cost to be presented at the net amount expected to be collected. This ASU requires that the income statement reflect the measurement of credit losses for newly recognized financial assets as well as the expected increases or decreases of expected credit losses that have taken place during the period. This ASU requires that credit losses of debt securities designated as available-for-sale be recorded through an allowance for credit losses and limits the credit loss to the amount by which fair value is below amortized cost. This ASU will be effective for us in the first quarter of 2021 with adoption permitted as early as the first quarter of 2020. This ASU requires modified retrospective adoption, with prospective adoption for debt securities for which an other-than-temporary impairment had been recognized before the effective date. We are evaluating the timing and effects of our adoption of this ASU on our financial statements. In February 2016, the FASB issued ASU 2016-02 – Leases, which amends a number of aspects of lease accounting, including requiring lessees to recognize operating leases with a term greater than one year on their balance sheet as a right-of- use asset and corresponding liability, measured at the present value of the lease payments. This ASU, as amended, will be effective for us in the first quarter of 2020 with early adoption permitted and allows for either a modified retrospective adoption or a retrospective adoption by recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The adoption of this ASU will result in an increase to our consolidated balance sheets for these right-of-use assets and corresponding liabilities. We are evaluating the timing and other effects of our adoption of this ASU on our financial statements. In January 2016, the FASB issued ASU 2016-01 – Recognition and Measurement of Financial Assets and Financial Liabilities, which provides guidance for the recognition, measurement, presentation, and disclosure of financial assets and liabilities. This ASU will be effective for us in the first quarter of 2019 and requires modified retrospective adoption, with prospective adoption for amendments related to equity securities without readily determinable fair values. Our assets and liabilities subject to this standard are not material. In May 2014, the FASB issued ASU 2014-09 – Revenue from Contracts with Customers, which supersedes nearly all existing revenue recognition guidance under generally accepted accounting principles in the United States. The core principal of this ASU, as amended, is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments, and assets recognized from costs incurred to obtain or fulfill a contract. This ASU is effective for us in the first quarter of 2019 and we expect to elect the modified retrospective adoption method. As a result of the adoption of this ASU, we will recognize revenue from sales of products to our distributors (which generally have agreements allowing rights of return or price protection) at the time control transfers to our distributors, which is generally earlier than recognizing revenue only upon resale by our distributors under existing revenue recognition guidance. Revenue recognized upon resale by our distributors under these arrangements was 19%, 20%, and 25% of our consolidated revenue for the 2018, 2017, and 2016, respectively. As of August 30, 2018, deferred income related to our distributor sales was $232 million. Upon adoption of this ASU, amounts deferred related to our sales to distributors, net of estimated price adjustments, will be recognized as an increase to retained earnings, net of taxes. We will also reclassify certain allowances from accounts receivable to accounts payable and accrued expenses in connection with new presentation requirements of this ASU. The tax effects of the adoption of this ASU will be recorded primarily as a reduction of net deferred tax assets.

Acquisition of Inotera

12 Months Ended

Aug. 30, 2018

Inotera

Business Acquisition [Line Items]

Acquisition of Inotera

Through December 6, 2016, we held a 33% ownership interest in Inotera, now known as MTTW, Nanya and certain of its affiliates held a 32% ownership interest, and the remaining ownership interest was publicly held. On December 6, 2016, we acquired the 67% remaining interest in Inotera not owned by us (the "Inotera Acquisition") and began consolidating Inotera's operating results. The cash paid for the Inotera Acquisition was funded, in part, with proceeds from the 2021 MSTW Term Loan and the sale of the Micron Shares (as defined below) to Nanya. Inotera manufactures DRAM products at its 300mm wafer fabrication facility in Taoyuan City, Taiwan, and previously sold such products exclusively to us through supply agreements. SG&A expenses for 2017 and 2016 included transaction costs of $13 million and $3 million, respectively, incurred in connection with the Inotera Acquisition.

In connection with the Inotera Acquisition, we revalued our previously-held 33% equity interest to its fair value. In determining the fair value, we used various valuation techniques, including the share price of Inotera prior to the announcement of the Inotera Acquisition and discounted cash flow projections using inputs including discount rate and terminal growth rate (Level 3). As a result, we recognized a non-operating gain of $71 million in 2017.

In connection with the Inotera Acquisition, we sold 58 million shares of our common stock to Nanya (the "Micron Shares") and received cash proceeds of $986 million. Because the sale of the Micron Shares to Nanya was contemporaneous with, and contingent upon, the closing of the Inotera Acquisition, the issuance of the Micron Shares was treated in purchase accounting as a non-cash exchange for a portion of the shares of Inotera held by Nanya. The Micron Shares were issued in a transaction exempt from the registration requirements of the Securities Act of 1933, as amended, and were subject to certain restrictions on transfers at the time of sale. To reflect the lack of transferability, the fair value of the Micron Shares (based on the trading price of our common stock on the acquisition date) was reduced by a discount of $81 million, based on the implied volatility derived from traded options on our stock and on the duration of the lack of transferability (Level 2).

The allocation of purchase price to assets acquired and liabilities assumed of Inotera was as follows:



Consideration
Cash paid for Inotera Acquisition	$	4,099
Less cash received from sale of Micron Shares	(986		)
Net cash paid for Inotera Acquisition	3,113
Fair value of our previously-held equity interest in Inotera	1,441
Fair value of Micron Shares exchanged for Inotera shares	995
Other	3
Payments attributed to intercompany balances with Inotera	(361		)
	$	5,191

Assets acquired and liabilities assumed
Cash and equivalents	$	118
Inventories	285
Other current assets	27
Property, plant, and equipment	3,722
Deferred tax assets	82
Goodwill	1,124
Other noncurrent assets	130
Accounts payable and accrued expenses	(232		)
Debt	(56		)
Other noncurrent liabilities	(9		)
	$	5,191

The Inotera Acquisition enhances our flexibility to drive new technology, optimize the deployment of capital, and adapt our product offerings to changes in market conditions. As a result of these synergies, we allocated goodwill of $829 million, $198 million, and $97 million to CNBU, MBU, and EBU, respectively. Goodwill resulting from the Inotera Acquisition is not deductible for Taiwan corporate income tax purposes; however, it is deductible for Taiwan surtax purposes.

Unaudited Pro Forma Financial Information

The following unaudited pro forma financial information presents the combined results of operations as if the Inotera Acquisition had occurred on September 4, 2015. The pro forma financial information includes the accounting effects of the business combination, including adjustments for depreciation of property, plant, and equipment, interest expense, elimination of intercompany activities, and revaluation of inventories. The unaudited pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the Inotera Acquisition occurred on September 4, 2015.



	Year ended
	August 31, 2017		September 1, 2016
Net sales	$	20,317	$	12,341
Net income (loss)	5,172		(543		)
Net income (loss) attributable to Micron	5,171		(544		)
Earnings (loss) per share
Basic	4.68		(0.50		)
Diluted	4.42		(0.50		)

The unaudited pro forma financial information for 2017 includes our results for the year ended August 31, 2017 (which includes the results of Inotera since our acquisition of Inotera on December 6, 2016), the results of Inotera for the three months ended November 30, 2016, and the adjustments described above. The pro forma information for 2016 includes our results for the year ended September 1, 2016, the results of Inotera for the twelve months ended August 31, 2016, and the adjustments described above.

Technology Transfer and License Agreements with Nanya

Effective December 6, 2016, the terms of technology transfer and license agreements provided Nanya with options to require us to transfer to Nanya certain technology for Nanya's use and deliverables related to the next DRAM process node generation after our 20nm process node (the "1X Process Node") and the next DRAM process node generation after the 1X Process Node (the "1Y Process Node"). Nanya's option for the 1X Process Node expired unexercised. If Nanya exercises its right for the 1Y Process Node, Nanya would pay us royalties for a license to the transferred 1Y Process Node technology based on revenues from products utilizing the technology, subject to specified caps, and we would also receive an equity interest in Nanya upon the achievement of certain milestones.

Cash and Investments

12 Months Ended

Aug. 30, 2018

Investments [Abstract]

Cash and Investments

Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows:



As of	2018								2017
	Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value		Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value
Cash	$	3,223	$	—	$	—	$	3,223	$	2,237	$	—	$	—	$	2,237
Level 1⁽²⁾
Money market funds	2,443		—		—		2,443		2,332		—		—		2,332
Level 2⁽³⁾
Corporate bonds	3		172		272		447		—		193		315		508
Certificates of deposit	806		11		2		819		483		24		3		510
Government securities	5		63		103		171		1		90		126		217
Asset-backed securities	—		34		96		130		—		2		173		175
Commercial paper	26		16		—		42		56		10		—		66
	6,506		$	296	$	473	$	7,275	5,109		$	319	$	617	$	6,045
Restricted cash⁽⁴⁾	81								107
Cash, cash equivalents, and restricted cash	$	6,587							$	5,216


⁽¹⁾	The maturities of long-term marketable securities range from one to four years.


⁽²⁾	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.

⁽³⁾

The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of August 30, 2018 or August 31, 2017.

⁽⁴⁾

Restricted cash is included in other noncurrent assets and included balances related to the MMJ Creditor Payments. The restrictions on the MMJ Creditor Payments lapse upon approval by the trustees and/or Tokyo District Court. Restricted cash as of August 31, 2017 also included interest reserve balances related to our 2021 MSTW Term Loan, which were released in 2018 in connection with our prepayment of the 2021 MSTW Term Loan. (See "Debt" note.)

Gross realized gains and losses from sales of available-for-sale securities were not material for any period presented. As of August 30, 2018, there were no available-for-sale securities that had been in a loss position for longer than 12 months.

Receivables

12 Months Ended

Aug. 30, 2018

Receivables [Abstract]



As of	2018		2017
Trade receivables	$	5,056	$	3,490
Income and other taxes	161		100
Other	261		169
	$	5,478	$	3,759

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

Inventories

12 Months Ended

Aug. 30, 2018

Inventory Disclosure [Abstract]

Property, Plant and Equipment [Abstract]



As of	2018		2017
Finished goods	$	815	$	856
Work in process	2,357		1,968
Raw materials and supplies	423		299
	$	3,595	$	3,123

Property, Plant, and Equipment

12 Months Ended

Aug. 30, 2018

Property, Plant, and Equipment



As of	2018			2017
Land	$	345		$	345
Buildings (includes $483 and $475, respectively, under capital leases)	8,680			7,958
Equipment⁽¹⁾ (includes $1,336 and $1,331, respectively, under capital leases)	38,249			32,187
Construction in progress⁽²⁾	1,162			499
Software	655			544
	49,091			41,533
Accumulated depreciation (includes $868 and $626, respectively, under capital leases)	(25,419		)	(22,102		)
	$	23,672		$	19,431


⁽¹⁾	Included costs related to equipment not placed into service of $1.73 billion and $994 million, as of August 30, 2018 and August 31, 2017, respectively.


⁽²⁾	Included building-related construction and tool installation costs for assets not placed into service.

Depreciation expense was $4.66 billion, $3.76 billion, and $2.86 billion for 2018, 2017, and 2016, respectively. As of August 30, 2018, production equipment, buildings, and land with an aggregate carrying value of $2.33 billion were pledged as collateral under various notes payable. Interest capitalized as part of the cost of property, plant, and equipment was $44 million, $7 million, and $43 million for 2018, 2017, and 2016, respectively.

Equity Method Investments

12 Months Ended

Aug. 30, 2018

Equity Method Investments and Joint Ventures [Abstract]

Equity Method Investments

Equity in net income (loss) of equity method investees, net of tax, included the following:



For the year ended	2018			2017			2016
Inotera	$	—		$	9		$	32
Tera Probe	—			(3		)	(11		)
Other	(1		)	2			4
	$	(1	)	$	8		$	25

Inotera

We held a 33% interest in Inotera, a Taiwan DRAM memory company, through December 6, 2016, at which time we acquired the remaining 67% interest in Inotera. From January 2013 through December 2015, we purchased all of Inotera's DRAM output under supply agreements at prices reflecting discounts from market prices for our comparable components. After December 2015 and until our acquisition of the remaining interest in Inotera, the price for DRAM products purchased by us was based on a formula that equally shared margin between Inotera and us. Under these agreements, we purchased $504 million and $1.43 billion of DRAM products in 2017 through the date of our acquisition and 2016, respectively. In 2016, we manufactured and sold specialized equipment to Inotera and recognized net sales of $55 million and margin of $16 million.

Tera Probe

In 2017, we sold our 40% interest in Tera Probe, which provided semiconductor wafer testing and probe services to us, in a transaction that included the sale of our assembly and test facility located in Akita, Japan. In 2017 and 2016, we recorded impairment charges of $16 million and $25 million, respectively, within equity in net income (loss) of equity method investees to write down the carrying value of our investment in Tera Probe to its fair value based on its trading price (Level 1). We incurred manufacturing costs for services performed by Tera Probe of $47 million and $70 million in 2017 through the date of sale and 2016, respectively.

Intangible Assets and Goodwill

12 Months Ended

Aug. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets and Goodwill



As of	2018					2017
	Gross Amount		Accumulated Amortization			Gross Amount		Accumulated Amortization
Amortizing assets
Product and process technology	$	567	$	(344	)	$	756	$	(477	)
Non-amortizing assets
In-process R&D	108		—			108		—

Total intangible assets	$	675	$	(344	)	$	864	$	(477	)

Goodwill	$	1,228				$	1,228

In 2018, 2017, and 2016, we capitalized $48 million, $29 million, and $30 million, respectively, for product and process technology with weighted-average useful lives of 10 years, 11 years, and 10 years, respectively. Expected amortization expense is $55 million for 2019, $38 million for 2020, $33 million for 2021, $23 million for 2022, and $17 million for 2023.

In 2016, we acquired Tidal Systems, Ltd., a developer of PCIe NAND Flash storage controllers, to enhance our NAND Flash controller technology for $148 million. In connection therewith, we recognized $108 million of in-process R&D; $81 million of goodwill, which was derived from expected cost reductions and other synergies and was assigned to SBU; and $41 million of deferred tax liabilities; which, in aggregate, represented substantially all of the purchase price. The in-process R&D was valued using a replacement cost approach, which included inputs of reproduction cost, including developer's profit, and opportunity cost. We expect to begin amortizing the in-process R&D in 2019 and will amortize it over its estimated useful life. The goodwill is not deductible for tax purposes.

Accounts Payable and Accrued Expenses

12 Months Ended

Aug. 30, 2018

Payables and Accruals [Abstract]

Accounts Payable and Accrued Expenses



As of	2018		2017
Accounts payable	$	1,692	$	1,333
Property, plant, and equipment payables	1,238		1,018
Salaries, wages, and benefits	841		603
Income and other taxes	402		163
Customer advances	207		197
Other	231		350
	$	4,611	$	3,664

Debt

12 Months Ended

Aug. 30, 2018

Debt Disclosure [Abstract]

Debt



As of	2018												2017
							Net Carrying Amount								Net Carrying Amount
Instrument	Stated Rate		Effective Rate		Principal		Current		Long-Term		Total⁽¹⁾		Principal		Current		Long-Term		Total⁽¹⁾
IMFT Member Debt	N/A		N/A		$	1,009	$	—	$	1,009	$	1,009	$	—	$	—	$	—	$	—
Capital lease obligations	N/A		3.86	%	845		310		535		845		1,190		357		833		1,190
MMJ Creditor Payments	N/A		9.76	%	520		309		183		492		695		$	157	474		631
2022 Term Loan B	3.83	%	4.24	%	735		5		720		725		743		5		725		730
2025 Notes	5.50	%	5.56	%	519		—		515		515		519		—		515		515
2032D Notes⁽²⁾	3.13	%	6.33	%	143		—		132		132		177		—		159		159
2033F Notes⁽²⁾⁽³⁾	2.13	%	4.93	%	107		235		—		235		297		278		—		278
2043G Notes⁽²⁾⁽⁴⁾	3.00	%	6.76	%	1,019		—		682		682		1,025		—		671		671
2021 MSAC Term Loan	4.42	%	4.65	%	—		—		—		—		800		99		697		796
2021 MSTW Term Loan	2.85	%	3.01	%	—		—		—		—		2,652		—		2,640		2,640
2023 Notes	5.25	%	5.43	%	—		—		—		—		1,000		—		991		991
2023 Secured Notes	7.50	%	7.69	%	—		—		—		—		1,250		—		1,238		1,238
2024 Notes	5.25	%	5.38	%	—		—		—		—		550		—		546		546
2026 Notes	5.63	%	5.73	%	—		—		—		—		129		—		128		128
2032C Notes	2.38	%	5.95	%	—		—		—		—		223		—		211		211
2033E Notes	1.63	%	1.63	%	—		—		—		—		173		202		—		202
Other notes	2.50	%	2.50	%	1		—		1		1		216		164		44		208
					$	4,898	$	859	$	3,777	$	4,636	$	11,639	$	1,262	$	9,872	$	11,134

⁽¹⁾

Net carrying amount is the principal amount less unamortized debt discount and issuance costs. In addition, the net carrying amount as of August 30, 2018 and August 31, 2017 included $132 million and $31 million, respectively, of derivative debt liabilities recognized as a result of our election to settle entirely in cash converted notes with an aggregate principal amount of $35 million and $16 million, respectively.

⁽²⁾

Since the closing price of our common stock exceeded 130% of the conversion price per share for at least 20 trading days in the 30 trading day period ended on June 30, 2018, these notes are convertible by the holders through the calendar quarter ended September 30, 2018. Additionally, the closing price of our common stock also exceeded the thresholds for the calendar quarter ended September 30, 2018; therefore, these notes are convertible by the holders at any time through December 31, 2018.

⁽³⁾

Current debt as of August 30, 2018 included an aggregate of $165 million for the settlement obligation (including principal and amounts in excess of principal) for conversions of our 2033F Notes that will settle in cash in the first quarter of 2019. The remainder of the 2033F Notes were classified as current as of August 30, 2018 because the terms of these notes require us to pay cash for the principal amount of any converted notes and holders of these notes had the right to convert their notes as of that date.


⁽⁴⁾	The 2043G Notes outstanding as of August 30, 2018 have an original principal amount of $815 million that accretes up to $911 million through the expected term in November 2028 and $1.02 billion at maturity in 2043.

Our convertible and other senior notes are unsecured obligations that rank equally in right of payment with all of our other existing and future unsecured indebtedness, and are effectively subordinated to all of our other existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness. As of August 30, 2018, Micron had $1.56 billion of unsecured debt (net of unamortized discount and debt issuance costs), including all of its convertible notes and the 2025 Notes, that was structurally subordinated to all liabilities of its subsidiaries, including trade payables. The terms of our indebtedness generally contain cross payment default and cross acceleration provisions. Micron guarantees certain debt obligations of its subsidiaries, but does not guarantee the MMJ Creditor Payments. Micron's guarantees of its subsidiary debt obligations are unsecured obligations ranking equally in right of payment with all of Micron's other existing and future unsecured indebtedness.

IMFT Member Debt

In 2018, Intel provided debt financing ("IMFT Member Debt") of $1.01 billion to IMFT pursuant to the terms of the IMFT joint venture agreement. IMFT Member Debt is non-interest bearing, matures upon the completion of an auction and sale of assets of IMFT prior to the dissolution, liquidation, or other wind-up of IMFT, and is convertible, at the election of Intel, in whole or in part, into a capital contribution to IMFT. Additionally, to the extent IMFT distributes cash to its members under the terms of the IMFT joint venture agreement, Intel may, at its option, designate any portion of the distribution to be a repayment of the IMFT Member Debt. In the event Intel exercises its right to put its interest in IMFT to us, or if we exercise our right to call from Intel its interest in IMFT, any IMFT Member Debt outstanding at the time of the closing of the put or call transaction will transfer to Micron. (See "Equity – Noncontrolling Interest in Subsidiaries – IMFT" note.)

Capital Lease Obligations

In 2018, we recorded capital lease obligations aggregating $20 million at a weighted-average effective interest rate of 4.6%, with a weighted-average expected term of five years. In 2017, we recorded capital lease obligations aggregating $220 million.

MMJ Creditor Payments

Under the MMJ Companies' corporate reorganization proceedings, which set forth the treatment of the MMJ Companies' pre-petition creditors and their claims, the MMJ Companies were required to pay 200 billion yen, less certain expenses of the reorganization proceedings and other items, to their secured and unsecured creditors in seven annual installment payments (the "MMJ Creditor Payments"). The MMJ Creditor Payments do not provide for interest and, as a result of our acquisition of the MMJ Companies in 2013, we recorded the MMJ Creditor Payments at fair value. The fair-value discount is accreted to interest expense over the term of the installment payments.

Under the MMJ Companies' corporate reorganization proceedings, the secured creditors of MMJ will recover 100% of the amount of their fixed claims in six annual installment payments through October 2018 and the unsecured creditors will recover at least 17.4% of the amount of their fixed claims in seven annual installment payments through December 2019. The remaining portion of the unsecured claims of the creditors of MMJ not recovered pursuant to the corporate reorganization proceedings will be discharged, without payment, through December 2019. The following table presents the remaining amounts of MMJ Creditor Payments (stated in Japanese yen and U.S. dollars) and the amount of unamortized discount as of August 30, 2018:



2019	¥	36,392		$	326
2020	21,720			194
	58,112			520
Less unamortized discount	(3,186		)	(28		)
	¥	54,926		$	492

Pursuant to the terms of an Agreement on Support for Reorganization Companies that we executed in 2012 with the trustees of the MMJ Companies' pending corporate reorganization proceedings, we entered into a series of agreements with the MMJ Companies, including supply agreements, research and development services agreements, and general services agreements, which are intended to generate operating cash flows to meet the requirements of the MMJ Companies' businesses, including the funding of the MMJ Creditor Payments.

2022 Senior Secured Term Loan B

In April 2016, we issued $750 million in principal amount of 2022 Term Loan B notes due April 2022. The 2022 Term Loan B provides for periodic repricing of the interest rates and, as of August 30, 2018, the 2022 Term Loan B generally bears interest at LIBOR plus 1.75%. We may elect to convert outstanding term loan interest to other variable-rate indexes. Principal payments are due quarterly in an amount equal to 0.25% of the initial aggregate principal amount with the balance due at maturity and may be prepaid without penalty. Interest is payable at least quarterly.

The 2022 Term Loan B is collateralized by substantially all of the assets of Micron and MSP, a subsidiary of Micron, subject to certain permitted liens on such assets. Included in our consolidated balance sheet as of August 30, 2018 were $8.32 billion of assets which collateralize these notes. The 2022 Term Loan B is structurally subordinated to the indebtedness and other liabilities of all of Micron's subsidiaries that do not guarantee these debt obligations and is guaranteed by MSP.

The 2022 Term Loan B contains covenants that, among other things, limit, in certain circumstances, the ability of Micron and/or its domestic restricted subsidiaries to (1) create or incur certain liens and enter into sale-leaseback financing transactions; (2) in the case of domestic restricted subsidiaries, create, assume, incur, or guarantee additional indebtedness; and (3) in the case of Micron, consolidate or merge with or into, or sell, assign, convey, transfer, lease, or otherwise dispose of all or substantially all of its assets to another entity. These covenants are subject to a number of limitations, exceptions, and qualifications.

2025 Notes

The 2025 unsecured notes contain covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our domestic restricted subsidiaries (which are generally subsidiaries in the U.S. in which we own at least 80% of the voting stock) to (1) create or incur certain liens and enter into sale and lease-back transactions, (2) create, assume, incur, or guarantee certain additional secured indebtedness and unsecured indebtedness of our domestic restricted subsidiaries, and (3) consolidate with or merge with or into, or convey, transfer or lease all or substantially all of our assets, to another entity. These covenants are subject to a number of limitations, exceptions, and qualifications.

Cash Redemption at Our Option: Prior to August 1, 2019, we may redeem the 2025 Notes, in whole or in part, at a price equal to the principal amount of the 2025 Notes to be redeemed plus a make-whole premium as described in the indenture governing the 2025 Notes, together with accrued and unpaid interest. On or after August 1, 2019, we may redeem the 2025 Notes, in whole or in part, at prices above the principal amount that decline over time, as specified in the indenture, together with accrued and unpaid interest.

Convertible Senior Notes



	Holder Put Date⁽¹⁾	Maturity Date	Conversion Price Per Share		Conversion Price Per Share Threshold⁽²⁾		Underlying Shares of Common Stock	Conversion Value in Excess of Principal⁽³⁾		Principal Settlement Option⁽⁴⁾
2032D Notes	May 2021	May 2032	$	9.98	$	12.97	14	$	615	Cash and/or shares
2033F Notes⁽⁵⁾	Feb 2020	Feb 2033	10.93		14.21		10	408		Cash
2043G Notes	Nov 2028	Nov 2043	29.16		37.91		35	824		Cash and/or shares
							59	$	1,847


⁽¹⁾	Debt discount and debt issuance costs are amortized through the earliest holder put date.


⁽²⁾	Represents 130% of the conversion price per share. If the trading price of our common stock exceeds such threshold for a specified period, holders may convert such notes during a specified period. See "Conversion Rights" below.


⁽³⁾	Based on the trading price of our common stock of $52.76 as of August 30, 2018.

⁽⁴⁾

It is our current intent to settle in cash the principal amount of our convertible notes upon conversion. As a result, only the amounts payable in excess of the principal amounts upon conversion of our convertible notes are considered in diluted earnings per share under the treasury stock method. For each of our convertible notes, we may elect to settle any amounts in excess of the principal in cash, shares of our common stock, or a combination thereof.


⁽⁵⁾	Holders may put their notes to us on February 15, 2023.

Conversion Rights: Holders of our convertible notes may convert their notes under the following circumstances: (1) if the notes are called for redemption; (2) during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price (see "Conversion Price Per Share Threshold" in the table above); (3) if the trading price of the notes is less than 98% of the product of the closing price of our common stock and the conversion rate of the notes during the periods specified in the indentures; (4) if specified distributions or corporate events occur, as set forth in the indenture for the notes; or (5) during the last three months prior to the maturity date of the notes. For the calendar quarter ended September 30, 2018, the closing price of our common stock exceeded 130% of the conversion price for each series of our convertible notes; therefore, those notes are convertible by the holders through December 31, 2018.

In August 2018, holders of our 2033F Notes with an aggregate principal amount of $35 million converted their notes, which were settled in cash the first quarter of 2019. As a result of our election to settle all amounts due upon conversion in cash for these notes, such settlement obligations became derivative debt liabilities in 2018 subject to mark-to-market accounting treatment based on the volume-weighted-average price of our common stock over a period of 20 consecutive trading days. Accordingly, at the dates of our elections to settle the conversions in cash, we reclassified the fair values of the equity components of each of the converted notes from additional capital to derivative debt liabilities within current debt in our consolidated balance sheet. The net carrying amount for 2018 included $132 million for the fair values of the derivative debt liabilities as of August 30, 2018. The 20 consecutive trading day period ended in the first quarter of 2019, and we settled the conversion for $153 million in cash.

Cash Redemption at Our Option: We may redeem our convertible notes under the circumstances listed in the table below. The redemption price for the notes will equal the principal amount at maturity, or the accreted principal amount in the case of the 2043G Notes redeemed on or after November 20, 2018, plus accrued and unpaid interest.



	Conditional Redemption Period at Our Option⁽¹⁾	Unconditional Redemption Period at Our Option	Redemption Period Requiring Make-Whole
2032D Notes	On or after May 1, 2017	On or after May 4, 2021	Prior to May 4, 2021⁽²⁾
2033F Notes	N/A	On or after Feb 20, 2020	N/A
2043G Notes	Prior to Nov 20, 2018	On or after Nov 20, 2018	Prior to Nov 20, 2018⁽³⁾


⁽¹⁾	We may redeem for cash on or after the applicable dates if the volume weighted average price of our common stock has been at least 130% of the conversion price for at least 20 trading days during any 30 consecutive trading day period.


⁽²⁾	If we redeem prior to the applicable date, we will pay a make-whole premium in cash equal to the present value of the remaining scheduled interest payments from the redemption date to May 4, 2021.


⁽³⁾	If we redeem prior to the applicable date, we will be required to pay a make-whole premium only if, as a result of our redemption notice, holders convert their notes. The make-whole premium will be based on the price of our common stock and the conversion date, as set forth in the indenture, and is payable at our election in cash and/or shares.

Cash Repurchase at the Option of the Holders: We may be required by the holders of our convertible notes to repurchase for cash all or a portion of the notes on the "Holder Put Date" listed in the table above. The repurchase price would equal the principal amount, or the accreted principal amount in the case of the 2043G Notes, plus accrued and unpaid interest. Also, upon a change in control or a termination of trading, as defined in the respective indentures, holders of our convertible notes may require us to repurchase for cash all or a portion of their notes.

Other: Interest expense for our convertible notes consisted of contractual interest of $44 million, $51 million, and $51 million for 2018, 2017, and 2016, respectively, and amortization of discount and issuance costs of $32 million, $37 million, and $36 million for 2018, 2017, and 2016, respectively. As of August 30, 2018 and August 31, 2017, the carrying amounts of the equity components of our convertible notes, which are included in additional capital in the accompanying consolidated balance sheets, were $208 million and $287 million, respectively.

Available Revolving Credit Facility

On August 9, 2018, we terminated our undrawn revolving credit facility scheduled to expire in February 2020, under which we were able draw up to the lesser of $750 million or 80% of the net outstanding balance of certain trade receivables.

On July 3, 2018, we entered into a revolving credit facility that expires in July 2023, under which we can draw up to $2.00 billion. Borrowings under the facility will generally bear interest, at a rate equal to LIBOR plus 1.25% to 2.00%, depending on our corporate credit ratings or leverage ratio. Any amounts drawn are collateralized by substantially all of the assets of Micron and MSP, a subsidiary of Micron, subject to certain permitted liens. Additionally, any amounts drawn are pari passu with the 2022 Term Loan B and are structurally subordinated to the indebtedness and other liabilities of all of Micron's subsidiaries that do not guarantee these debt obligations, and is guaranteed by MSP. As of August 30, 2018, there were no outstanding amounts drawn under this facility. We may suspend the security interest in the collateral under the facility upon achieving specified credit ratings and repayment of the 2022 Term Loan B; however, the security interest will be automatically reinstated upon a decline in our corporate credit rating.

Under the terms of the revolving credit agreement, we must maintain a ratio calculated as of the last day of each fiscal quarter of total indebtedness to adjusted EBITDA not to exceed 2.75 to 1.00. We must also maintain a ratio of adjusted EBITDA to net interest expense of not less than 3.50 to 1.00. The facility contains other covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our restricted subsidiaries to (1) create or incur certain liens and enter into sale and lease-back transactions, (2) create, assume, incur, or guarantee certain additional secured indebtedness and unsecured indebtedness of our restricted subsidiaries, and (3) consolidate with or merge with or into, or convey, transfer, lease, or otherwise dispose of all or substantially all of our assets, to another entity. These covenants are subject to a number of limitations, exceptions, and qualifications.

Debt Prepayments, Repurchases, and Conversions

During 2018, we prepaid, repurchased, and settled conversions of debt with an aggregate principal amount of $6.96 billion. When we receive a notice of conversion for any of our convertible notes and elect to settle in cash any amount of the conversion obligation in excess of the principal amount, the cash settlement obligations become derivative debt liabilities subject to mark-to-market accounting treatment based on the volume-weighted-average price of our common stock over a period of 20 consecutive trading days. Accordingly, at the date of our election to settle a conversion in cash, we reclassify the fair value of the equity component of the converted notes from additional capital to derivative debt liability within current debt in our consolidated balance sheet.

The following table presents the effects of prepayments, repurchases, and conversions of debt in 2018:



	Decrease in Principal			Increase (Decrease) in Carrying Value			Decrease in Cash			Decrease in Equity			Gain (Loss)
Prepayments and repurchases
2021 MSAC Term Loan	$	(730	)	$	(727	)	$	(730	)	$	—		$	(3	)
2021 MSTW Term Loan	(2,625		)	(2,616		)	(2,625		)	—			(10		)
2023 Notes	(1,000		)	(991		)	(1,046		)	—			(55		)
2023 Secured Notes	(1,250		)	(1,238		)	(1,373		)	—			(135		)
2024 Notes	(550		)	(546		)	(572		)	—			(25		)
2026 Notes	(129		)	(129		)	(139		)	—			(11		)
2033F Notes	(66		)	(63		)	(316		)	(252		)	(1		)
Other Notes	(46		)	(44		)	(46		)	—			(2		)
Settled conversions
2032C Notes	(223		)	(216		)	(1,230		)	(965		)	(50		)
2032D Notes	(34		)	(31		)	(182		)	(145		)	(6		)
2033E Notes⁽¹⁾	(173		)	(203		)	(552		)	(297		)	(52		)
2033F Notes	(124		)	(118		)	(596		)	(462		)	(16		)
2043G Notes	(6		)	(4		)	(13		)	(5		)	(4		)
Conversions not settled
2033F Notes⁽²⁾	—			132			—			(117		)	(15		)
	$	(6,956	)	$	(6,794	)	$	(9,420	)	$	(2,243	)	$	(385	)


⁽¹⁾	Settlement included issuance of 4 million shares of our treasury stock in addition to payment of cash.


⁽²⁾	As of August 30, 2018, an aggregate of $35 million principal amount of our 2033F Notes (with a carrying value of $165 million) had converted but not settled. These notes settled in the first quarter of 2019 for $153 million in cash.

In 2017, we repurchased $631 million of principal amount of our 2025 Notes (carrying value of $625 million), repurchased $321 million of principal amount of our 2026 Notes (carrying value of $318 million), and redeemed $600 million principal amount of our 2022 Notes (carrying value of $592 million) for an aggregate of $1.63 billion in cash. In connection with the transactions, we recognized aggregate non-operating losses of $94 million in 2017.

In 2016, we repurchased $57 million of principal amount of our 2033E Notes (carrying value of $54 million) for $94 million in cash. The liability and equity components of the repurchased notes had previously been stated separately within debt and equity in our consolidated balance sheet. As a result, the repurchase decreased the carrying value of debt by $54 million and equity by $38 million.

Maturities of Notes Payable and Future Minimum Lease Payments

As of August 30, 2018, maturities of notes payable (including the MMJ Creditor Payments) and future minimum lease payments under capital lease obligations were as follows:



	Notes Payable			Capital Lease Obligations
2019	$	501		$	339
2020	274			231
2021	151			100
2022	713			66
2023	—			42
2024 and thereafter	2,439			187
Unamortized discounts and interest, respectively	(287		)	(120		)
	$	3,791		$	845

Commitments

12 Months Ended

Aug. 30, 2018

Commitments and Contingencies Disclosure [Abstract]

Commitments

As of August 30, 2018, we had commitments of approximately $1.8 billion for the acquisition of property, plant, and equipment. We lease certain facilities and equipment under operating leases, for which expense was $63 million, $52 million, and $46 million for 2018, 2017, and 2016, respectively. Minimum future operating lease commitments as of August 30, 2018 were as follows:



2019	$	37
2020	43
2021	50
2022	50
2023	45
2024 and thereafter	391
	$	616

Contingencies	12 Months Ended
Contingencies	Aug. 30, 2018
Loss Contingency [Abstract]
Contingencies	Contingencies We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which is expected to have a material adverse effect on our business, results of operations, or financial condition. Patent Matters As is typical in the semiconductor and other high-tech industries, from time to time, others have asserted, and may in the future assert, that our products or manufacturing processes infringe upon their intellectual property rights. On November 21, 2014, Elm 3DS Innovations, LLC ("Elm") filed a patent infringement action against Micron, MSP, and Micron Consumer Products Group, Inc. in the U.S. District Court for the District of Delaware. On March 27, 2015, Elm filed an amended complaint against the same entities. The amended complaint alleges that unspecified semiconductor products of ours that incorporate multiple stacked die infringe 13 U.S. patents and seeks damages, attorneys' fees, and costs. On December 15, 2014, Innovative Memory Solutions, Inc. ("IMS") filed a patent infringement action against Micron in the U.S. District Court for the District of Delaware. The complaint alleges that a variety of our NAND products infringe eight U.S. patents and seeks damages, attorneys' fees, and costs. On July 23, 2018, IMS served a patent infringement complaint on Micron Semiconductor (Deutschland) GmbH and Micron Europe Limited alleging that products including our SSDs infringe a European patent. The complaint seeks unspecified damages and an order forbidding Micron Semiconductor (Deutschland) GmbH and Micron Europe Limited from offering to sell, using, and importing the accused products. On August 31, 2018, Micron was served with a complaint filed by IMS in Shenzhen Intermediate People's Court in Guangdong Province, China. The complaint alleges that certain of our NAND flash products infringe a Chinese patent. The complaint seeks an order requiring Micron to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of 1 million Chinese yuan plus expenses. On June 24, 2016, the President and Fellows of Harvard University filed a patent infringement action against Micron in the U.S. District Court for the District of Massachusetts. The complaint alleged that a variety of our DRAM products infringed two U.S. patents and sought damages, injunctive relief, and other unspecified relief. On March 1, 2018, we executed a settlement agreement resolving this litigation. The settlement amount did not have a material effect on our business, results of operations, or financial condition. On March 19, 2018, Micron Semiconductor (Xi’an) Co., Ltd. ("MXA") was served with a patent infringement complaint filed by Fujian Jinhua Integrated Circuit Co., Ltd. ("Jinhua") in the Fuzhou Intermediate People’s Court in Fujian Province, China (the "Fuzhou Court"). On April 3, 2018, Micron Semiconductor (Shanghai) Co. Ltd. ("MSS") was served with the same complaint. The complaint alleges that MXA and MSS infringe a Chinese patent by manufacturing and selling certain Crucial DDR4 DRAM modules. The complaint seeks an order requiring MXA and MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of 98 million Chinese yuan plus court fees incurred. On March 21, 2018, MXA was served with a patent infringement complaint filed by United Microelectronics Corporation ("UMC") in the Fuzhou Court. On April 3, 2018, MSS was served with the same complaint. The complaint alleges that MXA and MSS infringe a Chinese patent by manufacturing and selling certain Crucial DDR4 DRAM modules. The complaint seeks an order requiring MXA and MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of 90 million Chinese yuan plus court fees incurred. On April 3, 2018, MSS was served with another patent infringement complaint filed by Jinhua and two additional complaints filed by UMC in the Fuzhou Court. The three additional complaints allege that MSS infringes three Chinese patents by manufacturing and selling certain Crucial MX300 SSDs and certain GDDR5 memory chips. The two complaints filed by UMC each seek an order requiring MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of 90 million Chinese yuan plus court fees incurred. The complaint filed by Jinhua seeks an order requiring MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of 98 million Chinese yuan plus court fees incurred. On October 9, 2018, UMC withdrew its complaint that alleged MSS infringed a Chinese patent by manufacturing and selling certain GDDR5 memory chips. On July 5, 2018, MXA and MSS were notified that the Fuzhou Court granted a preliminary injunction against those entities that enjoins them from manufacturing, selling, or importing certain Crucial and Ballistic-branded DRAM modules and solid-state drives in China. The affected products make up slightly more than 1% of our annualized revenues. We are complying with the ruling and have requested the Fuzhou Court to reconsider or stay its decision. Among other things, the above lawsuits pertain to substantially all of our DRAM, NAND, and other memory and storage products we manufacture, which account for a significant portion of our net sales. We are unable to predict the outcome of assertions of infringement made against us and therefore cannot estimate the range of possible loss. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing could have a material adverse effect on our business, results of operations, or financial condition. Qimonda On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda's insolvency proceedings, filed suit against Micron and Micron Semiconductor B.V., our Netherlands subsidiary ("Micron B.V."), in the District Court of Munich, Civil Chamber. The complaint seeks to void, under Section 133 of the German Insolvency Act, a share purchase agreement between Micron B.V. and Qimonda signed in fall 2008, pursuant to which Micron B.V. purchased substantially all of Qimonda's shares of Inotera (the "Inotera Shares"), representing approximately 18% of Inotera's outstanding shares as of August 30, 2018, and seeks an order requiring us to re-transfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate, under Sections 103 or 133 of the German Insolvency Code, a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement. Following a series of hearings with pleadings, arguments, and witnesses on behalf of the Qimonda estate, on March 13, 2014, the court issued judgments: (1) ordering Micron B.V. to pay approximately $1 million in respect of certain Inotera Shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on the Inotera Shares and all other benefits; (4) denying Qimonda's claims against Micron for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda's obligations under the patent cross-license agreement are canceled. In addition, the court issued interlocutory judgments ordering, among other things: (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by Micron B.V. and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by Micron B.V. from ownership of the Inotera Shares. The interlocutory judgments have no immediate, enforceable effect on us, and, accordingly, we expect to be able to continue to operate with full control of the Inotera Shares subject to further developments in the case. We have filed a notice of appeal, and the parties have submitted briefs to the appeals court. We are unable to predict the outcome of the matter and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera Shares or monetary damages, unspecified damages based on the benefits derived by Micron B.V. from the ownership of the Inotera Shares, and/or the termination of the patent cross-license, which could have a material adverse effect on our business, results of operation, or financial condition. Antitrust Matters On April 27, 2018, a purported class-action lawsuit was filed against Micron and other DRAM suppliers in the U.S. District Court for the Northern District of California asserting claims based on alleged price-fixing of DRAM products during the period from June 1, 2016 to February 1, 2018. Similar cases were subsequently filed in federal court in the United States, as well as in Canadian courts in Quebec, Montreal and Toronto, Ontario. The complaints seek treble monetary damages, costs, interest, attorneys' fees, and other injunctive and equitable relief. We are unable to predict the outcome of these matters and therefore cannot estimate the range of possible loss. The final resolution of these matters could result in significant liability and could have a material adverse effect on our business, results of operations, or financial condition. On May 15, 2018, the Chinese State Administration for Market Regulation ("SAMR") notified Micron that it was investigating potential collusion among DRAM suppliers in China. On May 31, 2018, SAMR made unannounced visits to our sales offices in Beijing, Shanghai, and Shenzhen to seek certain information as part of its investigation. We are cooperating with SAMR in its investigation. Other On December 5, 2017, Micron filed a complaint against UMC and Jinhua in the U.S. District Court for the Northern District of California. The complaint alleges that UMC and Jinhua violated the Defend Trade Secrets Act, the civil provisions of the Racketeer Influenced and Corrupt Organizations Act, and California's Uniform Trade Secrets Act by misappropriating Micron's trade secrets and other misconduct. Micron's complaint seeks damages, restitution, disgorgement of profits, injunctive relief, and other appropriate relief. In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations, or financial condition.

Redeemable Convertible Notes	12 Months Ended
Redeemable Convertible Notes	Aug. 30, 2018
Temporary Equity [Abstract]
Redeemable Convertible Notes	Redeemable Convertible Notes Under the terms of the indentures governing our 2033 Notes, upon conversion, we would be required to pay cash equal to the lesser of (1) the aggregate principal amount or (2) the conversion value of the notes being converted. To the extent the conversion value exceeds the principal amount, we could pay cash, shares of common stock, or a combination thereof, at our option, for the amount of such excess. The closing price of our common stock met the threshold for conversion and our 2033 Notes were convertible by their holders as of August 30, 2018 and August 31, 2017. As a result, the balance of these notes was classified as current debt and the difference between the principal amount and the carrying value was classified as redeemable convertible notes in the accompanying consolidated balance sheet.

Redeemable Noncontrolling Interest	12 Months Ended
Redeemable Noncontrolling Interest	Aug. 30, 2018
Noncontrolling Interest [Abstract]
Redeemable Noncontrolling Interest	Redeemable Noncontrolling Interest Redeemable noncontrolling interest reflects 100,000 preferred shares authorized and issued by Micron Semiconductor Asia Operations Pte. Ltd., a subsidiary of Micron, in August 2018 for proceeds, net of issuance related costs, of $97 million, which are redeemable by the holders after August 29, 2028. The preferred shareholders are entitled to a cumulative fixed dividend of 7.75% per annum, which is reflected in net income attributable to noncontrolling interests, and a liquidation preference senior to the entity's common shares. We have the right to reacquire the preferred shares during the period beginning August 31, 2020 through August 29, 2026.

Equity

12 Months Ended

Aug. 30, 2018

Equity [Abstract]

Equity

Micron Shareholders' Equity

Common Stock Repurchase Authorization: In May 2018, we announced that our Board of Directors had authorized the discretionary repurchase of up to $10 billion of our outstanding common stock beginning in 2019. We may purchase shares on a discretionary basis through open-market purchases, block trades, privately-negotiated transactions, derivative transactions, and/or pursuant to a Rule 10b5-1 trading plan, subject to market conditions and our ongoing determination of the best use of available cash. The repurchase authorization does not obligate us to acquire any common stock.

Accelerated Share Repurchase: On August 10, 2018, we entered into an accelerated share repurchase ("ASR") agreement with a financial institution to purchase $1.00 billion of our common stock under our common stock repurchase authorization. The number of shares purchased will be calculated by dividing $1.00 billion by a volume-weighted average price of our common stock from September 5, 2018 through as late as November 29, 2018 (the "Measurement Period"), subject to an agreed-upon discount. On September 5, 2018, we paid $1.00 billion to the financial institution and received an initial installment of 14 million shares, equal to $750 million divided by the closing price of our common stock on September 4, 2018. Based on the final number of shares purchased at the end of the Measurement Period, we will either receive an incremental number of shares, or settle any amount owed to the financial institution in either cash or shares, at our option. In the first quarter of 2019, we recorded the initial shares as treasury stock. The second installment is treated as an equity-linked contract indexed to our stock and therefore qualifies for equity accounting.

Other Repurchases: From August 31, 2018 through October 12, 2018, we repurchased an aggregate of 15 million shares of our common stock for an aggregate of $653 million under a Rule 10b5-1 plan and through open market repurchases.

Common Stock Issuance: In October 2017, we issued 34 million shares of our common stock for $41.00 per share in a public offering, for net proceeds of $1.36 billion, net of underwriting fees and other offering costs.

Treasury Stock: In connection with the Inotera Acquisition, we sold 58 million shares of our common stock to Nanya for $986 million in cash, of which 54 million shares were issued from treasury stock. As a result, in 2017, treasury stock decreased by $1.03 billion while retained earnings decreased by $104 million for the difference between the carrying value of the treasury stock and its $925 million fair value.

Outstanding Capped Calls: In connection with our 2033F Notes, we entered into the 2033F Capped Calls, which cover, subject to anti-dilution adjustments similar to those contained in the 2033F Notes, 27 million shares of common stock and are intended to reduce the effect of potential dilution. The 2033F Capped Calls have an initial strike price of $10.93, subject to certain adjustments, which equals the conversion price of the 2033 Notes, a cap price of $14.51, and provide for our receipt of cash or shares, at our election, from our counterparties if the trading price of our stock is above the strike prices on the expiration dates. The 2033F Capped Calls expire on various dates between January 2020 and February 2020. As of August 30, 2018, the dollar value of cash or shares that we would receive from our 2033F Capped Calls upon their expiration dates range from $0, if the trading price of our stock is below the strike prices at expiration, to $98 million, if the trading price of our stock is at or above the cap prices. Settlement of the capped calls prior to the expiration dates may be for an amount less than the maximum value at expiration.

Expiration of Capped Calls: In 2018, we share-settled certain capped calls upon their expirations, and received 9 million shares, equal to a value of $429 million. In 2017, we cash-settled and share-settled certain capped calls upon their expirations, and received $125 million in cash and 4 million shares, equal to a value of $67 million and in 2016, we share-settled certain capped calls upon their expirations and received 2 million shares of our stock, equal to a value of $23 million. The amounts received upon settlement were based on volume-weighted-average trading prices of our stock at the expiration dates. The shares received in all periods were recorded as treasury stock.

Accumulated Other Comprehensive Income: Changes in accumulated other comprehensive by component for the year ended August 30, 2018 were as follows:



	Cumulative Foreign Currency Translation Adjustments			Gains (Losses) on Derivative Instruments			Pension Liability Adjustments			Unrealized Gains (Losses) on Investments			Total
As of August 31, 2017	$	(1	)	$	17		$	13		$	—		$	29
Other comprehensive income	1			(17		)	(3		)	(3		)	(22		)
Amount reclassified out of accumulated other comprehensive income	—			(1		)	(1		)	—			(2		)
Tax effects	—			3			1			1			5
Other comprehensive income	1			(15		)	(3		)	(2		)	(19		)
As of August 30, 2018	$	—		$	2		$	10		$	(2	)	$	10

Noncontrolling Interests in Subsidiaries



As of	2018				2017
	Balance		Percentage		Balance		Percentage
IMFT	$	853	49	%	$	832	49	%
Other	17		Various		17		Various
	$	870			$	849

IMFT: Since 2006, we have owned 51% of IMFT, a joint venture between us and Intel. IMFT is governed by a Board of Managers, for which the number of managers appointed by each member varies based on the members' respective ownership interests. IMFT manufactures semiconductor products exclusively for its members under a long-term supply agreement at prices approximating cost. In the first quarter of 2018, IMFT discontinued production of NAND and subsequent to that time has been entirely focused on 3D XPoint memory production. Through our IMFT joint venture, we continue to jointly develop 3D XPoint technologies with Intel through the second generation of 3D XPoint technology, which is expected to be completed in the second half of 2019. To better optimize the 3D XPoint technology for our product roadmap and maximize the benefits for our customers and shareholders, in the fourth quarter of 2018, we announced that we will no longer jointly develop with Intel subsequent generations of 3D XPoint technology. IMFT will continue to manufacture memory based on 3D XPoint technology at the fabrication facility in Lehi, Utah for its members. IMFT sales to Intel were $507 million, $438 million, and $457 million for 2018, 2017, and 2016, respectively.

The IMFT joint venture agreement extends through 2024 and includes certain buy-sell rights. At any time through December 2018, Intel can put to us, and from January 2019 through December 2021, we can call from Intel, Intel's interest in IMFT, in either case, for a price that approximates Intel's interest in the net book value of IMFT plus member debt at the time of the closing. If Intel exercises its put right, we can elect to set the closing date of the transaction any time between six months and two years following such election by Intel and we can elect to receive financing of the purchase price from Intel for one to two years from the closing date. If we exercise our call right, Intel can elect to set the closing date of the transaction to be any time between six months and one year following such election. Following the closing date resulting from exercise of either the put or the call, we will continue to supply to Intel for a period of one year between 50% and 100%, at Intel's choice, of Intel's immediately preceding six-month period pre-closing volumes of IMFT products for the first six-month period following the closing and between 0% and 100%, at Intel's choice, of Intel's first six-month period following the closing volumes of IMFT products for the second six-month period following the closing, at a margin that varies depending on whether the put or call was exercised.

IMFT's capital requirements are generally determined based on an annual plan approved by the members, and capital contributions to IMFT are requested as needed. Capital requests are made to the members in proportion to their then-current ownership interest. Members may elect to not contribute their proportional share, and in such event, the contributing member may elect to contribute any amount of the capital request, either in the form of an equity contribution or member debt financing. Under the supply agreement, the members have rights and obligations to the capacity of IMFT in proportion to their investment, including member debt financing. Any capital contribution or member debt financing results in a proportionate adjustment to the sharing of output on an eight-month lag. Members pay their proportionate share of fixed costs associated with IMFT's capacity.

Creditors of IMFT have recourse only to IMFT's assets and do not have recourse to any other of our assets. The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets:



As of	2018		2017
Assets
Cash and equivalents	$	91	$	87
Receivables	126		81
Inventories	114		128
Other current assets	8		7
Total current assets	339		303
Property, plant, and equipment	2,641		1,852
Other noncurrent assets	45		49
Total assets	$	3,025	$	2,204

Liabilities
Accounts payable and accrued expenses	$	138	$	299
Deferred income	9		6
Current debt	20		19
Total current liabilities	167		324
Long-term debt	1,064		75
Other noncurrent liabilities	74		88
Total liabilities	$	1,305	$	487

Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

In 2016, IMFT distributed $36 million and $34 million to us and Intel, respectively, and we and Intel contributed $38 million and $37 million, respectively, to IMFT.

Fair Value Measurements

12 Months Ended

Aug. 30, 2018

Fair Value Disclosures [Abstract]

Fair Value Measurements

All of our marketable debt and equity investments were classified as available-for-sale and carried at fair value. Amounts reported as cash and equivalents, receivables, and accounts payable and accrued expenses approximate fair value. The estimated fair value and carrying value of our outstanding debt instruments (excluding the carrying value of equity and mezzanine equity components of our convertible notes) were as follows:



As of	2018				2017
	Fair Value		Carrying Value		Fair Value		Carrying Value
Convertible notes	$	3,124	$	1,049	$	3,901	$	1,521
Notes and MMJ Creditor Payments	2,798		2,742		8,793		8,423

The fair values of our convertible notes were determined based on Level 2 inputs, including the trading price of our convertible notes when available, our stock price, and interest rates based on similar debt issued by parties with credit ratings similar to ours. The fair values of our other debt instruments were estimated based on Level 2 inputs, including discounted cash flows, the trading price of our notes, when available, and interest rates based on similar debt issued by parties with credit ratings similar to ours.

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments

12 Months Ended

Aug. 30, 2018

Derivative Instruments



	Gross Notional Amount⁽¹⁾		Fair Value of
	Gross Notional Amount⁽¹⁾		Current Assets⁽²⁾		Current Liabilities⁽³⁾			Noncurrent Assets⁽⁴⁾
As of August 30, 2018
Derivative instruments with hedge accounting designation
Cash flow currency hedges	$	538	$	—	$	(13	)	$	—

Derivative instruments without hedge accounting designation
Non-designated currency hedges	1,919		14		(10		)	—
Convertible notes settlement obligation⁽⁵⁾			—		(167		)	—
			14		(177		)	—

			$	14	$	(190	)	$	—

As of August 31, 2017
Derivative instruments with hedge accounting designation
Cash flow currency hedges	$	456	$	17	$	—		$	—

Derivative instruments without hedge accounting designation
Non-designated currency hedges	4,847		34		(5		)	1
Convertible notes settlement obligation⁽⁵⁾			—		(47		)	—
			34		(52		)	1

			$	51	$	(52	)	$	1


⁽¹⁾	Notional amounts of currency hedge contracts in U.S. dollars.


⁽²⁾	Included in receivables – other.


⁽³⁾	Included in accounts payable and accrued expenses – other for forward contracts and in current debt for convertible notes settlement obligations.


⁽⁴⁾	Included in other noncurrent assets.


⁽⁵⁾	Notional amounts of convertible notes settlement obligations as of August 30, 2018 and August 31, 2017 were 3 million and 2 million shares of our common stock, respectively.

Derivative Instruments with Hedge Accounting Designation

We utilize currency forward contracts that generally mature within 12 months to hedge our exposure to changes in currency exchange rates. Currency forward contracts are measured at fair value based on market-based observable inputs including currency exchange spot and forward rates, interest rates, and credit-risk spreads (Level 2). We do not use derivative instruments for speculative purposes.

Cash Flow Hedges: We utilize cash flow hedges for our exposure from changes in currency exchange rates for certain capital expenditures. For derivative instruments designated as cash flow hedges, the effective portion of the realized and unrealized gains or losses on derivatives is included as a component of accumulated other comprehensive income. Amounts in accumulated other comprehensive income are reclassified into earnings in the same line items and in the same periods in which the underlying transactions affect earnings. For the periods presented prior to the second quarter of 2018, the ineffective and excluded portion of the realized and unrealized gain or loss was included in other non-operating income (expense). As a result of adopting ASU 2017-12, beginning in the second quarter of 2018, the excluded portion of such amounts is included in the same line item in which the underlying transactions affect earnings and the ineffective portion of the realized and unrealized gains or losses on derivatives is included as a component of accumulated other comprehensive income.

We recognized losses of $17 million and gains of $15 million and $10 million for 2018, 2017, and 2016, respectively, in accumulated other comprehensive income from the effective portion of cash flow hedges. Neither the amount excluded from hedge effectiveness nor the reclassifications from accumulated other comprehensive income to earnings were material in 2018, 2017, or 2016. The amounts from cash flow hedges included in accumulated other comprehensive income that are expected to be reclassified into earnings in the next 12 months were also not material.

Fair Value Hedges: We utilize fair value hedges for our exposure from changes in currency exchange rates for certain monetary assets and liabilities. For derivative forward contracts designated as fair value hedges, hedge effectiveness is determined by the change in the fair value of the undiscounted spot rate of the forward contract. The changes in fair values of hedge instruments attributed to changes in undiscounted spot rates are recognized in other non-operating income (expense). The time value associated with hedge instruments is excluded from the assessment of the effectiveness of hedges and is recognized on a straight-line basis over the life of hedges to other non-operating income (expense). Amounts recorded to other comprehensive income (loss) for 2018 were not material. The effects of fair value hedges on our consolidated statements of operations were as follows:



	Other Non-Operating Income (Expense)
For the year ended	2018
Gain (loss) on remeasurement of hedged assets and liabilities	$	(25	)
Gain (loss) on derivatives designated as hedging instruments	25
Amortization of amounts excluded from hedge effectiveness	(32		)
	$	(32	)

Derivative Instruments without Hedge Accounting Designation

Currency Derivatives: Except for certain assets and liabilities hedged using fair value hedges, we generally utilize a rolling hedge strategy with currency forward contracts that mature within nine months to hedge our exposures of monetary assets and liabilities from changes in currency exchange rates. At the end of each reporting period, monetary assets and liabilities denominated in currencies other than the U.S. dollar are remeasured into U.S. dollars and the associated outstanding forward contracts are marked to market. Currency forward contracts are valued at fair values based on the middle of bid and ask prices of dealers or exchange quotations (Level 2). Realized and unrealized gains and losses on derivative instruments without hedge accounting designation as well as the changes in the underlying monetary assets and liabilities from changes in currency exchange rates are included in other non-operating income (expense). For derivative instruments without hedge accounting designation, we recognized losses of $38 million and $45 million, and gains of $185 million for 2018, 2017, and 2016, respectively.

Convertible Notes Settlement Obligations: For settlement obligations associated with our convertible notes subject to mark-to-market accounting treatment, the fair values of the underlying derivative settlement obligations were initially determined using the Black-Scholes option valuation model (Level 2), which requires inputs of stock price, expected stock-price volatility, estimated option life, risk-free interest rate, and dividend rate. The subsequent measurement amounts were based on the volume-weighted-average trading price of our common stock (Level 2). (See "Debt" note.) We recognized losses of $124 million for 2018 in other non-operating income (expense), net for the changes in fair value of the derivative settlement obligations. Recognized gains and losses for 2017 and 2016 were not material.

Derivative Counterparty Credit Risk and Master Netting Arrangements

Our derivative instruments expose us to credit risk to the extent counterparties may be unable to meet the terms of the contracts. Our maximum exposure to loss due to credit risk if counterparties fail completely to perform according to the terms of the contracts would generally equal the fair value of assets for these contracts as listed in the tables above. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading risk across multiple financial institutions. As of August 30, 2018 and August 31, 2017, amounts netted under our master netting arrangements were not material.

Equity Plans

12 Months Ended

Aug. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Equity Plans

As of August 30, 2018, 125 million shares of our common stock were available for future awards under our equity plans, including 33 million shares approved for issuance under our employee stock purchase plan ("ESPP").

Stock Options

Our stock options are generally exercisable in increments of either one-fourth or one-third per year beginning one year from the date of grant. Stock options issued after February 2014 expire eight years from the date of grant. Options issued prior to February 2014 expire six years from the date of grant. Option activity for 2018 is summarized as follows:



	Number of Shares		Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Life (In Years)	Aggregate Intrinsic Value
Outstanding as of August 31, 2017	33		$	19.32
Granted	2		43.30
Exercised	(16	)	17.82
Canceled or expired	(1	)	22.67
Outstanding as of August 30, 2018	18		23.38		4.8	$	527

Exercisable as of August 30, 2018	8		$	21.66	3.2	$	233
Unvested as of August 30, 2018	10		24.61		6.0	294

The total intrinsic value was $446 million, $198 million, and $52 million for options exercised in 2018, 2017, and 2016, respectively.

Stock options granted and assumptions used in the Black-Scholes option valuation model were as follows:



For the year ended	2018			2017			2016
Stock options granted	2			8			8
Weighted-average grant-date fair value per share	$	18.65		$	8.68		$	6.94
Average expected life in years	5.5			5.5			5.5
Weighted-average expected volatility	44		%	46		%	47		%
Weighted-average risk-free interest rate	2.2		%	1.8		%	1.7		%
Expected dividend yield	0.0		%	0.0		%	0.0		%

Stock price volatility was based on an average of historical volatility and the implied volatility derived from traded options on our stock. The expected lives of options granted were based, in part, on historical experience and on the terms and conditions of the options. The risk-free interest rates utilized were based on the U.S. Treasury yield in effect at each grant date.

Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")

As of August 30, 2018, there were 15 million shares of Restricted Stock Awards outstanding, of which 13 million contained only service conditions. For service-based Restricted Stock Awards, restrictions generally lapse in one-fourth or one-third increments during each year of employment after the grant date. Restrictions lapse on Restricted Stock granted in 2018 with performance or market conditions over a three year period if conditions are met. At the end of the performance period, the number of actual shares to be awarded will vary between 0% and 200% of target amounts, depending upon the achievement level. Restricted Stock Awards activity for 2018 is summarized as follows:



	Number of Shares		Weighted-Average Grant Date Fair Value Per Share
Outstanding as of August 31, 2017	19		$	19.78
Granted	4		42.48
Restrictions lapsed	(6	)	21.70
Canceled	(2	)	21.93
Outstanding as of August 30, 2018	15		25.18



For the year ended	2018		2017		2016
Restricted stock award shares granted	4		8		10
Weighted-average grant-date fair value per share	$	42.48	$	18.77	$	15.40
Aggregate vesting-date fair value of shares vested	$	259	$	115	$	71

Employee Stock Purchase Plan

Our ESPP permits eligible employees to purchase shares of our common stock through payroll deductions of up to 10% of their eligible compensation, subject to certain limitations. The purchase price of the shares under the ESPP equals 85% of the lower of the fair market value of our common stock on either the first or last day of each six-month offering period. Our ESPP was offered to substantially all employees beginning in August 2018. Compensation expense is calculated as of the beginning of the offering period as the fair value of the employees' purchase rights utilizing the Black-Scholes option valuation model and is recognized over the offering period. Assumptions used in the Black-Scholes option valuation model for the offering period beginning August 1, 2018 were as follows:



Weighted-average grant-date fair value per share	$	14.55
Average expected life in years	0.5
Weighted-average expected volatility	43		%
Weighted-average risk-free interest rate	2.2		%
Expected dividend yield	0.0		%

Stock-based Compensation Expense



For the year ended	2018		2017		2016
Stock-based compensation expense by caption
Cost of goods sold	$	83	$	88	$	76
Selling, general, and administrative	61		75		66
Research and development	54		52		49
	$	198	$	215	$	191

Stock-based compensation expense by type of award
Stock options	$	55	$	71	$	79
Restricted stock awards	140		144		112
ESPP	3		—		—
	$	198	$	215	$	191

The income tax benefit related to share-based compensation was $158 million, $97 million and $41 million for 2018, 2017 and 2016, respectively. The income tax benefits related to share-based compensation for the periods presented prior to the second quarter of 2018 were offset by an increase in the U.S. valuation allowance. Stock-based compensation expense of $19 million and $20 million was capitalized and remained in inventory as of August 30, 2018 and August 31, 2017, respectively. As of August 30, 2018, $316 million of total unrecognized compensation costs for unvested awards, before the effect of any future forfeitures, was expected to be recognized through the fourth quarter of 2022, resulting in a weighted-average period of 1.3 years.

Employee Benefit Plans	12 Months Ended
Employee Benefit Plans	Aug. 30, 2018
Retirement Benefits [Abstract]
Employee Benefit Plans	Employee Benefit Plans We have employee retirement plans at our U.S. and international sites. Details of the more significant plans are discussed as follows: Employee Savings Plan for U.S. Employees We have a 401(k) retirement plan under which U.S. employees may contribute up to 75% of their eligible pay (subject to Internal Revenue Service ("IRS") annual contribution limits) to various savings alternatives, none of which include direct investment in our stock. We match in cash eligible contributions from employees up to 5% of the employee's annual eligible earnings. Contribution expense for the 401(k) plan was $61 million, $52 million, and $54 million in 2018, 2017, and 2016, respectively. Retirement Plans We have pension plans in various countries available to local employees which are generally government mandated. As of August 30, 2018, the projected benefit obligations of our plans were $190 million and plan assets were $171 million. As of August 31, 2017, the projected benefit obligations of our plans were $175 million and plan assets were $150 million. Pension expense was not material for 2018, 2017, or 2016.

Research and Development	12 Months Ended
Research and Development	Aug. 30, 2018
Research and Development [Abstract]
Research and Development	Research and Development We share the cost of certain product and process development activities with development partners. Our R&D expenses were reduced by reimbursements under these arrangements by $201 million, $213 million, and $205 million for 2018, 2017, and 2016, respectively. We have agreements to jointly develop NAND and 3D XPoint technologies with Intel. We continue to jointly develop NAND technologies with Intel through the third generation of 3D NAND, which is expected to be completed in the second half of 2019. In the second quarter of 2018, we and Intel agreed to independently develop subsequent generations of 3D NAND in order to better optimize the technology and products for our respective business needs. We continue to jointly develop 3D XPoint technologies with Intel through the second generation of 3D XPoint technology, which is expected to be completed in the second half of 2019. To better optimize 3D XPoint technology for our product roadmap and maximize the benefits for our customers and shareholders, in the fourth quarter of 2018, we announced that we will no longer jointly develop with Intel subsequent generations of 3D XPoint technology.

Other Operating (Income) Expense, Net

12 Months Ended

Aug. 30, 2018

Other Income and Expenses [Abstract]

Other Operating (Income) Expense, Net



For the year ended	2018			2017			2016
(Gain) loss on disposition of property, plant, and equipment	$	(96	)	$	(22	)	$	(4	)
Restructure and asset impairments	28			18			67
Other	11			5			(2		)
	$	(57	)	$	1		$	61

Restructure and asset impairments in 2018 primarily consisted of costs incurred as a result of our continued emphasis to centralize certain key functions. In 2017, we recognized gains of $15 million related to our sale of assembly and test facility located in Akita, Japan and our 40% ownership interest in Tera Probe; assets associated with our 200mm fabrication facility in Singapore; and assets related to Lexar and also expect to recognize an additional gain of approximately $100 million in 2019 upon the completion of the sale of the Singapore facility. We also incurred charges of $33 million and $58 million in 2017 and 2016, respectively, related to the elimination of certain projects and programs, workforce reductions in certain areas of our business, and other non-headcount related spending reductions.

Other Non-Operating Income (Expense), Net

12 Months Ended

Aug. 30, 2018

Other Nonoperating Income (Expense) [Abstract]

Other Non-Operating Income (Expense), Net



For the year ended	2018			2017			2016
Loss on debt prepayments, repurchases, and conversions	$	(385	)	$	(100	)	$	(4	)
Loss from changes in currency exchange rates	(75		)	(74		)	(24		)
Gain on remeasurement of previously-held equity interest in Inotera	—			71			—
Other	(5		)	(9		)	(26		)
	$	(465	)	$	(112	)	$	(54	)

In 2016, we recognized other non-operating expense of $30 million to write off indemnification receivables upon the resolution of uncertain tax positions.

Income Taxes

12 Months Ended

Aug. 30, 2018

Income Tax Disclosure [Abstract]

Income Taxes

On December 22, 2017, the United States enacted tax legislation commonly referred to as the Tax Cuts and Jobs Act (the "Tax Act") which lowered the U.S. corporate income tax rate from 35% to 21% and significantly affects how income from foreign operations is taxed in the United States. Our U.S. statutory federal rate was 25.7% for 2018 (based on the 35% corporate rate through December 31, 2017 and 21% from that date through the end of fiscal year 2018) and will be 21% beginning in 2019. The Tax Act imposed a one-time transition tax in 2018 on accumulated foreign income (the "Repatriation Tax"); provided a U.S. federal tax exemption on foreign earnings distributed to the United States after January 1, 2018; and beginning in 2019, created a new minimum tax on certain foreign earnings in excess of a deemed return on tangible assets (the "Foreign Minimum Tax"). The Tax Act allows us to elect to pay any Repatriation Tax due in eight annual, interest-free payments in increasing amounts beginning in December 2018. In connection with the provisions of the Tax Act, we made an accounting policy election to treat the Foreign Minimum Tax provision as a period cost in the period the tax is incurred.

SEC Staff Accounting Bulletin No. 118 ("SAB 118") allows the use of provisional amounts (reasonable estimates) if our analyses of the impacts of the Tax Act have not been completed when our financial statements are issued. The provisional amounts below for 2018 represent reasonable estimates of the effects of the Tax Act for which our analysis is not yet complete. As we complete our analysis of the Tax Act, including collecting, preparing, and analyzing necessary information, performing and refining calculations, and obtaining additional guidance from the IRS, U.S. Treasury Department, FASB, or other standard setting and regulatory bodies on the Tax Act, we may record adjustments to the provisional amounts, which may be material. In accordance with SAB 118, our accounting for the tax effects of the Tax Act will be completed during the measurement period, which should not extend beyond one year from the enactment date. At August 30, 2018, there were no provisions for which we were unable to record a reasonable estimate of the impact.

Our income tax (provision) benefit consisted of the following:



For the year ended	2018			2017			2016
Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees
U.S.	$	141		$	(56	)	$	72
Foreign	14,166			5,252			(353		)
	$	14,307		$	5,196		$	(281	)

Income tax (provision) benefit
Current
U.S. federal	$	(54	)	$	—		$	—
State	1			(1		)	(1		)
Foreign	(374		)	(152		)	(27		)
	(427		)	(153		)	(28		)
Deferred
U.S. federal	232			—			39
State	101			—			2
Foreign	(74		)	39			(32		)
	259			$	39		9

Income tax (provision) benefit	$	(168	)	$	(114	)	$	(19	)

The table below reconciles our tax (provision) benefit based on the U.S. federal statutory rate to our effective rate:



For the year ended	2018					2017					2016
U.S. federal income tax (provision) benefit at statutory rate	$	(3,677	)	25.7	%	$	(1,819	)	35.0	%	$	98		35.0	%
Foreign tax rate differential	2,572			(18.0	)%	1,571			(30.2	)%	(300		)	(106.8	)%
Repatriation Tax related to the Tax Act	(1,049		)	7.3	%	—			—	%	—			—	%
Remeasurement of deferred tax assets and liabilities related to the Tax Act	(179		)	1.3	%	—			—	%	—			—	%
Change in valuation allowance	2,079			(14.5	)%	64			(1.2	)%	63			22.4	%
Change in unrecognized tax benefits	60			(0.4	)%	12			(0.2	)%	52			18.5	%
Tax credits	90			(0.6	)%	66			(1.3	)%	48			17.1	%
Other	(64		)	0.4	%	(8		)	0.1	%	20			7.0	%
Income tax (provision) benefit	$	(168	)	1.2	%	$	(114	)	2.2	%	$	(19	)	(6.8	)%

Provisional estimates for 2018 in the table above included $1.34 billion of benefit for the release of the valuation allowance on the net deferred tax assets of our U.S. operations and $1.03 billion of provision for the Repatriation Tax, net of adjustments related to uncertain tax positions.

We operate in a number of tax jurisdictions outside the United States, including Singapore, where we have tax incentive arrangements, which expire in whole or in part at various dates through 2031, that are conditional, in part, upon meeting certain business operations and employment thresholds. The effect of tax incentive arrangements reduced our tax provision by $1.96 billion (benefiting our diluted earnings per share by $1.59) for 2018, by $742 million ($0.64 per diluted share) for 2017, and were not material in 2016.

Provision has been recognized for deferred taxes on undistributed earnings of non-U.S. subsidiaries to the extent that dividend payments from such companies are expected to result in additional tax liabilities. As a result of the Repatriation Tax, substantially all of our accumulated foreign earnings prior to December 31, 2017 were subject to U.S. federal taxation. Although these earnings have been subject to U.S. federal income tax under the Repatriation Tax, the repatriation to the United States of all or a portion of these earnings would potentially be subject to foreign withholding and state income tax. As of August 30, 2018, we had a deferred tax liability of $82 million associated with our undistributed earnings. As of August 30, 2018, certain non-U.S. subsidiaries had cumulative undistributed earnings of $2.35 billion that were deemed to be indefinitely reinvested. Determination of the amount of unrecognized deferred tax liabilities related to investments in these foreign subsidiaries is not practicable.

Deferred income taxes reflect the net tax effects of temporary differences between the bases of assets and liabilities for financial reporting and income tax purposes as well as carryforwards. Deferred tax assets and liabilities consist of the following:



As of	2018			2017
Deferred tax assets
Net operating loss and tax credit carryforwards	$	1,417		$	3,426
Accrued salaries, wages, and benefits	163			211
Other accrued liabilities	35			59
Other	80			86
Gross deferred tax assets	1,695			3,782
Less valuation allowance	(228		)	(2,321		)
Deferred tax assets, net of valuation allowance	1,467			1,461

Deferred tax liabilities
Debt discount	(77		)	(145		)
Property, plant, and equipment	(173		)	(300		)
Unremitted earnings on certain subsidiaries	(82		)	(123		)
Product and process technology	(62		)	(85		)
Other	(54		)	(59		)
Deferred tax liabilities	(448		)	(712		)

Net deferred tax assets	$	1,019		$	749

Reported as
Deferred tax assets	$	1,022		$	766
Deferred tax liabilities (included in other noncurrent liabilities)	(3		)	(17		)
Net deferred tax assets	$	1,019		$	749

We assess positive and negative evidence for each jurisdiction to determine whether it is more likely than not that existing deferred tax assets will be realized. As of August 30, 2018 and August 31, 2017, we had a valuation allowance of $28 million and $1.52 billion, respectively, against U.S. net deferred tax assets, primarily related to net operating loss and tax credit carryforwards. Income taxes on U.S. operations for 2017 and 2016 were substantially offset by changes in the valuation allowance. We had valuation allowances against net deferred tax assets, primarily related to net operating loss carryforwards, for our subsidiaries in Japan and for our other foreign subsidiaries, of $192 million and $8 million, respectively, as of August 30, 2018, and $627 million and $172 million, respectively, as of August 31, 2017. Changes in 2018 in the valuation allowance were due to the provisional estimate for the release of the valuation allowance in the U.S. as a result of the Tax Act, adjustments based on management's assessment of foreign net operating losses that are more likely than not to be realized, and changes in foreign currency. As a result of internal restructuring during the year, we have concluded that the possibility of utilizing certain of our net operating loss carryovers are now remote. As such, we have removed $119 million of deferred tax assets that were previously fully reserved with a valuation allowance.

As of August 30, 2018, our federal, state, and foreign net operating loss carryforward amounts and expiration periods, as reported to tax authorities, were as follows:



Year of Expiration	U.S. Federal		State		Japan		Taiwan		Other Foreign		Total
2019 - 2023	$	—	$	28	$	1,782	$	711	$	2	$	2,523
2024 - 2028	—		136		536		3		—		675
2029 - 2033	—		407		—		—		—		407
2034 - 2038	10		84		—		—		—		94
Indefinite	—		1		—		622		38		661
	$	10	$	656	$	2,318	$	1,336	$	40	$	4,360

As of August 30, 2018, our federal and state tax credit carryforward amounts and expiration periods, as reported to tax authorities, were as follows:



Year of Tax Credit Expiration	U.S. Federal		State		Total
2019 - 2023	$	122	$	63	$	185
2024 - 2028	44		46		90
2029 - 2033	69		90		159
2034 - 2038	275		3		278
Indefinite	—		62		62
	$	510	$	264	$	774

Below is a reconciliation of the beginning and ending amount of our unrecognized tax benefits:



For the year ended	2018			2017			2016
Beginning unrecognized tax benefits	$	327		$	304		$	351
Increases due to the Inotera Acquisition	—			54			—
Increases related to tax positions taken in current year	68			15			5
Foreign currency translation increases (decreases) to tax positions	—			2			—
Settlements with tax authorities	(8		)	(47		)	(47		)
Expiration of statute of limitations	—			(1		)	(5		)
Decreases related to tax positions from prior years	(126		)	—			—
Ending unrecognized tax benefits	$	261		$	327		$	304

The changes in uncertain tax positions in 2018 are primarily related to the Tax Act and transfer pricing. In connection with the Inotera Acquisition in 2017, we assumed $54 million of uncertain tax positions. The decreases to unrecognized tax benefits in 2017 and 2016 from settlements with tax authorities were primarily related to the favorable resolution of certain tax matters.

As of August 30, 2018, we had $256 million of unrecognized tax benefits that would, if recognized, affect our effective tax rate. The amount accrued for interest and penalties related to uncertain tax positions was not material for any period presented. The resolution of tax audits or expiration of statute of limitations could also reduce our unrecognized tax benefits. Although the timing of final resolution is uncertain, the estimated potential reduction in our unrecognized tax benefits in the next 12 months would not be material.

We and our subsidiaries file income tax returns with the U.S. federal government, various U.S. states, and various foreign jurisdictions throughout the world. Our U.S. federal and state tax returns remain open to examination for 2014 through 2018. In addition, tax returns that remain open to examination in Japan range from the years 2012 to 2018 and in Singapore and Taiwan from 2013 to 2018. We believe that adequate amounts of taxes and related interest and penalties have been provided, and any adjustments as a result of examinations are not expected to materially adversely affect our business, results of operations, or financial condition.

Earnings Per Share

12 Months Ended

Aug. 30, 2018

Earnings Per Share [Abstract]

Earnings Per Share



For the year ended	2018		2017		2016
Net income (loss) attributable to Micron – Basic and Diluted	$	14,135	$	5,089	$	(276	)

Weighted-average common shares outstanding – Basic	1,152		1,089		1,036
Dilutive effect of equity plans and convertible notes	77		65		—
Weighted-average common shares outstanding – Diluted	1,229		1,154		1,036

Earnings (loss) per share
Basic	$	12.27	$	4.67	$	(0.27	)
Diluted	11.51		4.41		(0.27		)

Listed below are the potential common shares, as of the end of the periods shown, that could dilute basic earnings per share in the future that were not included in the computation of diluted earnings per share because to do so would have been antidilutive:



For the year ended	2018	2017	2016
Equity plans	3	21	60
Convertible notes	—	26	119

Segment Information

12 Months Ended

Aug. 30, 2018

Segment Information

Segment information reported herein is consistent with how it is reviewed and evaluated by our chief operating decision maker. We have the following four business units, which are our reportable segments:

Compute and Networking Business Unit ("CNBU"): Includes memory products sold into cloud server, enterprise, client, graphics, and networking markets.

Mobile Business Unit ("MBU"): Includes memory products sold into smartphone and other mobile-device markets.

Storage Business Unit ("SBU"): Includes SSDs and component-level solutions sold into enterprise and cloud, client, and consumer SSD markets, other discrete storage products sold in component and wafer forms to the removable storage markets, and sales of 3D XPoint memory.

Embedded Business Unit ("EBU"): Includes memory and storage products sold into automotive, industrial, and consumer markets.

Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating income and expenses are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. We do not identify or report internally our assets (other than goodwill) or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments. As of August 30, 2018 and August 31, 2017, CNBU, MBU, SBU, and EBU had goodwill of $832 million, $198 million, $101 million, and $97 million, respectively.



For the year ended	2018			2017			2016
Net sales
CNBU	$	15,252		$	8,624		$	4,529
MBU	6,579			4,424			2,569
SBU	5,022			4,514			3,262
EBU	3,479			2,695			1,939
All Other	59			65			100
	$	30,391		$	20,322		$	12,399

Operating income (loss)
CNBU	$	9,773		$	3,755		$	(25	)
MBU	3,033			927			97
SBU	964			552			(123		)
EBU	1,473			975			473
All Other	—			23			28
	$	15,243		$	6,232		$	450

Unallocated
Stock-based compensation	$	(198	)	$	(215	)	$	(191	)
Restructure and asset impairments	(28		)	(18		)	(67		)
Flow-through of Inotera inventory step up	—			(107		)	—
Other	(23		)	(24		)	(24		)
	$	(249	)	$	(364	)	$	(282	)

Operating income	$	14,994		$	5,868		$	168

Depreciation and amortization expense included in operating income was as follows:



For the year ended	2018		2017		2016
CNBU	$	1,755	$	1,344	$	1,141
MBU	1,077		926		580
SBU	1,295		1,083		844
EBU	603		484		379
All Other	18		13		20
Unallocated	11		11		16
	$	4,759	$	3,861	$	2,980

Product Sales

12 Months Ended

Aug. 30, 2018

Segment Reconciliation [Abstract]

Product Sales



For the year ended	2018		2017		2016
DRAM	$	21,232	$	12,963	$	7,207
Trade NAND	7,843		6,228		4,138
Non-Trade	554		553		501
Other	762		578		553
	$	30,391	$	20,322	$	12,399

Non-Trade consists primarily of NAND and 3D XPoint memory products manufactured and sold to Intel through IMFT under a long-term supply agreement at prices approximating cost. Information regarding products that combine both NAND and DRAM components is reported within Trade NAND. Other includes sales of NOR and trade 3D XPoint memory products.

Certain Concentrations

12 Months Ended

Aug. 30, 2018

Risks and Uncertainties [Abstract]

Certain Concentrations

Markets with concentrations of net sales were approximately as follows:



For the year ended	2018		2017		2016
Compute and graphics	25	%	20	%	20	%
Server	25	%	15	%	10	%
Mobile	20	%	20	%	20	%
SSDs and other storage	15	%	20	%	20	%
Automotive, industrial, medical, and other embedded	10	%	15	%	15	%

Sales to Kingston Technology Company, Inc. ("Kingston"), as a percentage of total net sales, were 10% for 2018 and 2017. Sales to Intel, including Non-Trade sales through IMFT, as a percentage of total net sales, were 14% for 2016 and no other customer exceeded 10% of our total net sales. Our sales to Kingston were included in our CNBU, SBU, and MBU segments and substantially all of our sales to Intel were included in our SBU and CNBU segments.

We generally have multiple sources of supply for our raw materials and production equipment; however, only a limited number of suppliers are capable of delivering certain raw materials and production equipment that meet our standards and, in some cases, materials or production equipment are provided by a single supplier.

Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash, money market accounts, certificates of deposit, fixed-rate debt securities, trade receivables, share repurchase, capped call, and derivative contracts. We invest through high-credit-quality financial institutions and, by policy, generally limit the concentration of credit exposure by restricting investments with any single obligor and monitoring credit risk of bank counterparties on an ongoing basis. A concentration of credit risk may exist with respect to receivables of certain customers. We perform ongoing credit evaluations of customers worldwide and generally do not require collateral from our customers. Historically, we have not experienced material losses on receivables. A concentration of risk may also exist with respect to our foreign currency hedges as the number of counterparties to our hedges is limited and the notional amounts are relatively large. We seek to mitigate such risk by limiting our counterparties to major financial institutions and through entering into master netting arrangements. Share repurchase and capped call agreements expose us to credit risk to the extent the counterparties may be unable to meet the terms of the agreements. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading the risk across several major financial institutions. In addition, the potential risk of loss with any one counterparty resulting from this type of credit risk is monitored on an ongoing basis.

Geographic Information

12 Months Ended

Aug. 30, 2018

Quarterly Financial Information Disclosure [Abstract]

Geographic Information

Geographic net sales based on customer ship-to location were as follows:



For the year ended	2018		2017		2016
China	$	17,357	$	10,388	$	5,301
United States	3,624		2,763		1,925
Taiwan	2,798		2,544		1,521
Other Asia Pacific	2,559		1,808		1,610
Europe	2,128		1,360		937
Japan	1,254		1,025		831
Other	671		434		274
	$	30,391	$	20,322	$	12,399

Net property, plant, and equipment by geographic area was as follows:



As of	2018		2017
Taiwan	$	7,640	$	6,519
Singapore	6,933		5,261
United States	5,113		4,253
Japan	3,451		2,827
China	398		453
Other	137		118
	$	23,672	$	19,431

Quarterly Financial Information

12 Months Ended

Aug. 30, 2018

Quarterly Financial Information

Quarterly Financial Information (Unaudited)

(in millions except per share amounts)



2018	Fourth Quarter		Third Quarter		Second Quarter		First Quarter
Net sales	$	8,440	$	7,797	$	7,351	$	6,803
Gross margin	5,151		4,723		4,270		3,747
Operating income	4,377		3,953		3,567		3,097
Net income	4,326		3,823		3,311		2,678
Net income attributable to Micron	4,325		3,823		3,309		2,678

Earnings per share
Basic	$	3.73	$	3.30	$	2.86	$	2.36
Diluted	3.56		3.10		2.67		2.19



2017	Fourth Quarter		Third Quarter		Second Quarter		First Quarter
Net sales	$	6,138	$	5,566	$	4,648	$	3,970
Gross margin	3,112		2,609		1,704		1,011
Operating income	2,502		1,963		1,044		359
Net income	2,369		1,647		894		180
Net income attributable to Micron	2,368		1,647		894		180

Earnings per share
Basic	$	2.13	$	1.49	$	0.81	$	0.17
Diluted	1.99		1.40		0.77		0.16

Schedule II Valuation and Qualifying Accounts

12 Months Ended

Aug. 30, 2018

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

Schedule II Valuation and Qualifying Accounts

SCHEDULE II

VALUATION AND QUALIFYING ACCOUNTS

(in millions)

MICRON TECHNOLOGY, INC.



	Balance at Beginning of Year		Business Acquisitions		Charged (Credited) to Income Tax Provision			Currency Translation and Charges to Other Accounts			Balance at End of Year
Deferred Tax Asset Valuation Allowance
Year ended August 30, 2018	$	2,321	$	—	$	(2,079	)	$	(14	)	$	228
Year ended August 31, 2017	2,107		—		(64		)	278			2,321
Year ended September 1, 2016	2,051		10		(63		)	109			2,107

Amounts charged to other accounts for the year ended August 31, 2017 includes $325 million as a result of the adoption of ASU 2016-09 – Improvements to Employee Share-Based Payment Accounting.

Significant Accounting Policies (Policies)	12 Months Ended
Significant Accounting Policies (Policies)	Aug. 30, 2018
Accounting Policies [Abstract]
Basis of Presentation	The accompanying consolidated financial statements include the accounts of Micron and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America.
Reclassifications	Certain reclassifications have been made to prior period amounts to conform to current period presentation
Fiscal Period	Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2018, 2017, and 2016 each contained 52 weeks. All period references are to our fiscal periods unless otherwise indicated.
Derivative and Hedging Instruments	Derivative and Hedging Instruments: We use derivative instruments to manage our exposure to changes in currency exchange rates from (1) our monetary assets and liabilities denominated in currencies other than the U.S. dollar and (2) forecasted cash flows for certain capital expenditures. Derivative instruments are measured at their fair values and recognized as either assets or liabilities. The accounting for changes in the fair value of derivative instruments is based on the intended use of the derivative and the resulting designation. For derivative instruments that are not designated for hedge accounting, gains or losses from changes in fair values are recognized in other non-operating income (expense). For derivative instruments designated as cash flow hedges, the effective portion of the realized and unrealized gains or losses on derivatives is included as a component of accumulated other comprehensive income. Amounts in accumulated other comprehensive income are reclassified into earnings in the same line items and in the same periods in which the underlying transactions affect earnings. For the periods presented prior to the second quarter of 2018, the ineffective and excluded portion of the realized and unrealized gain or loss was included in other non-operating income (expense). As a result of adopting Accounting Standards Update ("ASU") 2017-12, beginning in the second quarter of 2018, such amounts are included in the same line item in which the underlying transactions affect earnings. For derivative forward contracts designated as fair value hedges, hedge effectiveness is determined by the change in the fair value of the undiscounted spot rate of the forward contract. The changes in fair values of hedge instruments attributed to changes in undiscounted spot rates are recognized in other non-operating income (expense). The time value associated with hedge instruments is excluded from the assessment of the effectiveness of hedges and is recognized on a straight-line basis over the life of hedges to other non-operating income (expense). We enter into master netting arrangements with our counterparties to mitigate credit risk in derivative hedge transactions. These master netting arrangements allow us and our counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled with each counterparty have been presented in our consolidated balance sheet on a net basis.
Financial Instruments, Cash Equivalents	Cash equivalents include highly liquid short-term investments with original maturities to us of three months or less that are readily convertible to known amounts of cash.
Financial Instruments, Investments	Other investments with remaining maturities of less than one year are included in short-term investments. Investments with remaining maturities greater than one year are included in long-term marketable investments. The carrying value of investment securities sold is determined using the specific identification method.
Functional Currency	Functional Currency: The U.S. dollar is the functional currency for us and all of our consolidated subsidiaries.
Goodwill	Goodwill and Non-Amortizing Intangible Assets: We perform an annual impairment assessment for goodwill and non-amortizing intangible assets in the fourth quarter of our fiscal year.
Non-Amortizing Intangible Assets	Goodwill and Non-Amortizing Intangible Assets: We perform an annual impairment assessment for goodwill and non-amortizing intangible assets in the fourth quarter of our fiscal year.
Government Incentives	Government Incentives: We receive incentives from governmental entities related to expenses, assets, and other activities. Our government incentives may require that we meet or maintain specified spending levels and other operational metrics and may be subject to reimbursement if such conditions are not met or maintained. Government incentives are recorded in the financial statements in accordance with their purpose: as a reduction of expenses, a reduction of asset costs, or other income. Incentives related to specific operating activities are offset against the related expense in the period the expense is incurred. Incentives related to the acquisition or construction of fixed assets are recognized as a reduction in the carrying amounts of the related assets and reduce depreciation expense over the useful lives of the assets. Other incentives are recognized as other operating income. Government incentives received prior to being earned are recognized in current or noncurrent deferred income, whereas government incentives earned prior to being received are recognized in current or noncurrent receivables. Cash received from government incentives related to operating expenses are included as an operating activity in the statement of cash flows, whereas cash received from incentives related to the acquisition of property, plant, and equipment are included as an investing activity.
Inventories	Inventories: Inventories are stated at the lower of average cost or net realizable value. Cost includes depreciation, labor, material, and overhead costs, including product and process technology costs. Determining net realizable value of inventories involves numerous judgments, including projecting future average selling prices, sales volumes, and costs to complete products in work in process inventories. When net realizable value is below cost, we record a charge to cost of goods sold to write down inventories to their estimated net realizable value in advance of when inventories are actually sold. We review the major characteristics of product type and markets in determining the unit of account for which we perform the lower of average cost or net realizable value analysis and categorize inventories primarily as memory (including DRAM, NAND, and other memory). We remove amounts from inventory and charge such amounts to cost of goods sold on an average cost basis.
Product and Process Technology	Product and Process Technology: Costs incurred to (1) acquire product and process technology, (2) patent technology, and (3) maintain patent technology, are capitalized and amortized on a straight-line basis over periods ranging up to 12.5 years. We capitalize a portion of the costs incurred to patent technology based on historical data of patents issued as a percent of patents we file. Capitalized product and process technology costs are amortized over the shorter of (1) the estimated useful life of the technology, (2) the patent term, or (3) the term of the technology agreement. Fully-amortized assets are removed from product and process technology and accumulated amortization.
Product Warranty	Product Warranty: We generally provide a limited warranty that our products are in compliance with applicable specifications existing at the time of delivery. Under our standard terms and conditions of sale, liability for certain failures of product during a stated warranty period is usually limited to repair or replacement of defective items or return of, or a credit with respect to, amounts paid for such items. Under certain circumstances, we provide more extensive limited warranty coverage than that provided under our standard terms and conditions. Our warranty obligations are not material.
Property, Plant, and Equipment	Property, Plant, and Equipment: Property, plant, and equipment is stated at cost and depreciated using the straight-line method over estimated useful lives of generally 10 to 30 years for buildings, 5 to 7 years for equipment, and 3 to 5 years for software. Assets held for sale are carried at the lower of cost or estimated fair value and are included in other noncurrent assets. When property, plant, or equipment is retired or otherwise disposed, the net book value is removed and we recognize any gain or loss in results of operations. We capitalize interest on borrowings during the period of time we carry out the activities necessary to bring assets to the condition of their intended use and location. Capitalized interest becomes part of the cost of assets. We periodically assess the estimated useful lives of our property, plant, and equipment. In the fourth quarter of 2016, we revised the estimated useful lives of equipment in our DRAM wafer fabrication facilities from five to seven years as a result of the lengthening period of time between DRAM product technology node transitions, an increased re-use rate of equipment, and industry trends. The effect of the revision reduced depreciation expense at the time by approximately $100 million
Research and Development	Research and Development: Costs related to the conceptual formulation and design of products and processes are charged to R&D expense as incurred. Development of a product is deemed complete when it is qualified through reviews and tests for performance and reliability. Subsequent to product qualification, product costs are included in cost of goods sold. Product design and other R&D costs for certain technologies may be shared with a development partner. Amounts receivable from cost-sharing arrangements are reflected as a reduction of R&D expense.
Revenue Recognition	Revenue Recognition: We recognize product or license revenue when persuasive evidence that a sales arrangement exists, delivery has occurred, the price is fixed or determinable, and collectibility is reasonably assured, which is generally at the time of shipment to our customers. If we are unable to reasonably estimate returns or the price is not fixed or determinable, sales made under agreements allowing rights of return or price protection are deferred until customers have resold the product.
Stock-based Compensation	Stock-based Compensation: Stock-based compensation is measured at the grant date, based on the fair value of the award, and recognized as expense under the straight-line attribution method over the requisite service period. We account for forfeitures as they occur. We issue new shares upon the exercise of stock options or conversion of share units.
Treasury Stock	Treasury Stock: Treasury stock is carried at cost. When we retire our treasury stock, any excess of the repurchase price paid over par value is allocated between additional capital and retained earnings.
Use of Estimates	Use of Estimates: The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that we believe to be reasonable under the circumstances. Estimates and judgments may differ under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis. Actual results could differ from estimates.

Variable Interest Entities (Policies)	12 Months Ended
Variable Interest Entities (Policies)	Aug. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	We have interests in entities that are VIEs. If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing, and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments.

Acquisition of Inotera (Tables) - Inotera

12 Months Ended

Aug. 30, 2018

Business Acquisition [Line Items]

Schedule of Inotera Acquisition

The allocation of purchase price to assets acquired and liabilities assumed of Inotera was as follows:



Consideration
Cash paid for Inotera Acquisition	$	4,099
Less cash received from sale of Micron Shares	(986		)
Net cash paid for Inotera Acquisition	3,113
Fair value of our previously-held equity interest in Inotera	1,441
Fair value of Micron Shares exchanged for Inotera shares	995
Other	3
Payments attributed to intercompany balances with Inotera	(361		)
	$	5,191

Assets acquired and liabilities assumed
Cash and equivalents	$	118
Inventories	285
Other current assets	27
Property, plant, and equipment	3,722
Deferred tax assets	82
Goodwill	1,124
Other noncurrent assets	130
Accounts payable and accrued expenses	(232		)
Debt	(56		)
Other noncurrent liabilities	(9		)
	$	5,191

Pro Forma Information including Inotera



	Year ended
	August 31, 2017		September 1, 2016
Net sales	$	20,317	$	12,341
Net income (loss)	5,172		(543		)
Net income (loss) attributable to Micron	5,171		(544		)
Earnings (loss) per share
Basic	4.68		(0.50		)
Diluted	4.42		(0.50		)

Cash and Investments (Tables)

12 Months Ended

Aug. 30, 2018

Investments [Abstract]

Cash and Investments

Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows:



As of	2018								2017
	Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value		Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value
Cash	$	3,223	$	—	$	—	$	3,223	$	2,237	$	—	$	—	$	2,237
Level 1⁽²⁾
Money market funds	2,443		—		—		2,443		2,332		—		—		2,332
Level 2⁽³⁾
Corporate bonds	3		172		272		447		—		193		315		508
Certificates of deposit	806		11		2		819		483		24		3		510
Government securities	5		63		103		171		1		90		126		217
Asset-backed securities	—		34		96		130		—		2		173		175
Commercial paper	26		16		—		42		56		10		—		66
	6,506		$	296	$	473	$	7,275	5,109		$	319	$	617	$	6,045
Restricted cash⁽⁴⁾	81								107
Cash, cash equivalents, and restricted cash	$	6,587							$	5,216


⁽¹⁾	The maturities of long-term marketable securities range from one to four years.


⁽²⁾	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.

⁽³⁾

⁽⁴⁾

Cash and equivalents and the fair values of available-for-sale investments

Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows:



As of	2018								2017
	Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value		Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value
Cash	$	3,223	$	—	$	—	$	3,223	$	2,237	$	—	$	—	$	2,237
Level 1⁽²⁾
Money market funds	2,443		—		—		2,443		2,332		—		—		2,332
Level 2⁽³⁾
Corporate bonds	3		172		272		447		—		193		315		508
Certificates of deposit	806		11		2		819		483		24		3		510
Government securities	5		63		103		171		1		90		126		217
Asset-backed securities	—		34		96		130		—		2		173		175
Commercial paper	26		16		—		42		56		10		—		66
	6,506		$	296	$	473	$	7,275	5,109		$	319	$	617	$	6,045
Restricted cash⁽⁴⁾	81								107
Cash, cash equivalents, and restricted cash	$	6,587							$	5,216


⁽¹⁾	The maturities of long-term marketable securities range from one to four years.


⁽²⁾	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.

⁽³⁾

⁽⁴⁾

Receivables (Tables)

12 Months Ended

Aug. 30, 2018

Receivables [Abstract]

Schedule of Receivables



As of	2018		2017
Trade receivables	$	5,056	$	3,490
Income and other taxes	161		100
Other	261		169
	$	5,478	$	3,759

Inventories (Tables)

12 Months Ended

Aug. 30, 2018

Inventory Disclosure [Abstract]

Schedule of Inventories



As of	2018		2017
Finished goods	$	815	$	856
Work in process	2,357		1,968
Raw materials and supplies	423		299
	$	3,595	$	3,123

Property, Plant, and Equipment (Tables)

12 Months Ended

Aug. 30, 2018

Property, Plant and Equipment [Abstract]

Schedule of Property, Plant, and Equipment



As of	2018			2017
Land	$	345		$	345
Buildings (includes $483 and $475, respectively, under capital leases)	8,680			7,958
Equipment⁽¹⁾ (includes $1,336 and $1,331, respectively, under capital leases)	38,249			32,187
Construction in progress⁽²⁾	1,162			499
Software	655			544
	49,091			41,533
Accumulated depreciation (includes $868 and $626, respectively, under capital leases)	(25,419		)	(22,102		)
	$	23,672		$	19,431


⁽¹⁾	Included costs related to equipment not placed into service of $1.73 billion and $994 million, as of August 30, 2018 and August 31, 2017, respectively.


⁽²⁾	Included building-related construction and tool installation costs for assets not placed into service.

Equity Method Investments (Tables)

12 Months Ended

Aug. 30, 2018

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Equity Method Investments

Equity in net income (loss) of equity method investees, net of tax, included the following:



For the year ended	2018			2017			2016
Inotera	$	—		$	9		$	32
Tera Probe	—			(3		)	(11		)
Other	(1		)	2			4
	$	(1	)	$	8		$	25

Intangible Assets and Goodwill (Tables)

12 Months Ended

Aug. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets and Goodwill



As of	2018					2017
	Gross Amount		Accumulated Amortization			Gross Amount		Accumulated Amortization
Amortizing assets
Product and process technology	$	567	$	(344	)	$	756	$	(477	)
Non-amortizing assets
In-process R&D	108		—			108		—

Total intangible assets	$	675	$	(344	)	$	864	$	(477	)

Goodwill	$	1,228				$	1,228

Accounts Payable and Accrued Expenses (Tables)

12 Months Ended

Aug. 30, 2018

Payables and Accruals [Abstract]

Schedule of Accounts Payable And Accrued Expenses



As of	2018		2017
Accounts payable	$	1,692	$	1,333
Property, plant, and equipment payables	1,238		1,018
Salaries, wages, and benefits	841		603
Income and other taxes	402		163
Customer advances	207		197
Other	231		350
	$	4,611	$	3,664

Debt (Tables)

12 Months Ended

Aug. 30, 2018

Debt Disclosure [Abstract]

Schedule of Debt



As of	2018												2017
							Net Carrying Amount								Net Carrying Amount
Instrument	Stated Rate		Effective Rate		Principal		Current		Long-Term		Total⁽¹⁾		Principal		Current		Long-Term		Total⁽¹⁾
IMFT Member Debt	N/A		N/A		$	1,009	$	—	$	1,009	$	1,009	$	—	$	—	$	—	$	—
Capital lease obligations	N/A		3.86	%	845		310		535		845		1,190		357		833		1,190
MMJ Creditor Payments	N/A		9.76	%	520		309		183		492		695		$	157	474		631
2022 Term Loan B	3.83	%	4.24	%	735		5		720		725		743		5		725		730
2025 Notes	5.50	%	5.56	%	519		—		515		515		519		—		515		515
2032D Notes⁽²⁾	3.13	%	6.33	%	143		—		132		132		177		—		159		159
2033F Notes⁽²⁾⁽³⁾	2.13	%	4.93	%	107		235		—		235		297		278		—		278
2043G Notes⁽²⁾⁽⁴⁾	3.00	%	6.76	%	1,019		—		682		682		1,025		—		671		671
2021 MSAC Term Loan	4.42	%	4.65	%	—		—		—		—		800		99		697		796
2021 MSTW Term Loan	2.85	%	3.01	%	—		—		—		—		2,652		—		2,640		2,640
2023 Notes	5.25	%	5.43	%	—		—		—		—		1,000		—		991		991
2023 Secured Notes	7.50	%	7.69	%	—		—		—		—		1,250		—		1,238		1,238
2024 Notes	5.25	%	5.38	%	—		—		—		—		550		—		546		546
2026 Notes	5.63	%	5.73	%	—		—		—		—		129		—		128		128
2032C Notes	2.38	%	5.95	%	—		—		—		—		223		—		211		211
2033E Notes	1.63	%	1.63	%	—		—		—		—		173		202		—		202
Other notes	2.50	%	2.50	%	1		—		1		1		216		164		44		208
					$	4,898	$	859	$	3,777	$	4,636	$	11,639	$	1,262	$	9,872	$	11,134

⁽¹⁾

⁽²⁾

⁽³⁾


⁽⁴⁾	The 2043G Notes outstanding as of August 30, 2018 have an original principal amount of $815 million that accretes up to $911 million through the expected term in November 2028 and $1.02 billion at maturity in 2043.

Schedule of MMJ Creditor Payments

The following table presents the remaining amounts of MMJ Creditor Payments (stated in Japanese yen and U.S. dollars) and the amount of unamortized discount as of August 30, 2018:



2019	¥	36,392		$	326
2020	21,720			194
	58,112			520
Less unamortized discount	(3,186		)	(28		)
	¥	54,926		$	492

Schedule of Convertible Senior Notes



	Holder Put Date⁽¹⁾	Maturity Date	Conversion Price Per Share		Conversion Price Per Share Threshold⁽²⁾		Underlying Shares of Common Stock	Conversion Value in Excess of Principal⁽³⁾		Principal Settlement Option⁽⁴⁾
2032D Notes	May 2021	May 2032	$	9.98	$	12.97	14	$	615	Cash and/or shares
2033F Notes⁽⁵⁾	Feb 2020	Feb 2033	10.93		14.21		10	408		Cash
2043G Notes	Nov 2028	Nov 2043	29.16		37.91		35	824		Cash and/or shares
							59	$	1,847


⁽¹⁾	Debt discount and debt issuance costs are amortized through the earliest holder put date.


⁽²⁾	Represents 130% of the conversion price per share. If the trading price of our common stock exceeds such threshold for a specified period, holders may convert such notes during a specified period. See "Conversion Rights" below.


⁽³⁾	Based on the trading price of our common stock of $52.76 as of August 30, 2018.

⁽⁴⁾


⁽⁵⁾	Holders may put their notes to us on February 15, 2023.

Redemption Features of Convertible Debt



	Conditional Redemption Period at Our Option⁽¹⁾	Unconditional Redemption Period at Our Option	Redemption Period Requiring Make-Whole
2032D Notes	On or after May 1, 2017	On or after May 4, 2021	Prior to May 4, 2021⁽²⁾
2033F Notes	N/A	On or after Feb 20, 2020	N/A
2043G Notes	Prior to Nov 20, 2018	On or after Nov 20, 2018	Prior to Nov 20, 2018⁽³⁾


⁽¹⁾	We may redeem for cash on or after the applicable dates if the volume weighted average price of our common stock has been at least 130% of the conversion price for at least 20 trading days during any 30 consecutive trading day period.


⁽²⁾	If we redeem prior to the applicable date, we will pay a make-whole premium in cash equal to the present value of the remaining scheduled interest payments from the redemption date to May 4, 2021.


⁽³⁾	If we redeem prior to the applicable date, we will be required to pay a make-whole premium only if, as a result of our redemption notice, holders convert their notes. The make-whole premium will be based on the price of our common stock and the conversion date, as set forth in the indenture, and is payable at our election in cash and/or shares.

Debt Prepayments, Repurchases, and Conversions

The following table presents the effects of prepayments, repurchases, and conversions of debt in 2018:



	Decrease in Principal			Increase (Decrease) in Carrying Value			Decrease in Cash			Decrease in Equity			Gain (Loss)
Prepayments and repurchases
2021 MSAC Term Loan	$	(730	)	$	(727	)	$	(730	)	$	—		$	(3	)
2021 MSTW Term Loan	(2,625		)	(2,616		)	(2,625		)	—			(10		)
2023 Notes	(1,000		)	(991		)	(1,046		)	—			(55		)
2023 Secured Notes	(1,250		)	(1,238		)	(1,373		)	—			(135		)
2024 Notes	(550		)	(546		)	(572		)	—			(25		)
2026 Notes	(129		)	(129		)	(139		)	—			(11		)
2033F Notes	(66		)	(63		)	(316		)	(252		)	(1		)
Other Notes	(46		)	(44		)	(46		)	—			(2		)
Settled conversions
2032C Notes	(223		)	(216		)	(1,230		)	(965		)	(50		)
2032D Notes	(34		)	(31		)	(182		)	(145		)	(6		)
2033E Notes⁽¹⁾	(173		)	(203		)	(552		)	(297		)	(52		)
2033F Notes	(124		)	(118		)	(596		)	(462		)	(16		)
2043G Notes	(6		)	(4		)	(13		)	(5		)	(4		)
Conversions not settled
2033F Notes⁽²⁾	—			132			—			(117		)	(15		)
	$	(6,956	)	$	(6,794	)	$	(9,420	)	$	(2,243	)	$	(385	)


⁽¹⁾	Settlement included issuance of 4 million shares of our treasury stock in addition to payment of cash.


⁽²⁾	As of August 30, 2018, an aggregate of $35 million principal amount of our 2033F Notes (with a carrying value of $165 million) had converted but not settled. These notes settled in the first quarter of 2019 for $153 million in cash.

Maturities of Notes Payable and Future Minimum Lease Payments

As of August 30, 2018, maturities of notes payable (including the MMJ Creditor Payments) and future minimum lease payments under capital lease obligations were as follows:



	Notes Payable			Capital Lease Obligations
2019	$	501		$	339
2020	274			231
2021	151			100
2022	713			66
2023	—			42
2024 and thereafter	2,439			187
Unamortized discounts and interest, respectively	(287		)	(120		)
	$	3,791		$	845

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Commitments and Contingencies Disclosure [Abstract]

Commitments (Tables)

12 Months Ended

Aug. 30, 2018

Schedule of Minimum Future Operating Lease Commitments

Minimum future operating lease commitments as of August 30, 2018 were as follows:



2019	$	37
2020	43
2021	50
2022	50
2023	45
2024 and thereafter	391
	$	616

Equity (Tables)

12 Months Ended

Aug. 30, 2018

Variable Interest Entity [Line Items]

Schedule of Accumulated Other Comprehensive Income (Loss)



	Cumulative Foreign Currency Translation Adjustments			Gains (Losses) on Derivative Instruments			Pension Liability Adjustments			Unrealized Gains (Losses) on Investments			Total
As of August 31, 2017	$	(1	)	$	17		$	13		$	—		$	29
Other comprehensive income	1			(17		)	(3		)	(3		)	(22		)
Amount reclassified out of accumulated other comprehensive income	—			(1		)	(1		)	—			(2		)
Tax effects	—			3			1			1			5
Other comprehensive income	1			(15		)	(3		)	(2		)	(19		)
As of August 30, 2018	$	—		$	2		$	10		$	(2	)	$	10

Schedule Of Noncontrolling Interests In Subsidiaries



As of	2018				2017
	Balance		Percentage		Balance		Percentage
IMFT	$	853	49	%	$	832	49	%
Other	17		Various		17		Various
	$	870			$	849

IM Flash Technologies, LLC

Variable Interest Entity [Line Items]

Total IMFT assets and liabilities

The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets:



As of	2018		2017
Assets
Cash and equivalents	$	91	$	87
Receivables	126		81
Inventories	114		128
Other current assets	8		7
Total current assets	339		303
Property, plant, and equipment	2,641		1,852
Other noncurrent assets	45		49
Total assets	$	3,025	$	2,204

Liabilities
Accounts payable and accrued expenses	$	138	$	299
Deferred income	9		6
Current debt	20		19
Total current liabilities	167		324
Long-term debt	1,064		75
Other noncurrent liabilities	74		88
Total liabilities	$	1,305	$	487

Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

Estimated fair value and carrying value of debt instruments

Fair Value Measurements (Tables)

12 Months Ended

Aug. 30, 2018

Fair Value Disclosures [Abstract]

The estimated fair value and carrying value of our outstanding debt instruments (excluding the carrying value of equity and mezzanine equity components of our convertible notes) were as follows:



As of	2018				2017
	Fair Value		Carrying Value		Fair Value		Carrying Value
Convertible notes	$	3,124	$	1,049	$	3,901	$	1,521
Notes and MMJ Creditor Payments	2,798		2,742		8,793		8,423

Derivative Instruments (Tables)

12 Months Ended

Aug. 30, 2018

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments



	Gross Notional Amount⁽¹⁾		Fair Value of
	Gross Notional Amount⁽¹⁾		Current Assets⁽²⁾		Current Liabilities⁽³⁾			Noncurrent Assets⁽⁴⁾
As of August 30, 2018
Derivative instruments with hedge accounting designation
Cash flow currency hedges	$	538	$	—	$	(13	)	$	—

Derivative instruments without hedge accounting designation
Non-designated currency hedges	1,919		14		(10		)	—
Convertible notes settlement obligation⁽⁵⁾			—		(167		)	—
			14		(177		)	—

			$	14	$	(190	)	$	—

As of August 31, 2017
Derivative instruments with hedge accounting designation
Cash flow currency hedges	$	456	$	17	$	—		$	—

Derivative instruments without hedge accounting designation
Non-designated currency hedges	4,847		34		(5		)	1
Convertible notes settlement obligation⁽⁵⁾			—		(47		)	—
			34		(52		)	1

			$	51	$	(52	)	$	1


⁽¹⁾	Notional amounts of currency hedge contracts in U.S. dollars.


⁽²⁾	Included in receivables – other.


⁽³⁾	Included in accounts payable and accrued expenses – other for forward contracts and in current debt for convertible notes settlement obligations.


⁽⁴⁾	Included in other noncurrent assets.


⁽⁵⁾	Notional amounts of convertible notes settlement obligations as of August 30, 2018 and August 31, 2017 were 3 million and 2 million shares of our common stock, respectively.

Schedule of Gains and Losses on Fair Value Hedges

The effects of fair value hedges on our consolidated statements of operations were as follows:



	Other Non-Operating Income (Expense)
For the year ended	2018
Gain (loss) on remeasurement of hedged assets and liabilities	$	(25	)
Gain (loss) on derivatives designated as hedging instruments	25
Amortization of amounts excluded from hedge effectiveness	(32		)
	$	(32	)

Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Equity Plans (Tables)

12 Months Ended

Aug. 30, 2018

Schedule of Option Activity

Option activity for 2018 is summarized as follows:



	Number of Shares		Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Life (In Years)	Aggregate Intrinsic Value
Outstanding as of August 31, 2017	33		$	19.32
Granted	2		43.30
Exercised	(16	)	17.82
Canceled or expired	(1	)	22.67
Outstanding as of August 30, 2018	18		23.38		4.8	$	527

Exercisable as of August 30, 2018	8		$	21.66	3.2	$	233
Unvested as of August 30, 2018	10		24.61		6.0	294

Stock Options Granted and Valuation Assumptions

Stock options granted and assumptions used in the Black-Scholes option valuation model were as follows:



For the year ended	2018			2017			2016
Stock options granted	2			8			8
Weighted-average grant-date fair value per share	$	18.65		$	8.68		$	6.94
Average expected life in years	5.5			5.5			5.5
Weighted-average expected volatility	44		%	46		%	47		%
Weighted-average risk-free interest rate	2.2		%	1.8		%	1.7		%
Expected dividend yield	0.0		%	0.0		%	0.0		%

Schedule of Restricted Stock Awards Activity

Restricted Stock Awards activity for 2018 is summarized as follows:



	Number of Shares		Weighted-Average Grant Date Fair Value Per Share
Outstanding as of August 31, 2017	19		$	19.78
Granted	4		42.48
Restrictions lapsed	(6	)	21.70
Canceled	(2	)	21.93
Outstanding as of August 30, 2018	15		25.18



For the year ended	2018		2017		2016
Restricted stock award shares granted	4		8		10
Weighted-average grant-date fair value per share	$	42.48	$	18.77	$	15.40
Aggregate vesting-date fair value of shares vested	$	259	$	115	$	71

Employee Stock Purchase Plan Valuation Assumptions

Assumptions used in the Black-Scholes option valuation model for the offering period beginning August 1, 2018 were as follows:



Weighted-average grant-date fair value per share	$	14.55
Average expected life in years	0.5
Weighted-average expected volatility	43		%
Weighted-average risk-free interest rate	2.2		%
Expected dividend yield	0.0		%

Stock-based Compensation Expense by Caption



For the year ended	2018		2017		2016
Stock-based compensation expense by caption
Cost of goods sold	$	83	$	88	$	76
Selling, general, and administrative	61		75		66
Research and development	54		52		49
	$	198	$	215	$	191

Stock-based compensation expense by type of award
Stock options	$	55	$	71	$	79
Restricted stock awards	140		144		112
ESPP	3		—		—
	$	198	$	215	$	191

Other Operating (Income) Expense, Net (Tables)

12 Months Ended

Aug. 30, 2018

Other Income and Expenses [Abstract]

Schedule of Other Operating (Income) Expense, Net



For the year ended	2018			2017			2016
(Gain) loss on disposition of property, plant, and equipment	$	(96	)	$	(22	)	$	(4	)
Restructure and asset impairments	28			18			67
Other	11			5			(2		)
	$	(57	)	$	1		$	61

Other Non-Operating Income (Expense), Net (Tables)

12 Months Ended

Aug. 30, 2018

Other Nonoperating Income (Expense) [Abstract]

Schedule of Other Nonoperating Income (Expense), Net



For the year ended	2018			2017			2016
Loss on debt prepayments, repurchases, and conversions	$	(385	)	$	(100	)	$	(4	)
Loss from changes in currency exchange rates	(75		)	(74		)	(24		)
Gain on remeasurement of previously-held equity interest in Inotera	—			71			—
Other	(5		)	(9		)	(26		)
	$	(465	)	$	(112	)	$	(54	)

Income Taxes (Tables)

12 Months Ended

Aug. 30, 2018

Income Tax Disclosure [Abstract]

Schedule of Income (loss) Before Tax and Other Items

Our income tax (provision) benefit consisted of the following:



For the year ended	2018			2017			2016
Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees
U.S.	$	141		$	(56	)	$	72
Foreign	14,166			5,252			(353		)
	$	14,307		$	5,196		$	(281	)

Income tax (provision) benefit
Current
U.S. federal	$	(54	)	$	—		$	—
State	1			(1		)	(1		)
Foreign	(374		)	(152		)	(27		)
	(427		)	(153		)	(28		)
Deferred
U.S. federal	232			—			39
State	101			—			2
Foreign	(74		)	39			(32		)
	259			$	39		9

Income tax (provision) benefit	$	(168	)	$	(114	)	$	(19	)

Schedule of Components of Income Tax (Provision) Benefit

Our income tax (provision) benefit consisted of the following:



For the year ended	2018			2017			2016
Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees
U.S.	$	141		$	(56	)	$	72
Foreign	14,166			5,252			(353		)
	$	14,307		$	5,196		$	(281	)

Income tax (provision) benefit
Current
U.S. federal	$	(54	)	$	—		$	—
State	1			(1		)	(1		)
Foreign	(374		)	(152		)	(27		)
	(427		)	(153		)	(28		)
Deferred
U.S. federal	232			—			39
State	101			—			2
Foreign	(74		)	39			(32		)
	259			$	39		9

Income tax (provision) benefit	$	(168	)	$	(114	)	$	(19	)

Schedule of Effective Income Tax Reconciliation

The table below reconciles our tax (provision) benefit based on the U.S. federal statutory rate to our effective rate:



For the year ended	2018					2017					2016
U.S. federal income tax (provision) benefit at statutory rate	$	(3,677	)	25.7	%	$	(1,819	)	35.0	%	$	98		35.0	%
Foreign tax rate differential	2,572			(18.0	)%	1,571			(30.2	)%	(300		)	(106.8	)%
Repatriation Tax related to the Tax Act	(1,049		)	7.3	%	—			—	%	—			—	%
Remeasurement of deferred tax assets and liabilities related to the Tax Act	(179		)	1.3	%	—			—	%	—			—	%
Change in valuation allowance	2,079			(14.5	)%	64			(1.2	)%	63			22.4	%
Change in unrecognized tax benefits	60			(0.4	)%	12			(0.2	)%	52			18.5	%
Tax credits	90			(0.6	)%	66			(1.3	)%	48			17.1	%
Other	(64		)	0.4	%	(8		)	0.1	%	20			7.0	%
Income tax (provision) benefit	$	(168	)	1.2	%	$	(114	)	2.2	%	$	(19	)	(6.8	)%

Schedule of Deferred Tax Assets and Liabilities

Deferred tax assets and liabilities consist of the following:



As of	2018			2017
Deferred tax assets
Net operating loss and tax credit carryforwards	$	1,417		$	3,426
Accrued salaries, wages, and benefits	163			211
Other accrued liabilities	35			59
Other	80			86
Gross deferred tax assets	1,695			3,782
Less valuation allowance	(228		)	(2,321		)
Deferred tax assets, net of valuation allowance	1,467			1,461

Deferred tax liabilities
Debt discount	(77		)	(145		)
Property, plant, and equipment	(173		)	(300		)
Unremitted earnings on certain subsidiaries	(82		)	(123		)
Product and process technology	(62		)	(85		)
Other	(54		)	(59		)
Deferred tax liabilities	(448		)	(712		)

Net deferred tax assets	$	1,019		$	749

Reported as
Deferred tax assets	$	1,022		$	766
Deferred tax liabilities (included in other noncurrent liabilities)	(3		)	(17		)
Net deferred tax assets	$	1,019		$	749

Net Operating Loss Carryforwards

As of August 30, 2018, our federal, state, and foreign net operating loss carryforward amounts and expiration periods, as reported to tax authorities, were as follows:



Year of Expiration	U.S. Federal		State		Japan		Taiwan		Other Foreign		Total
2019 - 2023	$	—	$	28	$	1,782	$	711	$	2	$	2,523
2024 - 2028	—		136		536		3		—		675
2029 - 2033	—		407		—		—		—		407
2034 - 2038	10		84		—		—		—		94
Indefinite	—		1		—		622		38		661
	$	10	$	656	$	2,318	$	1,336	$	40	$	4,360

Federal and State Tax Credit Carryforwards

As of August 30, 2018, our federal and state tax credit carryforward amounts and expiration periods, as reported to tax authorities, were as follows:



Year of Tax Credit Expiration	U.S. Federal		State		Total
2019 - 2023	$	122	$	63	$	185
2024 - 2028	44		46		90
2029 - 2033	69		90		159
2034 - 2038	275		3		278
Indefinite	—		62		62
	$	510	$	264	$	774

Unrecognized Tax Benefits Rollforward

Below is a reconciliation of the beginning and ending amount of our unrecognized tax benefits:



For the year ended	2018			2017			2016
Beginning unrecognized tax benefits	$	327		$	304		$	351
Increases due to the Inotera Acquisition	—			54			—
Increases related to tax positions taken in current year	68			15			5
Foreign currency translation increases (decreases) to tax positions	—			2			—
Settlements with tax authorities	(8		)	(47		)	(47		)
Expiration of statute of limitations	—			(1		)	(5		)
Decreases related to tax positions from prior years	(126		)	—			—
Ending unrecognized tax benefits	$	261		$	327		$	304

Earnings Per Share (Tables)

12 Months Ended

Aug. 30, 2018

Earnings Per Share [Abstract]

Basic and Diluted Earnings Per Share



For the year ended	2018		2017		2016
Net income (loss) attributable to Micron – Basic and Diluted	$	14,135	$	5,089	$	(276	)

Weighted-average common shares outstanding – Basic	1,152		1,089		1,036
Dilutive effect of equity plans and convertible notes	77		65		—
Weighted-average common shares outstanding – Diluted	1,229		1,154		1,036

Earnings (loss) per share
Basic	$	12.27	$	4.67	$	(0.27	)
Diluted	11.51		4.41		(0.27		)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share



For the year ended	2018	2017	2016
Equity plans	3	21	60
Convertible notes	—	26	119

Segment Information (Tables)

12 Months Ended

Aug. 30, 2018

Schedule of Results by Segment



For the year ended	2018			2017			2016
Net sales
CNBU	$	15,252		$	8,624		$	4,529
MBU	6,579			4,424			2,569
SBU	5,022			4,514			3,262
EBU	3,479			2,695			1,939
All Other	59			65			100
	$	30,391		$	20,322		$	12,399

Operating income (loss)
CNBU	$	9,773		$	3,755		$	(25	)
MBU	3,033			927			97
SBU	964			552			(123		)
EBU	1,473			975			473
All Other	—			23			28
	$	15,243		$	6,232		$	450

Unallocated
Stock-based compensation	$	(198	)	$	(215	)	$	(191	)
Restructure and asset impairments	(28		)	(18		)	(67		)
Flow-through of Inotera inventory step up	—			(107		)	—
Other	(23		)	(24		)	(24		)
	$	(249	)	$	(364	)	$	(282	)

Operating income	$	14,994		$	5,868		$	168

Depreciation and amortization expense included in operating income was as follows:



For the year ended	2018		2017		2016
CNBU	$	1,755	$	1,344	$	1,141
MBU	1,077		926		580
SBU	1,295		1,083		844
EBU	603		484		379
All Other	18		13		20
Unallocated	11		11		16
	$	4,759	$	3,861	$	2,980

Product Sales (Tables)

12 Months Ended

Aug. 30, 2018

Segment Reconciliation [Abstract]

Schedule of Product Sales



For the year ended	2018		2017		2016
DRAM	$	21,232	$	12,963	$	7,207
Trade NAND	7,843		6,228		4,138
Non-Trade	554		553		501
Other	762		578		553
	$	30,391	$	20,322	$	12,399

Certain Concentrations (Tables)

12 Months Ended

Aug. 30, 2018

Risks and Uncertainties [Abstract]

Schedule of Market Concentration Risk

Markets with concentrations of net sales were approximately as follows:



For the year ended	2018		2017		2016
Compute and graphics	25	%	20	%	20	%
Server	25	%	15	%	10	%
Mobile	20	%	20	%	20	%
SSDs and other storage	15	%	20	%	20	%
Automotive, industrial, medical, and other embedded	10	%	15	%	15	%

Geographic Information (Tables)

12 Months Ended

Aug. 30, 2018

Geographic Net Sales based on Ship-to Location

Geographic net sales based on customer ship-to location were as follows:



For the year ended	2018		2017		2016
China	$	17,357	$	10,388	$	5,301
United States	3,624		2,763		1,925
Taiwan	2,798		2,544		1,521
Other Asia Pacific	2,559		1,808		1,610
Europe	2,128		1,360		937
Japan	1,254		1,025		831
Other	671		434		274
	$	30,391	$	20,322	$	12,399

Net Property, Plant, and Equipment by Geographic Areas

Net property, plant, and equipment by geographic area was as follows:



As of	2018		2017
Taiwan	$	7,640	$	6,519
Singapore	6,933		5,261
United States	5,113		4,253
Japan	3,451		2,827
China	398		453
Other	137		118
	$	23,672	$	19,431

Quarterly Financial Information (Tables)

12 Months Ended

Aug. 30, 2018

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information



2018	Fourth Quarter		Third Quarter		Second Quarter		First Quarter
Net sales	$	8,440	$	7,797	$	7,351	$	6,803
Gross margin	5,151		4,723		4,270		3,747
Operating income	4,377		3,953		3,567		3,097
Net income	4,326		3,823		3,311		2,678
Net income attributable to Micron	4,325		3,823		3,309		2,678

Earnings per share
Basic	$	3.73	$	3.30	$	2.86	$	2.36
Diluted	3.56		3.10		2.67		2.19



2017	Fourth Quarter		Third Quarter		Second Quarter		First Quarter
Net sales	$	6,138	$	5,566	$	4,648	$	3,970
Gross margin	3,112		2,609		1,704		1,011
Operating income	2,502		1,963		1,044		359
Net income	2,369		1,647		894		180
Net income attributable to Micron	2,368		1,647		894		180

Earnings per share
Basic	$	2.13	$	1.49	$	0.81	$	0.17
Diluted	1.99		1.40		0.77		0.16

Schedule II Valuation and Qualifying Accounts (Tables)

12 Months Ended

Aug. 30, 2018

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

Deferred Tax Asset Valuation Allowance



	Balance at Beginning of Year		Business Acquisitions		Charged (Credited) to Income Tax Provision			Currency Translation and Charges to Other Accounts			Balance at End of Year
Deferred Tax Asset Valuation Allowance
Year ended August 30, 2018	$	2,321	$	—	$	(2,079	)	$	(14	)	$	228
Year ended August 31, 2017	2,107		—		(64		)	278			2,321
Year ended September 1, 2016	2,051		10		(63		)	109			2,107

Significant Accounting Policies - Product and Process Technology (Details)	12 Months Ended
	Aug. 30, 2018
Product and process technology \| Maximum
Finite-Lived Intangible Assets [Line Items]
Maximum life of product and process technology intangible assets (in years)	12 years 6 months

Significant Accounting Policies - Property, Plant and Equipment (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 01, 2016	Jun. 02, 2016	Aug. 30, 2018
Buildings \| Minimum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)			10 years
Buildings \| Maximum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)			30 years
Equipment \| Minimum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)			5 years
Equipment \| Maximum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)			7 years
Software \| Minimum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)			3 years
Software \| Maximum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)			5 years
Service Life \| DRAM fabrication equipment
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	7 years	5 years
Quarterly decrease in depreciation expense from change in useful life	$ 100

Variable Interest Entities (Details) - USD ($) $ in Millions	Aug. 30, 2018	Aug. 31, 2017
Variable Interest Entity, Nonconsolidated, Carrying Amount, Assets and Liabilities, Net [Abstract]
Variable Interest Entity (PTI Xi'an), Nonconsolidated, Carrying Amount of Capital Leases	$ 63	$ 80
Variable Interest Entity (PTI Xi'an), Nonconsolidated, Carrying Amount of PP&E	$ 63	$ 76

Recently Issued Accounting Standards (Details) - ASU 2014-09 - USD ($) $ in Millions	12 Months Ended
	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Customers with Price Protection or Rights of Return
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Percent of revenue from customers with price protection or rights of return	19.00%	20.00%	25.00%
Distribution Customers
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Deferred revenue related to sales to distributors	$ 232

Acquisition of Inotera (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		12 Months Ended
	Dec. 06, 2016	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016	Dec. 05, 2016
Acquisition of Inotera
Gain on remeasurement of previously-held equity interest in Inotera		$ 0	$ 71	$ 0
Consideration
Payments attributed to intercompany balances with Inotera		0	361	0
Assets acquired and liabilities assumed
Goodwill		1,228	1,228
Unaudited Pro Forma Financial Information
Net sales			20,317	12,341
Net Income (Loss)			5,172	(543)
Net income (loss) attributable to Micron			$ 5,171	$ (544)
Earnings (loss) per share, basic (in dollars per share)			$ 4.68	$ (0.50)
Earnings (loss) per share, diluted (in dollars per share)			$ 4.42	$ (0.50)
CNBU
Assets acquired and liabilities assumed
Goodwill		832	$ 832
MBU
Assets acquired and liabilities assumed
Goodwill		198	198
EBU
Assets acquired and liabilities assumed
Goodwill		$ 97	97
Inotera \| Nanya and certain of its affiliates
Acquisition of Inotera
Percentage interest in Inotera held by Nanya immediately prior to acquisition (in hundredths)					32.00%
Inotera
Acquisition of Inotera
Ownership interest in Inotera immediately prior to acquisition (in hundredths)					33.00%
Percentage of Inotera voting interests acquired (in hundredths)	67.00%
Transaction costs incurred in connection with acquisition of Inotera			13	$ 3
Micron Shares
Proceeds from issuance of stock to Nanya	$ 986
Consideration
Cash paid for Inotera Acquisition	4,099
Less cash received from selling Micron Shares	(986)
Net cash paid for Inotera Acquisition	3,113
Fair value of our previously-held equity interest in Inotera	1,441
Fair value of Micron Shares exchanged for Inotera shares	995
Other	3
Payments attributed to intercompany balances with Inotera	(361)
Total fair value of consideration for Inotera including previously held equity interests	5,191
Assets acquired and liabilities assumed
Cash and equivalents	118
Inventories	285
Other current assets	27
Property, plant, and equipment	3,722
Deferred tax assets	82
Goodwill	1,124
Other noncurrent assets	130
Accounts payable and accrued expenses	(232)
Debt	(56)
Other noncurrent liabilities	(9)
Total assets acquired and liabilities assumed, including goodwill	5,191
Inotera \| CNBU
Assets acquired and liabilities assumed
Goodwill	829
Inotera \| MBU
Assets acquired and liabilities assumed
Goodwill	198
Inotera \| EBU
Assets acquired and liabilities assumed
Goodwill	$ 97
Inotera \| Level 3
Acquisition of Inotera
Gain on remeasurement of previously-held equity interest in Inotera			$ 71
Inotera \| Shares Issued to Nanya
Micron Shares
Number of Micron Shares issued to Nanya as consideration for Inotera shares not already owned (in shares)	58
Proceeds from issuance of stock to Nanya	$ 986
Consideration
Less cash received from selling Micron Shares	(986)
Inotera \| Shares Issued to Nanya \| Level 2
Micron Shares
Discount for lack of transferability on Micron Shares issued to Nanya	$ 81

Cash and Investments (Details) - USD ($)

12 Months Ended

Aug. 30, 2018

Aug. 31, 2017

Sep. 01, 2016

Sep. 03, 2015

Debt Securities, Available-for-sale [Line Items]

$ 6,506,000,000

$ 5,109,000,000

296,000,000

319,000,000

^[1]

473,000,000

617,000,000

Cash, cash equivalents, and restricted cash

7,275,000,000

6,045,000,000

Restricted cash

^[2]

81,000,000

107,000,000

6,587,000,000

5,216,000,000

$ 4,263,000,000

$ 2,375,000,000

Debt Securities, Available-for-sale, Unrealized Loss Position [Abstract]

Available-for-sale securities in an unrealized loss position for longer than twelve months

$ 0

Minimum

Debt Securities, Available-for-sale [Line Items]

Long-term marketable investments, general maturities (in years)

1 year

Maximum

Debt Securities, Available-for-sale [Line Items]

Long-term marketable investments, general maturities (in years)

4 years

Cash

Debt Securities, Available-for-sale [Line Items]

$ 3,223,000,000

2,237,000,000

Money market funds | Level 1

3,223,000,000

2,237,000,000

Debt Securities, Available-for-sale [Line Items]

^[3]

2,443,000,000

2,332,000,000

^[3]

^[1],[3]

Corporate Bonds | Level 2

^[3]

2,443,000,000

2,332,000,000

Debt Securities, Available-for-sale [Line Items]

^[4]

3,000,000

^[4]

172,000,000

193,000,000

^[1],[4]

272,000,000

315,000,000

Certificates of deposit | Level 2

^[4]

447,000,000

508,000,000

Debt Securities, Available-for-sale [Line Items]

^[4]

806,000,000

483,000,000

^[4]

11,000,000

24,000,000

^[1],[4]

2,000,000

3,000,000

Government securities | Level 2

^[4]

819,000,000

510,000,000

Debt Securities, Available-for-sale [Line Items]

^[4]

5,000,000

1,000,000

^[4]

63,000,000

90,000,000

^[1],[4]

103,000,000

126,000,000

Asset-backed securities | Level 2

^[4]

171,000,000

217,000,000

Debt Securities, Available-for-sale [Line Items]

^[4]

^[4]

34,000,000

2,000,000

^[1],[4]

96,000,000

173,000,000

Commercial paper | Level 2

^[4]

130,000,000

175,000,000

Debt Securities, Available-for-sale [Line Items]

^[4]

26,000,000

56,000,000

^[4]

16,000,000

10,000,000

^[1],[4]

Property, Plant and Equipment, Net, by Type [Abstract]

^[4]

$ 42,000,000

$ 66,000,000

[1]	The maturities of long-term marketable securities range from one to four years.
[2]	Restricted cash is included in other noncurrent assets and included balances related to the MMJ Creditor Payments. The restrictions on the MMJ Creditor Payments lapse upon approval by the trustees and/or Tokyo District Court. Restricted cash as of August 31, 2017 also included interest reserve balances related to our 2021 MSTW Term Loan, which were released in 2018 in connection with our prepayment of the 2021 MSTW Term Loan. (See "Debt" note.)
[3]	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.
[4]	The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of August 30, 2018 or August 31, 2017.

Receivables (Details) - USD ($) $ in Millions	Aug. 30, 2018	Aug. 31, 2017
Receivables [Abstract]
Trade receivables	$ 5,056	$ 3,490
Income and other taxes	161	100
Other	261	169
Receivables	$ 5,478	$ 3,759

Inventories (Details) - USD ($) $ in Millions	Aug. 30, 2018	Aug. 31, 2017
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Finished goods	$ 815	$ 856
Work in process	2,357	1,968
Raw materials and supplies	423	299
Inventories	$ 3,595	$ 3,123

Property, Plant, and Equipment (Details) - USD ($)
$ in Millions

12 Months Ended

Aug. 30, 2018

Aug. 31, 2017

Sep. 01, 2016

Property, plant, and equipment, net

$ 49,091

$ 41,533

Accumulated depreciation

(25,419)

(22,102)

23,672

19,431

Capital Leases, Balance Sheet, Assets by Major Class, Net [Abstract]

Capital leases, accumulated depreciation

(868)

(626)

Depreciation [Abstract]

Depreciation expense

4,660

3,760

$ 2,860

Capitalized Interest Costs, Including Allowance for Funds Used During Construction [Abstract]

Interest capitalized as part of the cost of property, plant, and equipment

$ 43

Property, Plant, and Equipment

Debt Instruments [Abstract]

Production equipment, buildings, and land pledged as collateral under various notes payable

2,330

Land

Property, Plant and Equipment, Net, by Type [Abstract]

Property, Plant and Equipment, Net, by Type [Abstract]

345

Buildings

Capital Leases, Balance Sheet, Assets by Major Class, Net [Abstract]

8,680

7,958

Capital leased assets, gross

483

475

Equipment

Property, Plant and Equipment, Net, by Type [Abstract]

Capital Leases, Balance Sheet, Assets by Major Class, Net [Abstract]

^[1]

38,249

32,187

Capital leased assets, gross

1,336

1,331

Equipment not placed into service

Property, Plant and Equipment, Net, by Type [Abstract]

Property, Plant and Equipment, Net, by Type [Abstract]

1,730

994

Construction in progress

Property, Plant and Equipment, Net, by Type [Abstract]

^[2]

1,162

499

Software

Long-term Debt, by Current and Noncurrent [Abstract]

$ 655

$ 544

[1]	Included costs related to equipment not placed into service of $1.73 billion and $994 million, as of August 30, 2018 and August 31, 2017, respectively.
[2]	Included building-related construction and tool installation costs for assets not placed into service.

Equity Method Investments (Details) - USD ($) $ in Millions	12 Months Ended
Equity Method Investments (Details) - USD ($) $ in Millions	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016	Dec. 06, 2016	Dec. 05, 2016
Schedule of Equity Method Investments [Line Items]
Equity in net income (loss) of equity method investees, net of tax	$ (1)	$ 8	$ 25
Inotera
Business Combination, Step Acquisition [Abstract]
Ownership interest in Inotera immediately prior to acquisition (in hundredths)					33.00%
Percentage of Inotera voting interests acquired (in hundredths)				67.00%
Inotera
Schedule of Equity Method Investments [Line Items]
Equity in net income (loss) of equity method investees, net of tax	0	9	32
Tera Probe
Schedule of Equity Method Investments [Line Items]
Equity in net income (loss) of equity method investees, net of tax	0	$ (3)	(11)
Business Combination, Step Acquisition [Abstract]
Ownership interest in Tera Probe disposed of during 2017		40.00%
Tera Probe \| Level 1
Business Combination, Step Acquisition [Abstract]
Other than temporary impairment in Tera Probe		$ 16	25
Other
Schedule of Equity Method Investments [Line Items]
Equity in net income (loss) of equity method investees, net of tax	$ (1)	$ 2	$ 4

Equity Method Investments - 2 (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 05, 2016	Aug. 31, 2017	Sep. 01, 2016
Inotera
Related Party Transaction [Line Items]
Purchases of DRAM products from Inotera	$ 504		$ 1,430
Revenue from sales of specialized equipment to Inotera			55
Margin recognized from sales of specialized equipment sold to Inotera			16
Tera Probe
Related Party Transaction [Line Items]
Related party purchases from Tera Probe		$ 47	$ 70

Intangible Assets and Goodwill - Intangible Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Amortizing assets [Line Items]
Accumulated Amortization, Product and process technology	$ (344)	$ (477)
Annual amortization expense for intangible assets [Abstract]
2019	55
2020	38
2021	33
2022	23
2023	17
Intangible Assets, Net (Including Goodwill) [Abstract]
Intangible Assets, Gross (Excluding Goodwill)	675	864
Goodwill	1,228	1,228
In-process R&D
Non-amortizing assets [Line Items]
Gross Amount, In-process R&D	108	108
Product and process technology
Amortizing assets [Line Items]
Gross Amount, Product and process technology	567	756
Accumulated Amortization, Product and process technology	(344)	(477)
Product and process technology intangible asset capitalized during period	$ 48	$ 29	$ 30
Product and process technology intangible asset capitalized during period, weighted-average useful lives (in years)	10 years	11 years	10 years

Intangible Assets and Goodwill - Tidal Acquisition (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2016	Aug. 30, 2018	Aug. 31, 2017
Business Acquisition [Line Items]
Goodwill recognized in acquisition		$ 1,228	$ 1,228
SBU
Business Acquisition [Line Items]
Goodwill recognized in acquisition		$ 101	$ 101
Tidal Systems, Ltd.
Business Acquisition [Line Items]
Payments to acquire Tidal Systems, Ltd.	$ 148
Deferred tax liabilities recognized in Tidal acquisition	41
Tidal Systems, Ltd. \| SBU
Business Acquisition [Line Items]
Goodwill recognized in acquisition	81
Tidal Systems, Ltd. \| In-process R&D
Business Acquisition [Line Items]
In-process R&D recognized in Tidal acquisition	$ 108

Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Millions	Aug. 30, 2018	Aug. 31, 2017
Accounts Payable and Accrued Liabilities, Current [Abstract]
Accounts payable	$ 1,692	$ 1,333
Property, plant, and equipment payables	1,238	1,018
Salaries, wages, and benefits	841	603
Income and other taxes	402	163
Customer advances	207	197
Other	231	350
Total accounts payable and accrued expenses	$ 4,611	$ 3,664

Debt - Schedule of Long-term Debt (Details)
$ / shares in Units, shares in Millions, $ in Millions

12 Months Ended

Aug. 30, 2018

USD ($)

$ / shares

Aug. 31, 2017

USD ($)

Sep. 01, 2016

USD ($)

Aug. 09, 2018

USD ($)

Apr. 30, 2016

USD ($)

$ 4,898

$ 11,639

859

1,262

3,777

9,872

Debt financing provided to IMFT by Intel

^[1]

4,636

11,134

$ 1,009

3,311

$ 2,199

Share Price (in dollars per share) | $ / shares

$ 52.76

Interest Costs Incurred [Abstract]

Amortization of debt discount and issuance costs

$ 101

125

126

Micron Technology, Inc.

Long-term Debt, by Current and Noncurrent [Abstract]

Subordinated Debt

1,560

Convertible Debt

Long-term Debt, by Current and Noncurrent [Abstract]

Derivative debt liability

Principal amount elected to be settled in cash

$ 35

Underlying Shares of Common Stock (in shares) | shares

Conversion rights, threshold percentage of applicable conversion price (in hundredths)

^[2],[3]

$ 1,847

130.00%

Conversion rights, minimum number of trading days (in days) | d

Conversion rights, consecutive trading period (in days) | d

Conversion rights, maximum percentage of product of stock price and conversion rate (in hundredths)

98.00%

Interest Costs Incurred [Abstract]

Contractual interest expense

$ 44

Amortization of debt discount and issuance costs

$ 36

Equity component of convertible debt included in additional paid in capital

208

287

Convertible Debt | IMFT Member Debt

Long-term Debt, by Current and Noncurrent [Abstract]

1,009

1,009

1,009

Convertible Debt | IMFT Member Debt | IM Flash Technologies, LLC

Long-term Debt, by Current and Noncurrent [Abstract]

Debt financing provided to IMFT by Intel

$ 1,010

Convertible Debt | 2032D Notes

Long-term Debt, by Current and Noncurrent [Abstract]

3.13%

6.33%

$ 143

177

^[4]

132

^[4]

159

$ 132

159

Conversion Price Per Share | $ / shares

$ 9.98

Conversion Price Per Share Threshold (dollars per share) | $ / shares

^[5]

$ 12.97

Underlying Shares of Common Stock (in shares) | shares

Convertible Debt | 2033F Notes

^[2],[3]

$ 615

Long-term Debt, by Current and Noncurrent [Abstract]

2.13%

4.93%

$ 107

297

235

^[4],[6]

278

^[4]

Derivative debt liability

235

278

$ 132

Conversion Price Per Share | $ / shares

$ 10.93

Conversion Price Per Share Threshold (dollars per share) | $ / shares

^[5]

$ 14.21

Underlying Shares of Common Stock (in shares) | shares

Convertible Debt | 2043G Notes

^[2],[3]

$ 408

Long-term Debt, by Current and Noncurrent [Abstract]

3.00%

6.76%

$ 1,019

1,025

^[4]

682

^[4]

671

Original principal amount of 2043G Notes

682

^[7]

671

815

Debt Instrument, Scheduled Accreted Principal Amount

911

Debt Instrument, Face Amount

$ 1,020

Conversion Price Per Share | $ / shares

$ 29.16

Conversion Price Per Share Threshold (dollars per share) | $ / shares

^[5]

$ 37.91

Underlying Shares of Common Stock (in shares) | shares

Convertible Debt | 2032C Notes

^[2],[3]

$ 824

Long-term Debt, by Current and Noncurrent [Abstract]

2.38%

5.95%

$ 0

223

211

Convertible Debt | 2033E Notes

$ 0

211

Long-term Debt, by Current and Noncurrent [Abstract]

1.63%

1.63%

$ 0

173

202

Capital lease obligations

202

Long-term Debt, by Current and Noncurrent [Abstract]

845

1,190

310

357

535

833

Capital lease obligations incurred

845

1,190

Leases, Capital [Abstract]

$ 20

220

Capital lease obligations | Weighted Average

Long-term Debt, by Current and Noncurrent [Abstract]

Weighted-average effective interest rate

3.86%

Leases, Capital [Abstract]

4.60%

Original term

5 years

Reorganization obligation

Long-term Debt, by Current and Noncurrent [Abstract]

9.76%

$ 520

695

309

157

183

474

Secured Debt | 2022 Term Loan B

$ 492

631

Long-term Debt, by Current and Noncurrent [Abstract]

3.83%

4.24%

$ 735

743

720

725

Debt Instrument, Face Amount

$ 725

730

$ 750

Debt Instrument, Quarterly Principal Amortization Percentage

0.25%

Debt Instrument, Collateral Amount

$ 8,320

Secured Debt | 2022 Term Loan B | LIBOR

1.75%

Secured Debt | 2021 MSAC Term Loan

1.75%

Long-term Debt, by Current and Noncurrent [Abstract]

$ 0

800

697

Secured Debt | 2021 MSAC Term Loan | Weighted Average

$ 0

796

Long-term Debt, by Current and Noncurrent [Abstract]

4.42%

Secured Debt | 2021 MSTW Term Loan

4.65%

Long-term Debt, by Current and Noncurrent [Abstract]

2.85%

3.01%

$ 0

2,652

2,640

Secured Debt | 2023 Secured Notes

$ 0

2,640

Long-term Debt, by Current and Noncurrent [Abstract]

7.50%

7.69%

$ 0

1,250

1,238

Corporate Bonds | 2025 Notes

$ 0

1,238

Long-term Debt, by Current and Noncurrent [Abstract]

5.50%

5.56%

$ 519

519

515

Debt Instrument, Domestic Restricted Subsidiaries, Ownership Percentage by Parent

$ 515

515

Unsecured Debt [Abstract]

80.00%

Corporate Bonds | 2023 Notes

Long-term Debt, by Current and Noncurrent [Abstract]

5.25%

5.43%

$ 0

1,000

991

Corporate Bonds | 2024 Notes

$ 0

991

Long-term Debt, by Current and Noncurrent [Abstract]

5.25%

5.38%

$ 0

550

546

Corporate Bonds | 2026 Notes

$ 0

546

Long-term Debt, by Current and Noncurrent [Abstract]

5.63%

5.73%

$ 0

129

128

Notes Payable, Other Payables

$ 0

128

Long-term Debt, by Current and Noncurrent [Abstract]

2.50%

2.50%

$ 1

216

164

Notes Payable, Other Payables | Revolving Credit Facility 4

$ 208

Line of credit facility, Maximum borrowing capacity

$ 750

Percentage of collateral to face value of issued and outstanding credit facility

80.00%

Notes Payable, Other Payables | Revolving Credit Facility 5

Line of credit facility, Maximum borrowing capacity

$ 2,000

Debt Instrument, Covenant, Ratio Of Total Debt To Adjusted EBITDA

2.75

Debt Instrument, Covenant, Ratio of Adjusted EBITDA to Net Interest Expense

3.5

Notes Payable, Other Payables | Revolving Credit Facility 5 | LIBOR | Minimum

1.25%

Notes Payable, Other Payables | Revolving Credit Facility 5 | LIBOR | Maximum

1.25%

2.00%

2.00%

[1]	Net carrying amount is the principal amount less unamortized debt discount and issuance costs. In addition, the net carrying amount as of August 30, 2018 and August 31, 2017 included $132 million and $31 million, respectively, of derivative debt liabilities recognized as a result of our election to settle entirely in cash converted notes with an aggregate principal amount of $35 million and $16 million, respectively.
[2]	Based on the trading price of our common stock of $52.76 as of August 30, 2018.
[3]	It is our current intent to settle in cash the principal amount of our convertible notes upon conversion. As a result, only the amounts payable in excess of the principal amounts upon conversion of our convertible notes are considered in diluted earnings per share under the treasury stock method. For each of our convertible notes, we may elect to settle any amounts in excess of the principal in cash, shares of our common stock, or a combination thereof.
[4]	Since the closing price of our common stock exceeded 130% of the conversion price per share for at least 20 trading days in the 30 trading day period ended on June 30, 2018, these notes are convertible by the holders through the calendar quarter ended September 30, 2018. Additionally, the closing price of our common stock also exceeded the thresholds for the calendar quarter ended September 30, 2018; therefore, these notes are convertible by the holders at any time through December 31, 2018.
[5]	Represents 130% of the conversion price per share. If the trading price of our common stock exceeds such threshold for a specified period, holders may convert such notes during a specified period. See "Conversion Rights" below.
[6]	Current debt as of August 30, 2018 included an aggregate of $165 million for the settlement obligation (including principal and amounts in excess of principal) for conversions of our 2033F Notes that will settle in cash in the first quarter of 2019. The remainder of the 2033F Notes were classified as current as of August 30, 2018 because the terms of these notes require us to pay cash for the principal amount of any converted notes and holders of these notes had the right to convert their notes as of that date.
[7]	The 2043G Notes outstanding as of August 30, 2018 have an original principal amount of $815 million that accretes up to $911 million through the expected term in November 2028 and $1.02 billion at maturity in 2043.

Debt - MMJ Creditor Payments (Details)
¥ in Millions, $ in Millions

Aug. 30, 2018

JPY (¥)

payment

Aug. 30, 2018

USD ($)

payment

Aug. 31, 2017

USD ($)

Reorganization obligation

Debt | $

$ 4,636

^[1]

$ 11,134

^[1]

Reorganization obligation | Micron Memory Japan, Inc.

Debt | $

$ 492

$ 631

Troubled Debt Restructuring, Debtor, Subsequent Periods [Line Items]

Total MMJ Creditor Payments | ¥

¥ 200,000

Number of periodic MMJ creditor installment payments

Less unamortized discount

¥ (3,186)

$ (28)

Debt

54,926

492

Reorganization obligation | Micron Memory Japan, Inc. | Scenario, Plan

Estimated Remaining Reorganization Payments to Third Party Creditors

2019

36,392

326

2020

21,720

194

¥ 58,112

$ 520

Reorganization obligation | Micron Memory Japan, Inc. | Secured Creditors

Troubled Debt Restructuring, Debtor, Subsequent Periods [Line Items]

Number of periodic MMJ creditor installment payments

Recovery Rate of Reorganization Plan Creditors

100.00%

Reorganization obligation | Micron Memory Japan, Inc. | Unsecured Creditors

Troubled Debt Restructuring, Debtor, Subsequent Periods [Line Items]

Number of periodic MMJ creditor installment payments

Reorganization obligation | Micron Memory Japan, Inc. | Unsecured Creditors | Minimum

Troubled Debt Restructuring, Debtor, Subsequent Periods [Line Items]

Recovery Rate of Reorganization Plan Creditors

17.40%

[1]

Debt - Debt Prepayments, Repurchases, and Conversions (Details) - USD ($)
shares in Millions, $ in Millions

1 Months Ended

12 Months Ended

Oct. 12, 2018

Aug. 30, 2018

Aug. 31, 2017

Sep. 01, 2016

$ 859

$ 1,262

Gain (Loss) on Extinguishment of Debt

(10,194)

(2,558)

$ (870)

(385)

(99)

(4)

Gain (Loss) on debt prepayments, repurchases, and conversions

(2,243)

(33)

(38)

(385)

(100)

(4)

Secured Debt | 2021 MSAC Term Loan

(730)

(727)

Gain (Loss) on debt prepayments, repurchases, and conversions

(730)

(3)

Secured Debt | 2021 MSTW Term Loan

(2,625)

(2,616)

Gain (Loss) on debt prepayments, repurchases, and conversions

(2,625)

(10)

Secured Debt | 2023 Secured Notes

(1,250)

(1,238)

Gain (Loss) on debt prepayments, repurchases, and conversions

(1,373)

(135)

Corporate Bonds

Gain (Loss) on Extinguishment of Debt

(1,630)

(94)

Corporate Bonds | 2023 Notes

(1,000)

(991)

Gain (Loss) on debt prepayments, repurchases, and conversions

(1,046)

(55)

Corporate Bonds | 2024 Notes

(550)

(546)

Gain (Loss) on debt prepayments, repurchases, and conversions

(572)

(25)

Corporate Bonds | 2026 Notes

(129)

(321)

(129)

(318)

Gain (Loss) on debt prepayments, repurchases, and conversions

(139)

$ (11)

Corporate Bonds | 2025 Notes

(631)

Corporate Bonds | 2022 Notes

(625)

(600)

$ (592)

Convertible Debt

Derivative, Term of Contract (in consecutive trading days)

20 days

Convertible Debt | 2033F Notes

$ (66)

(63)

(316)

Gain (Loss) on debt prepayments, repurchases, and conversions

(252)

(1)

Convertible Debt | 2033F Notes | Settled conversions

(124)

(118)

(596)

Gain (Loss) on debt prepayments, repurchases, and conversions

(462)

(16)

Convertible Debt | 2033F Notes | Conversions not settled

165

^[1]

^[1]

132

^[1]

Gain (Loss) on debt prepayments, repurchases, and conversions

^[1]

(117)

^[1]

(15)

Principal amount of settlement obligations to be settled in cash in Q1-19

Convertible Debt | 2032C Notes | Settled conversions

(223)

(216)

(1,230)

Gain (Loss) on debt prepayments, repurchases, and conversions

(965)

(50)

Convertible Debt | 2032D Notes | Settled conversions

(34)

(31)

(182)

Gain (Loss) on debt prepayments, repurchases, and conversions

(145)

$ (6)

Convertible Debt | 2033E Notes

(57)

(54)

(94)

Treasury shares issued for conversion of 2033E Notes

$ (38)

Convertible Debt | 2033E Notes | Settled conversions

$ (173)

(203)

^[2]

(552)

Gain (Loss) on debt prepayments, repurchases, and conversions

(297)

(52)

Convertible Debt | 2043G Notes | Settled conversions

(6)

(4)

(13)

Gain (Loss) on debt prepayments, repurchases, and conversions

(5)

(4)

Notes Payable, Other Payables

(46)

(44)

Gain (Loss) on debt prepayments, repurchases, and conversions

(46)

(2)

Unscheduled Settlement Activities

(6,956)

(6,794)

(9,420)

Subsequent Event | Convertible Debt | 2033F Notes

$ (2,243)

$ (153)

[1]	As of August 30, 2018, an aggregate of $35 million principal amount of our 2033F Notes (with a carrying value of $165 million) had converted but not settled. These notes settled in the first quarter of 2019 for $153 million in cash.
[2]	Settlement included issuance of 4 million shares of our treasury stock in addition to payment of cash.

Debt - Maturities (Details) $ in Millions	Aug. 30, 2018 USD ($)
Capital Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
2019	$ 339
2020	231
2021	100
2022	66
2023	42
2024 and thereafter	187
Capital Leases, Future Minimum Payments, Interest Included in Payments	(120)
Capital Lease Obligations	845
Notes Payable (including MMJ Creditor Payments)
Long-term Debt, by Maturity [Abstract]
2019	501
2020	274
2021	151
2022	713
2023	0
2024 and thereafter	2,439
Debt Instrument, Unamortized Discount	(287)
Notes Payable	$ 3,791

Commitments (Details) - USD ($) $ in Millions	12 Months Ended
Commitments (Details) - USD ($) $ in Millions	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Operating Leases, Rent Expense, Net [Abstract]
Rent expense	$ 63	$ 52	$ 46
Operating Leases, Future Minimum Payments Due [Abstract]
2019	37
2020	43
2021	50
2022	50
2023	45
2024 and thereafter	391
Total operating lease commitments	616
Capital Addition Purchase Commitments
Unrecorded Unconditional Purchase Obligation [Line Items]
Commitments for acquisition of property, plant, and equipment	$ 1,800

Contingencies (Details) ¥ in Millions, $ in Millions	1 Months Ended	12 Months Ended
Contingencies (Details) ¥ in Millions, $ in Millions	Oct. 12, 2018 CNY (¥) patent	Aug. 30, 2018 USD ($) patent
Pending Litigation \| Qimonda AG Inotera Share Purchase Proceedings
Loss Contingencies [Line Items]
Percentage of total Inotera shares subject to litigation (in hundredths)		18.00%
Loss contingency, judgment under appeal \| $		$ 1
Patent Matters
Loss Contingencies [Line Items]
Percent of annualized revenue derived from impacted products		1.00%
Patent Matters \| Pending Litigation \| Elm 3DS Innovations, LLC
Loss Contingencies [Line Items]
Number of patents allegedly infringed		13
Patent Matters \| Pending Litigation \| Innovative Memory Solutions, Inc. Complaint 1
Loss Contingencies [Line Items]
Number of patents allegedly infringed		8
Patent Matters \| Pending Litigation \| Innovative Memory Solutions, Inc. Complaint 2
Loss Contingencies [Line Items]
Number of patents allegedly infringed		1
Patent Matters \| Pending Litigation \| Innovative Memory Solutions, Inc. Complaint 3 \| Subsequent Event
Loss Contingencies [Line Items]
Number of patents allegedly infringed	1
Damages sought on alleged patent infringement \| ¥	¥ 1
Patent Matters \| Pending Litigation \| Fujian Jinhua Integrated Circuit Co., Ltd. Complaint 1
Loss Contingencies [Line Items]
Number of patents allegedly infringed		1
Damages sought on alleged patent infringement \| $		$ 98
Patent Matters \| Pending Litigation \| Fujian Jinhua Integrated Circuit Co., Ltd. Complaint 2
Loss Contingencies [Line Items]
Number of patents allegedly infringed		1
Damages sought on alleged patent infringement \| $		$ 98
Patent Matters \| Pending Litigation \| United Microelectronics Corporation Complaint 1
Loss Contingencies [Line Items]
Number of patents allegedly infringed		1
Damages sought on alleged patent infringement \| $		$ 90
Patent Matters \| Pending Litigation \| United Microelectronics Corporation Complaint 2
Loss Contingencies [Line Items]
Number of patents allegedly infringed		1
Damages sought on alleged patent infringement \| $		$ 90
Patent Matters \| Pending Litigation \| United Microelectronics Corporation Complaint 3
Loss Contingencies [Line Items]
Number of patents allegedly infringed		1
Damages sought on alleged patent infringement \| $		$ 90
Patent Matters \| Settled Litigation \| Harvard University
Loss Contingencies [Line Items]
Number of patents allegedly infringed		2

Redeemable Noncontrolling Interest (Details) - Micron Semiconductor Asia Operations Pt. Ltd. $ in Millions	1 Months Ended
	Aug. 30, 2018 USD ($) shares
Redeemable Noncontrolling Interest [Line Items]
Redeemable noncontrolling interest, shares authorized	100,000
Redeemable noncontrolling interest, shares Issued	100,000
Net proceeds from issuance of redeemable preferred stock \| $	$ 97
Cumulative fixed dividend on redeemable noncontrolling interests	7.75%

Equity - Common Stock Repurchase Authorization (Details) - USD ($) shares in Millions, $ in Millions		1 Months Ended	12 Months Ended
	Sep. 05, 2018	Oct. 12, 2018	Sep. 01, 2016	Aug. 10, 2018	May 31, 2018
Equity, Class of Treasury Stock [Line Items]
Common Stock Repurchase, Authorized Amount					$ 10,000
Value of Treasury Shares Acquired			$ 125
Accelerated Share Repurchase Agreement
Equity, Class of Treasury Stock [Line Items]
Accelerated Share Repurchase, Agreement Amount				$ 1,000
Accelerated Share Repurchase Agreement \| Subsequent Event
Equity, Class of Treasury Stock [Line Items]
Payments for Repurchase of Common Stock	$ 1,000
Treasury Shares Repurchased (in shares)	14
Value of Treasury Shares Acquired	$ 750
10b5-1 Plan and Other Repurchases \| Subsequent Event
Equity, Class of Treasury Stock [Line Items]
Payments for Repurchase of Common Stock		$ 653
Treasury Shares Repurchased (in shares)		15

Equity - Common Stock Issuance (Details) $ / shares in Units, shares in Millions, $ in Millions	1 Months Ended
	Oct. 31, 2017 USD ($) $ / shares shares
Statement of Stockholders' Equity [Abstract]
Common stock issued (in shares) \| shares	34
Common shares issued, Price per share \| $ / shares	$ 41.00
Proceeds from common stock issuance \| $	$ 1,360

Equity - Treasury Stock (Details) - USD ($) shares in Millions, $ in Millions		12 Months Ended
	Dec. 06, 2016	Aug. 31, 2017
Treasury Stock
Class of Stock [Line Items]
Decrease in retained earnings (decrease in treasury stock) due to reissuance of treasury shares at price lower than purchase price		$ (1,029)
Retained Earnings
Class of Stock [Line Items]
Decrease in retained earnings (decrease in treasury stock) due to reissuance of treasury shares at price lower than purchase price		$ 104
Inotera
Class of Stock [Line Items]
Proceeds from issuance of stock to Nanya	$ 986
Inotera \| Shares Issued to Nanya
Class of Stock [Line Items]
Number of Micron Shares issued to Nanya as consideration for Inotera shares not already owned (in shares)	58
Proceeds from issuance of stock to Nanya	$ 986
Inotera \| Shares Issued to Nanya \| Treasury Stock
Class of Stock [Line Items]
Proceeds from issuance of stock to Nanya	$ 925
Treasury shares included in sale of shares to Nanya (in shares)	54
Decrease in retained earnings (decrease in treasury stock) due to reissuance of treasury shares at price lower than purchase price	$ (1,030)
Inotera \| Shares Issued to Nanya \| Retained Earnings
Class of Stock [Line Items]
Decrease in retained earnings (decrease in treasury stock) due to reissuance of treasury shares at price lower than purchase price	$ 104

Equity - Capped Calls (Details) - USD ($) $ / shares in Units, shares in Millions	12 Months Ended
	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Option Indexed to Issuer's Equity [Line Items]
Settlement of capped calls, value of shares received	$ 0	$ (125,000,000)	$ 0
Treasury Stock
Option Indexed to Issuer's Equity [Line Items]
Settlement of capped calls, value of shares received	$ 429,000,000	67,000,000	$ 23,000,000
Call Option \| Purchased options
Option Indexed to Issuer's Equity [Line Items]
Proceeds received upon settlement of capped calls		$ 125,000,000
Treasury Shares from Capped Call Settlement	9	4	2
Call Option \| Purchased options \| Treasury Stock
Option Indexed to Issuer's Equity [Line Items]
Settlement of capped calls, value of shares received	$ 429,000,000	$ 67,000,000	$ 23,000,000
Call Option \| Purchased options \| 2033F Notes
Option Indexed to Issuer's Equity [Line Items]
Capped calls, underlying common shares (in shares)	27
Capped calls, initial strike price (in dollars per share)	$ 10.93
Capped calls, cap price (in dollars per share)	$ 14.51
Call Option \| Purchased options \| 2033F Notes \| Minimum
Option Indexed to Issuer's Equity [Line Items]
Potential value of capped calls at expiration	$ 0
Call Option \| Purchased options \| 2033F Notes \| Maximum
Option Indexed to Issuer's Equity [Line Items]
Potential value of capped calls at expiration	$ 98,000,000

Equity - Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	$ 29
Other comprehensive income (loss)	(19)	$ 64	$ (48)
Accumulated other comprehensive income	10	29
Cumulative Foreign Currency Translation Adjustment
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	(1)
Other comprehensive income before reclassifications	1
Amount reclassified out of accumulated other comprehensive income	0
Tax effects	0
Other comprehensive income (loss)	1
Accumulated other comprehensive income	0	(1)
Gains (Losses) on Derivative Instruments
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	17
Other comprehensive income before reclassifications	(17)
Amount reclassified out of accumulated other comprehensive income	(1)
Tax effects	3
Other comprehensive income (loss)	(15)
Accumulated other comprehensive income	2	17
Pension Liability Adjustments
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	13
Other comprehensive income before reclassifications	(3)
Amount reclassified out of accumulated other comprehensive income	(1)
Tax effects	1
Other comprehensive income (loss)	(3)
Accumulated other comprehensive income	10	13
Unrealized Gains (Losses) on Investments
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	0
Other comprehensive income before reclassifications	(3)
Amount reclassified out of accumulated other comprehensive income	0
Tax effects	1
Other comprehensive income (loss)	(2)
Accumulated other comprehensive income	(2)	0
Total Micron Shareholders' Equity
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	29
Other comprehensive income before reclassifications	(22)
Amount reclassified out of accumulated other comprehensive income	(2)
Tax effects	5
Other comprehensive income (loss)	(19)	64	$ (48)
Accumulated other comprehensive income	$ 10	$ 29

Equity - NCI and Consolidated VIE Disclosures (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Aug. 30, 2018	May 31, 2018	Mar. 01, 2018	Nov. 30, 2017	Aug. 31, 2017	Jun. 01, 2017	Mar. 02, 2017	Dec. 01, 2016	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Noncontrolling Interest [Line Items]
Noncontrolling Interest Balance	$ 870				$ 849				$ 870	$ 849
IMFT sales to Intel at prices approximating cost	8,440	$ 7,797	$ 7,351	$ 6,803	6,138	$ 5,566	$ 4,648	$ 3,970	$ 30,391	20,322	$ 12,399
Noncontrolling Interest Items [Abstract]
IMFT distributions to Intel											34
IM Flash Technologies, LLC
Joint Venture Agreement, Terms [Abstract]
Joint Venture Agreement, Terms, Partner Contribution Output Sharing Lag									8 months
Joint Venture Agreement, Terms, Continued Supply Period to Partner									1 year
Joint Venture Agreement, Terms, Supply Lookback Period									6 months
Joint Venture Agreement, Terms, Supply Allotment Subperiod Duration									6 months
Noncontrolling Interest Items [Abstract]
IMFT distributions to Micron											36
IMFT distributions to Intel											34
Micron contributions to IMFT											38
Intel contributions to IMFT											37
IM Flash Technologies, LLC \| Intel
Noncontrolling Interest [Line Items]
IMFT sales to Intel at prices approximating cost									$ 507	438	$ 457
Other Consolidated Entities
Noncontrolling Interest [Line Items]
Noncontrolling Interest Balance	$ 17				17				$ 17	17
Variable Interest Entity, Primary Beneficiary \| IM Flash Technologies, LLC
Noncontrolling Interest [Line Items]
Ownership interest in IMFT (in hundredths)	51.00%								51.00%
Variable Interest Entity, Primary Beneficiary \| IM Flash Technologies, LLC
Noncontrolling Interest [Line Items]
Noncontrolling Interest Balance	$ 853				$ 832				$ 853	$ 832
Noncontrolling Interest Percentage (in hundredths)	49.00%				49.00%				49.00%	49.00%
Minimum \| IM Flash Technologies, LLC
Joint Venture Agreement, Terms [Abstract]
Joint Venture Agreement, Terms, Period One Partner Output Allotment, Percentage									50.00%
Joint Venture Agreement, Terms, Period Two Partner Output Allotment, Percentage									0.00%
Maximum \| IM Flash Technologies, LLC
Joint Venture Agreement, Terms [Abstract]
Joint Venture Agreement, Terms, Period One Partner Output Allotment, Percentage									100.00%
Joint Venture Agreement, Terms, Period Two Partner Output Allotment, Percentage									100.00%
Put Option \| Minimum \| IM Flash Technologies, LLC
Joint Venture Agreement, Terms [Abstract]
Joint Venture Agreement, Terms, Period Between Election Date And Transaction Closing Date									6 months
Joint Venture Agreement, Terms, Partner Financing Period									1 year
Put Option \| Maximum \| IM Flash Technologies, LLC
Joint Venture Agreement, Terms [Abstract]
Joint Venture Agreement, Terms, Period Between Election Date And Transaction Closing Date									2 years
Joint Venture Agreement, Terms, Partner Financing Period									2 years
Call Option \| Minimum \| IM Flash Technologies, LLC
Joint Venture Agreement, Terms [Abstract]
Joint Venture Agreement, Terms, Period Between Election Date And Transaction Closing Date									6 months
Call Option \| Maximum \| IM Flash Technologies, LLC
Joint Venture Agreement, Terms [Abstract]
Joint Venture Agreement, Terms, Period Between Election Date And Transaction Closing Date									1 year

Equity - Consolidated VIE assets and liabilities (Details) - USD ($)
$ in Millions

Aug. 30, 2018

Aug. 31, 2017

Assets

Cash and equivalents

$ 6,506

$ 5,109

5,478

3,759

Property, plant, and equipment

3,595

3,123

Other current assets

164

147

Total current assets

16,039

12,457

23,672

19,431

Other noncurrent assets

611

450

Total assets

43,376

35,336

Liabilities

Accounts payable and accrued expenses

4,611

3,664

Deferred income

284

408

Total current liabilities

859

1,262

5,754

5,334

Other noncurrent liabilities

3,777

9,872

581

639

Total liabilities

10,112

15,845

Variable Interest Entity, Primary Beneficiary | IM Flash Technologies, LLC

Assets

Cash and equivalents

^[1]

^[1]

126

Property, plant, and equipment

^[1]

114

128

Other current assets

^[1]

Total current assets

^[1]

339

303

^[1]

2,641

1,852

Other noncurrent assets

^[1]

Total assets

^[1]

3,025

2,204

Liabilities

Accounts payable and accrued expenses

^[1]

138

299

Deferred income

^[1]

Total current liabilities

^[1]

^[1]

167

324

Other noncurrent liabilities

^[1]

1,064

^[1]

Total liabilities

^[1]

$ 1,305

$ 487

[1]	Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Fair Value Measurements - Fair and Carrying Value (Details) - USD ($)
$ in Millions

Aug. 30, 2018

Aug. 31, 2017

Fair Value | Level 2 | Convertible Notes

Carrying Value of Debt

^[1]

$ 4,636

$ 11,134

Fair Value of Convertible notes

3,124

3,901

Fair Value | Level 2 | Notes and MMJ creditor payments

Fair Value of Notes and MMJ creditor payments

2,798

8,793

Carrying Value | Convertible Notes

Carrying Value | Notes and MMJ creditor payments

Carrying Value of Debt

1,049

1,521

Carrying Value of Debt

$ 2,742

$ 8,423

[1]

Derivative Instruments - Notional Amounts and Fair Values (Details) shares in Millions, $ in Millions	12 Months Ended
	Aug. 30, 2018 USD ($) shares	Aug. 31, 2017 USD ($) shares
Derivative, Fair Value, Net [Abstract]
Fair Value of Liabilities	$ (190)	$ (52)
Receivables-other
Derivative, Fair Value, Net [Abstract]
Fair Value of Assets	14	51
Other noncurrent assets
Derivative, Fair Value, Net [Abstract]
Fair Value of Assets	$ 0	1
Designated hedging instruments
Derivative, Fair Value, Net [Abstract]
General maturity of currency forward contracts (in months)	12 months
Designated hedging instruments \| Cash flow hedges \| Currency forward
Notional Disclosures [Abstract]
Gross Notional Amount, Currency forwards	$ 538	456
Designated hedging instruments \| Cash flow hedges \| Receivables-other \| Currency forward
Derivative, Fair Value, Net [Abstract]
Fair Value of Assets	0	17
Designated hedging instruments \| Cash flow hedges \| Accounts payable and accrued expenses-other \| Currency forward
Derivative, Fair Value, Net [Abstract]
Fair Value of Liabilities	(13)	0
Designated hedging instruments \| Cash flow hedges \| Other noncurrent assets \| Currency forward
Derivative, Fair Value, Net [Abstract]
Fair Value of Assets	0	0
Not designated hedging instruments
Derivative, Fair Value, Net [Abstract]
Fair Value of Liabilities	$ (177)	(52)
General maturity of currency forward contracts (in months)	9 months
Not designated hedging instruments \| Currency forward
Notional Disclosures [Abstract]
Gross Notional Amount, Currency forwards	$ 1,919	$ 4,847
Not designated hedging instruments \| Convertible notes settlement obligation
Notional Disclosures [Abstract]
Gross Notional Amount, Convertible notes settlement obligation (in shares) \| shares	3	2
Not designated hedging instruments \| Receivables-other
Derivative, Fair Value, Net [Abstract]
Fair Value of Assets	$ 14	$ 34
Not designated hedging instruments \| Receivables-other \| Currency forward
Derivative, Fair Value, Net [Abstract]
Fair Value of Assets	14	34
Not designated hedging instruments \| Receivables-other \| Convertible notes settlement obligation
Derivative, Fair Value, Net [Abstract]
Fair Value of Assets	0	0
Not designated hedging instruments \| Accounts payable and accrued expenses-other \| Currency forward
Derivative, Fair Value, Net [Abstract]
Fair Value of Liabilities	(10)	(5)
Not designated hedging instruments \| Current debt \| Convertible notes settlement obligation
Derivative, Fair Value, Net [Abstract]
Fair Value of Liabilities	(167)	(47)
Not designated hedging instruments \| Other noncurrent assets
Derivative, Fair Value, Net [Abstract]
Fair Value of Assets	0	1
Not designated hedging instruments \| Other noncurrent assets \| Currency forward
Derivative, Fair Value, Net [Abstract]
Fair Value of Assets	0	1
Not designated hedging instruments \| Other noncurrent assets \| Convertible notes settlement obligation
Derivative, Fair Value, Net [Abstract]
Fair Value of Assets	$ 0	$ 0

Derivative Instruments - Gain (Loss) on Derivatives (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Designated hedging instruments \| Cash flow hedges
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) recognized in other comprehensive income, effective portion	$ (17)	$ 15	$ 10
Designated hedging instruments \| Fair value hedges
Gain (Loss) on Fair Value Hedges Recognized in Earnings [Abstract]
Gain (loss) on remeasurement of hedged assets and liabilities	(25)
Gain (loss) on derivatives designated as hedging instruments	25
Amortization of amounts excluded from hedge effectiveness	(32)
Gain (loss) on fair value hedges recognized in earnings	(32)
Currency forward \| Not designated hedging instruments
Gain (Loss) on Fair Value Hedges Recognized in Earnings [Abstract]
Net gains (losses) for derivative instruments without hedge accounting designation	(38)	$ (45)	$ 185
Convertible notes settlement obligation \| Not designated hedging instruments
Gain (Loss) on Fair Value Hedges Recognized in Earnings [Abstract]
Net gains (losses) for derivative instruments without hedge accounting designation	$ (124)

Equity Plans - Share Based Compensation (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future awards (in shares)	125
Employee stock option
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of shares outstanding (in shares)	33
Number of shares granted (in shares)	2	8	8
Number of shares exercised (in shares)	(16)
Number of shares canceled or expired (in shares)	(1)
Number of shares outstanding (in shares)	18	33
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Weighted average exercise price per share for options outstanding (in dollars per share)	$ 19.32
Weighted average exercise price per share for options granted (in dollars per share)	43.30
Weighted average exercise price per share for options exercised (in dollars per share)	17.82
Weighted average exercise price per share for options canceled or expired (in dollars per share)	22.67
Weighted average exercise price per share for options outstanding (in dollars per share)	$ 23.38	$ 19.32
Share-based Compensation Arrangement by Share-based Payment Award Options, Outstanding, Additiona Disclosures [Abstract]
Weighted average remaining contractual term for options outstanding (in years)	4 years 9 months
Aggregated intrinsic value for options outstanding	$ 527
Options exercisable (in shares)	8
Weighted average exercise price per share for options exercisable (in dollars per share)	$ 21.66
Weighted average remaining contractual term for options exercisable (in years)	3 years 2 months
Aggregated intrinsic value for options exercisable	$ 233
Options unvested (in shares)	10
Weighted average exercise price per share for options unvested (in dollars per share)	$ 24.61
Weighted average remaining contractual term for options unvested (in years)	6 years
Aggregate intrinsic value for options unvested	$ 294
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]
Total intrinsic value for option exercised	$ 446	$ 198	$ 52
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Fair Value Assumptions, Method Used	Black-Scholes
Stock options granted (in shares)	2	8	8
Weighted-average grant-date fair values per share (in dollars per share)	$ 18.65	$ 8.68	$ 6.94
Average expected life (in years)	5 years 6 months	5 years 6 months	5 years 6 months
Weighted-average expected volatility (in hundredths)	44.00%	46.00%	47.00%
Weighted-average risk-free interest rate (in thousandths)	2.20%	1.80%	1.70%
Expected dividend yield	0.00%	0.00%	0.00%
Employee stock option \| Annual vesting periods \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rights, percentage	25.00%
Employee stock option \| Annual vesting periods \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rights, percentage	33.00%
Employee stock option \| Awards Granted After February 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
General number of years from grant date until stock options expire (in years)	8 years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
ESPP offering period (in months)	8 years
Employee stock option \| Awards Granted Prior to February 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
General number of years from grant date until stock options expire (in years)	6 years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
ESPP offering period (in months)	6 years
Restricted stock award
Restricted Stock Awards activity
Number of Shares - Outstanding (in shares)	19
Number of Shares - Granted (in shares)	4	8	10
Number of Shares - Restrictions lapsed (in shares)	(6)
Number of Shares - Canceled (in shares)	(2)
Number of Shares - Outstanding (in shares)	15	19
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Weighted Average Grant Date Fair Value Per Share - Outstanding (in dollars per share)	$ 19.78
Weighted Average Grant Date Fair Value Per Share - Granted (in dollars per share)	42.48	$ 18.77	$ 15.40
Weighted Average Grant Date Fair Value Per Share - Restrictions lapsed (in dollars per share)	21.70
Weighted Average Grant Date Fair Value Per Share - Canceled (in dollars per share)	21.93
Weighted Average Grant Date Fair Value Per Share - Outstanding (in dollars per share)	$ 25.18	$ 19.78
Restricted stock awards granted (in shares)	4	8	10
Weighted-average grant-date fair values per share (in dollars per share)	$ 42.48	$ 18.77	$ 15.40
Aggregate vesting-date fair value of shares vested	$ 259	$ 115	$ 71
Performance and Market-based Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Restricted award vesting period	3 years
Performance and Market-based Restricted Stock Awards \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Restricted award achievement potential, percentage	0.00%
Performance and Market-based Restricted Stock Awards \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Restricted award achievement potential, percentage	200.00%
Service-based Restrictied Stock Awards
Restricted Stock Awards activity
Number of Shares - Outstanding (in shares)	13
Service-based Restrictied Stock Awards \| Annual vesting periods \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rights, percentage	25.00%
Service-based Restrictied Stock Awards \| Annual vesting periods \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rights, percentage	33.00%
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future awards (in shares)	33
General number of years from grant date until stock options expire (in years)	6 months
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Fair Value Assumptions, Method Used	Black-Scholes
Average expected life (in years)	6 months
Weighted-average expected volatility (in hundredths)	43.00%
Weighted-average risk-free interest rate (in thousandths)	2.20%
Expected dividend yield	0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Weighted Average Grant Date Fair Value Per Share - Granted (in dollars per share)	$ 14.55
Weighted-average grant-date fair values per share (in dollars per share)	$ 14.55
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
ESPP maximum percentage of eligible compensation	10.00%
ESPP purchase price of common stock, percent, first or last trading day of offering period	85.00%
ESPP offering period (in months)	6 months

Equity Plans - Stock-based compensation expense (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	$ 198	$ 215	$ 191
Employee Service Share-based Compensation, Aggregate Disclosures [Abstract]
Tax benefit from compensation expense	158	97	41
Total unrecognized compensation costs related to non-vested awards expected to be recognized	$ 316
Weighted average period that unrecognized compensation costs is expected to be recognized (in years)	1 year 3 months
Employee stock option
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	$ 55	71	79
Restricted stock award
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	140	144	112
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	3	0	0
Equity plans
Employee Service Share-based Compensation, Aggregate Disclosures [Abstract]
Stock compensation expense capitalized and remained in inventory	19	20
Cost of Goods Sold
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	83	88	76
Selling, general, and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	61	75	66
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation	$ 54	$ 52	$ 49

Employee Benefit Plans - (Details) - USD ($) $ in Millions	12 Months Ended
Employee Benefit Plans - (Details) - USD ($) $ in Millions	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Employee Savings Plan for U.S. Employees
Maximum annual contributions per employee (in hundredths)	75.00%
Maximum employer matching contribution, percent of employees' eligible earnings (in hundredths)	5.00%
Defined contribution plan contribution expense	$ 61	$ 52	$ 54
Retirement Plans
Projected pension benefit obligation	190	175
Pension plan assets	$ 171	$ 150

Research and Development (Details) - USD ($) $ in Millions	12 Months Ended
Research and Development (Details) - USD ($) $ in Millions	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Collaborative Arrangement Process Design and Process Development
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Reduction in R and D expenses for reimbursements from partners	$ 201	$ 213	$ 205

Other Operating (Income) Expense, Net (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Restructuring Cost and Reserve [Line Items]
(Gain) loss on disposition of property, plant, and equipment		$ (96)	$ (22)	$ (4)
Restructure and asset impairments		28	18	67
Other		11	5	(2)
Other operating (income) expense, net		$ (57)	$ 1	61
Forecast
Restructuring and Related Activities [Abstract]
Gain on asset sales and dispositions	$ 100
Tera Probe
Restructuring and Related Activities [Abstract]
Ownership interest in Tera Probe disposed of during 2017			40.00%
Other Restructuring Activities
Restructuring and Related Activities [Abstract]
Gain on asset sales and dispositions			$ 15
2016 Restructuring Plan
Restructuring and Related Activities [Abstract]
Expense from 2016 Restructuring Plan			$ 33	$ 58

Other Non-Operating Income (Expense), Net (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Component of Other Income Expense, Nonoperating [Line Items]
Loss on debt prepayments, repurchases, and conversions	$ (385)	$ (100)	$ (4)
Loss from changes in currency exchange rates	(75)	(74)	(24)
Gain on remeasurement of previously-held equity interest in Inotera	0	71	0
Other	(5)	(9)	(26)
Other non-operating income (expense), net	$ (465)	$ (112)	(54)
Indemnification Receivable Writeoff
Component of Other Income Expense, Nonoperating [Line Items]
Other			$ (30)

Income Taxes - Income (loss) before Taxes and Other Items (Details 1) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 30, 2018	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Income Tax Contingency [Line Items]
U.S. federal statutory rate (percent)	35.00%	21.00%		25.70%	35.00%	35.00%
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]
U.S.				$ 141	$ (56)	$ 72
Foreign				14,166	5,252	(353)
Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees				14,307	5,196	(281)
Current [Abstract]
U.S. federal				(54)	0	0
State				1	(1)	(1)
Foreign				(374)	(152)	(27)
Total income tax (provision) benefit - current				(427)	(153)	(28)
Deferred [Abstract]
U.S. federal				232	0	39
State				101	0	2
Foreign				(74)	39	(32)
Deferred Income Tax Expense (Benefit)				259	39	9
Income tax (provision) benefit				$ (168)	$ (114)	$ (19)
Forecast
Income Tax Contingency [Line Items]
U.S. federal statutory rate (percent)			21.00%

Income Taxes - Effective Income Tax Rate Reconciliation (Details 2) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 30, 2018	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Effective Income Tax Rate Reconciliation, Amount [Abstract]
U.S. federal income tax (provision) benefit at statutory rate			$ (3,677)	$ (1,819)	$ 98
Foreign tax rate differential			2,572	1,571	(300)
Repatriation Tax related to the Tax Act			(1,049)	0	0
Remeasurement of deferred tax assets and liabilities related to the Tax Act			(179)	0	0
Change in valuation allowance			2,079	64	63
Change in unrecognized tax benefits			60	12	52
Tax credits			90	66	48
Other			(64)	(8)	20
Income tax (provision) benefit			$ (168)	$ (114)	$ (19)
Effective Income Tax Rate Reconciliation, Percent [Abstract]
U.S. federal statutory rate (percent)	35.00%	21.00%	25.70%	35.00%	35.00%
Foreign tax rate differential (percent)			(18.00%)	(30.20%)	(106.80%)
Repatriation Tax related to the Tax Act (percent)			7.30%	0.00%	0.00%
Remeasurement of deferred tax assets and liabilities related to the Tax Act (percent)			1.30%	0.00%	0.00%
Change in valuation allowance (percent)			(14.50%)	(1.20%)	22.40%
Change in unrecognized tax benefits (percent)			(0.40%)	(0.20%)	18.50%
Tax credits (percent)			(0.60%)	(1.30%)	17.10%
Other (percent)			0.40%	0.10%	7.00%
Effective tax rate (percent)			1.20%	2.20%	(6.80%)
Provisional release of valuation allowance on net deferred tax assets of US operations			$ 1,340
Provisional Repatriation Tax, net of adjustments related to uncertain tax positions			$ (1,030)

Income Taxes Income Taxes - Tax Holiday (Details 3) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Aug. 30, 2018	Aug. 31, 2017
Income Tax Disclosure [Abstract]
Tax benefit from incentive arrangements	$ 1,960	$ 742
Tax benefit per diluted share from incentive arrangements	$ 1.59	$ 0.64

Income Taxes - Deferred tax assets and liabilities (Details 4) - USD ($) $ in Millions	Aug. 30, 2018	Aug. 31, 2017
Income Tax Disclosure [Abstract]
Undistributed earnings of foreign subsidiaries deemed indefinitely reinvested	$ 2,350
Deferred Tax Assets Abstract]
Net operating loss and tax credit carryforwards	1,417	$ 3,426
Accrued salaries, wages, and benefits	163	211
Other accrued liabilities	35	59
Other	80	86
Gross deferred tax assets	1,695	3,782
Less valuation allowance	(228)	(2,321)
Deferred tax assets, net of valuation allowance	1,467	1,461
Deferred Tax Liabilities [Abstract]
Debt discount	(77)	(145)
Property, plant, and equipment	(173)	(300)
Unremitted earnings on certain subsidiaries	(82)	(123)
Product and process technology	(62)	(85)
Other	(54)	(59)
Deferred tax liabilities	(448)	(712)
Net deferred tax assets	1,019	749
Reported as [Abstract]
Deferred tax assets	1,022	766
Deferred tax liabilities (included in other noncurrent liabilities)	$ (3)	$ (17)

Income Taxes Income Taxes - Valuation Allowances (Details 5) - USD ($) $ in Millions	12 Months Ended
	Aug. 30, 2018	Aug. 31, 2017
Valuation Allowance [Line Items]
Valuation allowance	$ 228	$ 2,321
Decrease in operating loss carryforward DTA from changes in expected utilization (offset by change in VA)	119
U.S.
Valuation Allowance [Line Items]
Valuation allowance	28	1,520
Japan
Valuation Allowance [Line Items]
Valuation allowance	192	627
Other foreign subsidiaries member
Valuation Allowance [Line Items]
Valuation allowance	$ 8	$ 172

Income Taxes - Tax Credit Carryforwards (Details 7) $ in Millions	Aug. 30, 2018 USD ($)
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	$ 774
2019 - 2023
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	185
2024 - 2028
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	90
2029 - 2033
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	159
2034 - 2038
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	278
Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	62
U.S. Federal
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	510
U.S. Federal \| 2019 - 2023
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	122
U.S. Federal \| 2024 - 2028
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	44
U.S. Federal \| 2029 - 2033
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	69
U.S. Federal \| 2034 - 2038
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	275
U.S. Federal \| Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
State
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	264
State \| 2019 - 2023
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	63
State \| 2024 - 2028
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	46
State \| 2029 - 2033
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	90
State \| 2034 - 2038
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	3
State \| Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	$ 62

Income Taxes - Unrecognized Tax Benefits (Details 8) - USD ($) $ in Millions	12 Months Ended
	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Beginning unrecognized tax benefits	$ 327	$ 304	$ 351
Increases due to the Inotera Acquisition	0	54	0
Increases related to tax positions taken in current year	68	15	5
Foreign currency translation increases to tax positions	0	2	0
Settlements with tax authorities	(8)	(47)	(47)
Expiration of statute of limitations	0	(1)	(5)
Decreases related to tax positions from prior years	(126)	0	0
Ending unrecognized tax benefits	261	327	$ 304
Unrecognized tax benefits that affect our effective tax rate	$ 256
Inotera
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Increases due to the Inotera Acquisition		$ 54

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended								12 Months Ended
	Aug. 30, 2018	May 31, 2018	Mar. 01, 2018	Nov. 30, 2017	Aug. 31, 2017	Jun. 01, 2017	Mar. 02, 2017	Dec. 01, 2016	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Earnings Per Share Reconciliation [Abstract]
Net income (loss) attributable to Micron	$ 4,325	$ 3,823	$ 3,309	$ 2,678	$ 2,368	$ 1,647	$ 894	$ 180	$ 14,135	$ 5,089	$ (276)
Net income (loss) attributable to Micron shareholders – Diluted									$ 14,135	$ 5,089	$ (276)
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]
Weighted-average common shares outstanding - Basic (in shares)									1,152	1,089	1,036
Dilutive effect of equity plans and convertible notes (in shares)									77	65	0
Weighted-average common shares outstanding - Diluted (in shares)									1,229	1,154	1,036
Earnings Per Share, Basic [Abstract]
Basic (in dollars per share)	$ 3.73	$ 3.30	$ 2.86	$ 2.36	$ 2.13	$ 1.49	$ 0.81	$ 0.17	$ 12.27	$ 4.67	$ (0.27)
Earnings Per Share, Diluted [Abstract]
Diluted (in dollars per share)	$ 3.56	$ 3.10	$ 2.67	$ 2.19	$ 1.99	$ 1.40	$ 0.77	$ 0.16	$ 11.51	$ 4.41	$ (0.27)

Earnings Per Share - Potential Common Shares Excluded in the Computation of Diluted Earnings Per Share Because They Would Have Been Antidilutive (Details) - shares shares in Millions	12 Months Ended
	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Equity plans
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive potential common shares that could dilute basic earnings per share in the future (in shares)	3	21	60
Convertible notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive potential common shares that could dilute basic earnings per share in the future (in shares)	0	26	119

Segment Information (Details) $ in Millions	3 Months Ended								12 Months Ended
Segment Information (Details) $ in Millions	Aug. 30, 2018 USD ($)	May 31, 2018 USD ($)	Mar. 01, 2018 USD ($)	Nov. 30, 2017 USD ($)	Aug. 31, 2017 USD ($)	Jun. 01, 2017 USD ($)	Mar. 02, 2017 USD ($)	Dec. 01, 2016 USD ($)	Aug. 30, 2018 USD ($) segment	Aug. 31, 2017 USD ($)	Sep. 01, 2016 USD ($)
Reportable Segments
Number of reportable segments \| segment									4
Segment Reporting Information, Additional Information [Abstract]
Goodwill	$ 1,228				$ 1,228				$ 1,228	$ 1,228
Net sales
Net sales	8,440	$ 7,797	$ 7,351	$ 6,803	6,138	$ 5,566	$ 4,648	$ 3,970	30,391	20,322	$ 12,399
Operating income (loss)
Stock-based compensation									(198)	(215)	(191)
Restructure and asset impairments									(28)	(18)	(67)
Other									57	(1)	(61)
Operating income (loss)	4,377	$ 3,953	$ 3,567	$ 3,097	2,502	$ 1,963	$ 1,044	$ 359	14,994	5,868	168
Depreciation and amortization
Depreciation and amortization expense by segment									4,759	3,861	2,980
CNBU
Segment Reporting Information, Additional Information [Abstract]
Goodwill	832				832				832	832
Net sales
Net sales									15,252	8,624	4,529
MBU
Segment Reporting Information, Additional Information [Abstract]
Goodwill	198				198				198	198
Net sales
Net sales									6,579	4,424	2,569
SBU
Segment Reporting Information, Additional Information [Abstract]
Goodwill	101				101				101	101
Net sales
Net sales									5,022	4,514	3,262
EBU
Segment Reporting Information, Additional Information [Abstract]
Goodwill	$ 97				$ 97				97	97
Net sales
Net sales									3,479	2,695	1,939
All Other
Net sales
Net sales									59	65	100
Operating Segments
Operating income (loss)
Operating income (loss)									15,243	6,232	450
Operating Segments \| CNBU
Operating income (loss)
Operating income (loss)									9,773	3,755	(25)
Depreciation and amortization
Depreciation and amortization expense by segment									1,755	1,344	1,141
Operating Segments \| MBU
Operating income (loss)
Operating income (loss)									3,033	927	97
Depreciation and amortization
Depreciation and amortization expense by segment									1,077	926	580
Operating Segments \| SBU
Operating income (loss)
Operating income (loss)									964	552	(123)
Depreciation and amortization
Depreciation and amortization expense by segment									1,295	1,083	844
Operating Segments \| EBU
Operating income (loss)
Operating income (loss)									1,473	975	473
Depreciation and amortization
Depreciation and amortization expense by segment									603	484	379
Operating Segments \| All Other
Operating income (loss)
Operating income (loss)									0	23	28
Depreciation and amortization
Depreciation and amortization expense by segment									18	13	20
Unallocated
Operating income (loss)
Stock-based compensation									(198)	(215)	(191)
Restructure and asset impairments									(28)	(18)	(67)
Flow-through of Inotera inventory step up									0	(107)	0
Other									(23)	(24)	(24)
Operating income (loss)									(249)	(364)	(282)
Depreciation and amortization
Depreciation and amortization expense by segment									$ 11	$ 11	$ 16

Product Sales (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
Product Sales (Details) - USD ($) $ in Millions	Aug. 30, 2018	May 31, 2018	Mar. 01, 2018	Nov. 30, 2017	Aug. 31, 2017	Jun. 01, 2017	Mar. 02, 2017	Dec. 01, 2016	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Revenue from External Customer [Line Items]
Net sales	$ 8,440	$ 7,797	$ 7,351	$ 6,803	$ 6,138	$ 5,566	$ 4,648	$ 3,970	$ 30,391	$ 20,322	$ 12,399
DRAM
Revenue from External Customer [Line Items]
Net sales									21,232	12,963	7,207
Trade NAND
Revenue from External Customer [Line Items]
Net sales									7,843	6,228	4,138
Non-Trade
Revenue from External Customer [Line Items]
Net sales									554	553	501
Other
Revenue from External Customer [Line Items]
Net sales									$ 762	$ 578	$ 553

Certain Concentrations (Details) - Net Sales	12 Months Ended
Certain Concentrations (Details) - Net Sales	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Product Concentration Risk \| Compute and graphics
Concentration Risk [Line Items]
Concentration risk, percentage of net sales (in hundredths)	25.00%	20.00%	20.00%
Product Concentration Risk \| Server
Concentration Risk [Line Items]
Concentration risk, percentage of net sales (in hundredths)	25.00%	15.00%	10.00%
Product Concentration Risk \| Mobile
Concentration Risk [Line Items]
Concentration risk, percentage of net sales (in hundredths)	20.00%	20.00%	20.00%
Product Concentration Risk \| SSDs and other storage
Concentration Risk [Line Items]
Concentration risk, percentage of net sales (in hundredths)	15.00%	20.00%	20.00%
Product Concentration Risk \| Automotive, industrial, medical, and other embedded
Concentration Risk [Line Items]
Concentration risk, percentage of net sales (in hundredths)	10.00%	15.00%	15.00%
Customer Concentration Risk \| Kingston
Concentration Risk [Line Items]
Concentration risk, percentage of net sales (in hundredths)	10.00%	10.00%
Customer Concentration Risk \| Intel
Concentration Risk [Line Items]
Concentration risk, percentage of net sales (in hundredths)			14.00%

Geographic Information (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
Geographic Information (Details) - USD ($) $ in Millions	Aug. 30, 2018	May 31, 2018	Mar. 01, 2018	Nov. 30, 2017	Aug. 31, 2017	Jun. 01, 2017	Mar. 02, 2017	Dec. 01, 2016	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Geographic Areas, Revenues from External Customers [Abstract]
Net sales	$ 8,440	$ 7,797	$ 7,351	$ 6,803	$ 6,138	$ 5,566	$ 4,648	$ 3,970	$ 30,391	$ 20,322	$ 12,399
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	23,672				19,431				23,672	19,431
China
Geographic Areas, Revenues from External Customers [Abstract]
Net sales									17,357	10,388	5,301
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	398				453				398	453
United States
Geographic Areas, Revenues from External Customers [Abstract]
Net sales									3,624	2,763	1,925
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	5,113				4,253				5,113	4,253
Taiwan
Geographic Areas, Revenues from External Customers [Abstract]
Net sales									2,798	2,544	1,521
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	7,640				6,519				7,640	6,519
Other Asia Pacific
Geographic Areas, Revenues from External Customers [Abstract]
Net sales									2,559	1,808	1,610
Singapore
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	6,933				5,261				6,933	5,261
Europe
Geographic Areas, Revenues from External Customers [Abstract]
Net sales									2,128	1,360	937
Japan
Geographic Areas, Revenues from External Customers [Abstract]
Net sales									1,254	1,025	831
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	3,451				2,827				3,451	2,827
Other
Geographic Areas, Revenues from External Customers [Abstract]
Net sales									671	434	$ 274
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	$ 137				$ 118				$ 137	$ 118

Quarterly Financial Information (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Aug. 30, 2018	May 31, 2018	Mar. 01, 2018	Nov. 30, 2017	Aug. 31, 2017	Jun. 01, 2017	Mar. 02, 2017	Dec. 01, 2016	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Quarterly Financial Information Disclosure [Abstract]
Net sales	$ 8,440	$ 7,797	$ 7,351	$ 6,803	$ 6,138	$ 5,566	$ 4,648	$ 3,970	$ 30,391	$ 20,322	$ 12,399
Gross margin	5,151	4,723	4,270	3,747	3,112	2,609	1,704	1,011	17,891	8,436	2,505
Operating income	4,377	3,953	3,567	3,097	2,502	1,963	1,044	359	14,994	5,868	168
Net income	4,326	3,823	3,311	2,678	2,369	1,647	894	180	14,138	5,090	(275)
Net income attributable to Micron	$ 4,325	$ 3,823	$ 3,309	$ 2,678	$ 2,368	$ 1,647	$ 894	$ 180	$ 14,135	$ 5,089	$ (276)
Earnings per share
Basic (in dollars per share)	$ 3.73	$ 3.30	$ 2.86	$ 2.36	$ 2.13	$ 1.49	$ 0.81	$ 0.17	$ 12.27	$ 4.67	$ (0.27)
Diluted (in dollars per share)	$ 3.56	$ 3.10	$ 2.67	$ 2.19	$ 1.99	$ 1.40	$ 0.77	$ 0.16	$ 11.51	$ 4.41	$ (0.27)

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686